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Abstract 
The preimplantation period of development represents the highest interval of embryonic 
loss throughout pregnancy.  It is therefore imperative that we elucidate the mechanisms 
involved in regulating preimplantation embryonic responses to stress and that govern 
development.  The MAPK pathways are involved in both responding to environmental 
stress and regulation of development throughout embryogenesis, and are therefore good 
candidates to study the mechanisms involved in preimplantation embryonic adaptation to 
stress and development. The preimplantation embryo culminates in the development of a 
fluid filled structure called the blastocyst.  It is at this stage the first differentiation events 
occur and the trophectoderm (TE), which will go on to form the embryonic portion of the 
placenta, develops.  The p38 MAPK is required for embryo development to proceed 
beyond the 8-16 cell stage as well to play an adaptive role in regulating embryonic 
response to culture stress.  My hypothesis is that the MAPK pathways regulate expression 
of TE associated proteins and apoptosis in response to culture stress and may regulate 
expression of TE associated proteins by affecting SNAI1 and SNAI2 expression or 
localization during blastocyst formation. I have shown that p38 MAPK regulates Aqp3 
and Aqp9 expression in response to hyperosmotic stress in the blastocyst.  I have also 
demonstrated that p38 MAPK is required for blastocyst expansion and hatching and 
regulates tight junction permeability and TJP1 localization during blastocyst formation.  
The p38 MAPK pathway also affects Aqp3 mRNA expression and protein detection. The 
p38 MAPK does not regulate apoptosis, however, the JNK/SAPK pathway does.  I have 
demonstrated that two transcription factors, Snai1 and Snai2, which are downstream 
targets of the p38 MAPK pathway, are present throughout preimplantation development. 
In other cell types, SNAI1 and SNAI2 regulate many genes involved in blastocyst 
formation.  I have shown that in the preimplantation embryo, SNAI1 and SNAI2 have a 
unique asymmetric distribution pattern from the 2-cell to 8-cell stage, and are then 
segregated to the TE of the blastocyst.  These results suggest that SNAI1 and SNAI2 may 
be involved in TE differentiation or regulation.  Taken together, this data reveal the 
contributions of p38 MAPK to the regulation of preimplantation development.  
Key words: Blastocyst, Culture, Stress, Development, p38 MAPK, JNK/SAPK, 
AQP3, AQP9, Trophectoderm, SNAI1, SNAI2 
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1.1 Overview 
Preimplantation development is defined as the period extending from fertilization to 
attachment and implantation to the uterine wall, and is unique to mammals (Watson, 
1992; Watson et al., 1992; Watson et al., 1999; Watson & Barcroft, 2001; Yamanaka et 
al., 2006; Rossant, 2007; Bell et al., 2008).  During preimplantation development, the 
embryo undergoes several molecular and morphological events, including compaction, 
and blastocyst formation and cavitation, as a prelude to implantation. Compaction is 
characterized by the establishment of cell-cell junctions that foster a dramatic change in 
the appearance of the embryo from a small group of circular cells or blastomeres to a 
tightly grouped mass of blastomeres lacking individual cell outlines (Fleming et al., 1991; 
Fleming, et al., 2000; Ohsugi et al., 1996).  The blastocyst is a fluid filled structure 
composed of two distinct cell types, the undifferentiated and apolar inner cell mass (ICM) 
that will give rise to the embryo proper and the extraembryonic ectoderm, and the 
trophectoderm (TE), a polarized epithelium that will contribute to the embryonic portion 
of the placenta (Hansis et al., 2000; MacPhee et al., 2000; Pampfer, 2000; Sheth et al., 
2000; Fleming et al.,  2001; Leunda-Casi et al., 2001; Watson & Barcroft, 2001; Kidder, 
2002; Barcroft et al., 2003; Ghassemifar et al., 2003; Kim et al., 2004; Kunath et al., 
2004; Watson et al.,  2004; Niwa et al., 2005; Ralston & Rossant, 2005; Strumpf et al., 
2005; Nagy & Vintersten, 2006; Oda et al., 2006; Yamanaka et al., 2006; Rossant, 2007).   
The studies composing my thesis focus on defining the molecular and signaling events 
that control the developmental program that results in TE differentiation and 
subsequently, blastocyst formation.  As assisted reproductive technologies (ARTs) 
expose the preimplantation embryo to exogenous stress, my studies also investigate 
signaling events that contribute to the preimplantation embryo’s ability to adapt to an in 
vitro environment (Bell et al., 2008). The outcomes of my studies reveal new paradigms 
for understanding how critical gene families that are implicated in TE differentiation and 
blastocyst formation are regulated and also provide insights into how exposure to culture 
environments affects these developmental programs.  
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1.2 Assisted Reproduction 
ARTs seek to aid couples who may be suffering from subfertility/infertility. Elucidating 
how these technologies may be affecting embryonic health is imperative (Seamark & 
Robinson, 1995; Rizos et al., 2002; Gardner et al., 2005; Wells et al., 2005; Giritharan et 
al., 2007). In 2008 alone, over 61,000 births (>1%) in the United States were conceived 
through ART.  However over the past few years, research has demonstrated that singleton 
children born through ART have increased adverse outcomes compared to singleton 
babies born from naturally conceived pregnancies.  These adverse outcomes include 
preterm birth, low birth weight, or very low birth weight (reviewed in Kalra & Barnhart, 
2011;  Schieve et al., 2002; Bower & Hansen, 2005; Gardner et al.,  2005; Wells et al., 
2005)  
The majority of adverse ART outcomes are primarily due to the complications associated 
with multiple births (Kalra & Barnhart, 2011).  This is due to the common practice of 
transferring multiple embryos into the uterus to increase the opportunity for implantation 
and pregnancy with a 14x increase of twins and a 54x increase of triplets in ART 
pregnancies. This practice is related to our inability to judge embryonic developmental 
capacity before embryo transfer.  This inability is directly related to our relatively poor 
understanding of the critical mechanisms controlling preimplantation development and 
the impact of placing early embryos into foreign culture environments (Chambers et al., 
2007; Boulet et al., 2008).   
What is clear is that cultured embryos display significant changes in gene expression 
patterns, preimplantation embryo survival, implantation, fetal development, newborn 
health and susceptibility to disease in later life, compared to their in vivo counterparts 
(Lee et al., 2010). Although there is a relatively good understanding of the basic 
mechanisms controlling preimplantation development, little is known about the 
relationship between environmental cues and internal signaling events that may be 
directing and regulating early development.  
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1.3 Preimplantation Development 
1.3.1 Preimplantation Development 
Preimplantation development, also known as the “free-living” phase of development, 
begins with fertilization of the mammalian oocyte and concludes with implantation of the 
embryo into the uterine wall (Figure 1.1) (reviewed in Bell et al., 2008; Watson et al., 
2004).  It is characterized by several molecular and morphological events required for 
normal implantation and maintenance of pregnancy.  It begins with fertilization of a 
competent ovulated oocyte, which is fertilized in the oviduct/fallopian tube, resulting in a 
one-cell zygote (Figure 1.1a)(Gosden, 2002; Sirard et al., 2006; Thelie et al., 2007).   
As the preimplantation embryo travels down the oviduct/fallopian tube toward the uterus, 
it undergoes a series of cell divisions resulting in a 2-cell (Figure 1.1b), 4-cell (Figure 
1.1c), and 8-cell (Figure 1.1d) embryo.  At the 8-16 cell stage, the cells, or blastomeres, 
acquire positional significance, resulting in inside cells surrounded by an outside cell 
layer. Compaction, the first morphological event, begins, resulting in a morula (16-32 
cell) (Figure 1.1e) where individual blastomeres are no longer distinguishable. The 
embryo then expands into a fully formed blastocyst (64 cells) (Figure 1.1f) and is now 
located in the uterus.  The blastocyst is comprised of blastomeres that are differentiated 
into the TE (Figure 1.1f) or that remain undifferentiated within the ICM (Figure 1.1f).  
Correct formation of the blastocyst is critical for successful implantation, maintenance of 
pregnancy and fetal development (reviewed in Gandolfi & Gandolfi, 2001; Sirard et al., 
2006; Bell et al., 2008). 
In addition to the morphological events characteristic of preimplantation development, 
there are also several molecular events required for normal blastocyst formation and 
implantation.  Prior to fertilization, the oocyte produces and stores mRNA and proteins 
required for the first embryonic cleavage division post fertilization (reviewed in Bell et 
al., 2008).  Transcription and storage of maternal mRNA occurs during follicular growth 
but ceases as the germinal vesicle undergoes breakdown during meiosis (Brevini-
Gandolfi et al., 1999; Gandolfi & Gandolfi, 2001; Fair et al., 2004; Bell et al., 2008).  The 
embryo is dependent on stored maternal mRNA until at least the maternal-embryonic 
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transition (MET) when transcription of the embryonic genome begins with significant 
initial output at the 2-cell stage in mice (Flach et al., 1982; Brevini-Gandolfi et al., 1999; 
Gosden, 2002; Schultz, 2002; Bell et al., 2008).  The embryo is now partially sustained 
by its own genome, along with maternal transcripts that persist and are required for 
subsequent cellular cleavages (Figure 1.2) (Alizadeh et al, 2005; Calder et al., 2008). 
As the embryo travels through the oviduct towards the uterus, it undergoes a series of cell 
cleavages resulting in a 4-cell embryo and then an 8-cell embryo.  Compaction is 
generally initiated at the 8-cell stage in the mouse and is characterized by increased 
intercellular contact between individual blastomeres. Each blastomere begins to assemble 
adherens junctions (AJ) and tight junction (TJ) proteins, resulting in the formation of the 
necessary cell-cell contacts that regulate blastocyst formation (Figure 1.1) (Fleming et al., 
1989). This process is coincident with another significant output of transcriptional 
activity, the mid-preimplantation gene activation (MGA), and together with compaction, 
is required for successful TE differentiation and blastocyst formation (Hamatani et al., 
2004)(Figure 1.2). The 16-cell compacted embryo is the first embryonic stage to consist 
of both ‘inside’ cells surrounded by an ‘outside’ cell layer.  The outer cells begin 
polarizing and develop both an apical and basolateral membrane.  The inner cells 
continue to propagate inner daughter cells, while the outer cells can divide both 
symmetrically and asymmetrically producing either two ‘outer’ daughter cells, or an 
‘outer’ and ‘inner’ daughter cell respectively (Figure 1.1).     
As compaction progresses, tight junctions form cell-cell contacts generating a permeable 
seal around the outer cells of the embryo, allowing the embryo to accumulate water 
within a nascent blastocyst cavity (Kim et al., 2004; Watson et al., 2004; Wang et al., 
2008). The blastocyst cavity enables the embryo to expand into a fully formed blastocyst. 
It is during blastocyst formation where the first differentiation events are completed, 
resulting in the appearance of the outer epithelial TE (Watson et al., 2004).   
The blastocyst is now composed of two distinct cell types: undifferentiated cells known 
as the (ICM) and a trophectoderm layer composed of extraembryonic trophoblast cells. 
The ICM will later form the embryo proper (Fig 1.1.f).  The TE is the first epithelium to 
differentiate throughout development and is required for blastocyst formation, embryo-
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uterine interactions and is necessary for proper implantation into the uterine wall. It also 
forms the embryonic portion of the placenta (reviewed in Yamanaka et al., 2006; Bell et 
al., 2008).  
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Figure 1.1 Mouse Preimplantation Development 
As the embryo divides, the blastomeres go through symmetrical or asymmetrical cellular 
divisions resulting in embryos that can have anywhere between 1-8 cells prior to 
compaction.   These are representative images of some of those cleavage stages.  The 
oocyte is fertilized in the oviduct resulting in a 1-cell zygote (A) which then undergoes a 
series of cellular divisions.  (B) 2-cell stage, (C) 4-cell stage (D) 8-cell stage.  It is at this 
stage that compaction is generally initiated.  Cellular division continues resulting in a 
morula (E) where outer cells surrounding the inner cells begin polarization and TE 
differentiation.  It is also at this stage of development where the embryo would transit 
from the oviduct to the uterus.  Cellular division progresses and a fluid filled cavity is 
formed resulting in an expanded blastocyst (F) with a fully differentiated TE surrounding 
undifferentiated cells within the ICM. Scale bar = 10 microns. 
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Figure 1.2 Characterization of Global Gene Expression Patterns During 
Preimplantation Development. 
The majority of maternal products (90%) that are required during oogenesis are degraded by the 
2-cell stage, while the remaining maternally stored mRNAs and proteins are required for 
preimplantation development. There are two main waves of embryonic gene activation during 
preimplantation development corresponding with the maternal-embryonic transition (MET) and a 
second mid-preimplantation development that contributes to events associated with TE 
differentiation and blastocyst formation (Hamatani et al., 2004). General gene expression patterns 
are indicated; loss of maternal mRNAs (red); activation of embryonic genome at the 2-cell stage 
(green) and 8-cell stage (blue). Examples of genes expressed in each category are also indicated 
(Adapted from Bell et al., 2008). 
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1.3.2 Models of Cell Fate Determination 
Two models describing how the TE and ICM are established during preimplantation 
development have been proposed (Yamanaka et al., 2006).  The Inside-Outside model 
predicts cell fate decisions in the early embryo are determined initially by cell-to-cell 
interactions so that outer cells, that have free, unopposed surfaces, begin to polarize, 
while inner cells, those that are enclosed by other cells on all surfaces, do not.  This 
model predicts that cell fate is determined by the late morula stage, when ‘inside’ and 
‘outside’ cells are fully established (Figure 1.3A). Alternatively, the Cell Polarity model 
predicts that cell fate is determined at the 8-cell stage and occurs via the establishment of 
an apical-basal polarity axis in each outer blastomere (Figure 1.3B).  When blastomeres 
undergo symmetric divisions, each daughter blastomere inherits equal components of the 
mother blastomere and both resulting daughter blastomeres will contribute to the TE.  
When the outer blastomeres undergo asymmetric division, each daughter blastomere 
inherits a different portion of the polarized cell resulting in the production of a polarized 
outer blastomere and an apolar inner blastomere (Figure 1.3B). These two models are in 
some ways complimentary; however, the Inside-Outside model predicts that it is cell 
position that determines cell fate, while the Cell Polarity model predicts that it is cell fate 
that determines cellular position (reviewed in Yamanaka et al., 2006). 
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Figure 1.3 Models of Cell Fate Determination 
A) The Inside/Outside model predicts location of the cell dictates cell fate. 
B) The Cell Polarity model predicts that molecular chemistry of a cell will dictate 
cell fate. A polarized outer cell can divide either symmetrically to produce two polarized 
daughter cells, which will contribute to the TE or a polarized outer cell could divide 
asymmetrically and produce a polarized daughter cell, which will contribute to the TE 
and an apolar daughter cell, which will contribute to the ICM.   Adapted from Yamanaka 
et al., 2006. 
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1.3.3 Embryonic and TE Lineage Segregation 
TE differentiation begins at the 8-cell stage, prior to cavitation, and occurs in cells that 
maintain the expression of the zinc-fingered transcription factor caudal type homeobox 2 
(Cdx2).  Cdx2 is first expressed in all cells at the 8-cell stage but is segregated to the outer 
cells as the blastocyst develops (Strumpf et al., 2005).  Gene deletion studies of Cdx2 
revealed the importance of CDX2 to TE differentiation and maintenance (Strumpf et al., 
2005).  Cdx2-/- embryos cavitate and form an early blastocyst. However, the cavity 
quickly collapses and the TE is not fully functional (Strumpf et al., 2005).  Attempts at 
deriving trophectoderm stem (TS) cell colonies from Cdx2 -/- embryos have been 
unsuccessful, further demonstrating the importance of CDX2 to TE differentiation 
(Strumpf et al., 2005).  Cdx2-/- embryos also ectopically express embryonic lineage 
specific markers in TE cells (Strumpf et al., 2005).  Taken together, these studies 
demonstrate that CDX2 is a critical marker of TE specification and can be used to 
determine changes to TE differentiation in the blastocyst.   
Recently, it was discovered that the transcription factor TEA domain family member 4 
(TEAD4) also regulates TE formation and may regulate CDX2 expression in the 
preimplantation embryo (Yagi et al., 2007).  Tead4-/- mice display a preimplantation 
lethality and do not express CDX2.  These embryos cannot form the TE and do not 
produce a blastocyst cavity.  They do express the undifferentiated cell marker POU class 
5 homeobox 1(POU5F1, previously known as OCT4), and embryonic stem (ES) cells can 
be successfully derived from Tead4-/- mice (Nishioka et al., 2007; Yagi et al., 2007).   
TEAD4 expression is thus critical for TE formation and differentiation (Nishioka et al., 
2007).  POU5F1 is another TF expressed at the 8-cell stage but in contrast to CDX2 
expression, POU5F1 becomes segregated to the ICM in mouse blastocysts (Palmieri et 
al., 1994; Niwa et al., 2005). Pou5f1-/- embryos are not able to form TE; however, upon 
the addition of a POU5F1 target, Fibroblast Growth Factor 4 (FGF), TE precursors can be 
re-established in the Pou5f1-/- mouse embryo (Nichols et al., 1998). POU5F1 and CDX2 
are not expressed in the same cells and can be used to identify an inner mass cell versus a 
trophoblast cell respectively (Nichols et al., 1998; Takahashi et al., 2007; Park et al., 
2008).   
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1.3.4 Adherens Junctions and Preimplantation Development 
Trophectoderm differentiation is required for blastocyst formation and is dependent on 
the interaction of several molecules, such as AJs, TJs, aquaporins (AQP), the Na/K-
ATPase and several TFs, such as CDX2 and TEAD4. Research in our lab has uncovered 
the roles of some of these molecules in TE differentiation and maintenance and has 
contributed to the development of a model of TE differentiation (Figure 1.4).   Successful 
expression and localization of AJs is critical to the proper formation of a cavitated 
blastocyst (Watson et al., 2004). AJs form the intercellular connections required to 
establish and maintain a mature epithelium by physically connecting adjacent cells to one 
another (Figure 1.4) (Aberle et al., 1996; Baum & Georgiou, 2011).  Additionally, AJs 
form at the boundary of an apical-basolateral axis and are required for polarization of an 
epithelium (Baum & Georgiou, 2011). AJs are composed of several molecules that 
respond to mechanical and environmental stimuli while maintaining proper cell-cell 
contacts (Baum & Georgiou, 2011). The structure of the AJ consists of a transmembrane 
protein called cadherin-1 (CDH1; previously known as E-cadherin or Uvomorulin), 
which has both an extracellular and cytoplasmic domain.  The extracellular domains of 
CDH1 interact with neighboring CDH1 molecules in a calcium dependent manner to 
form a ‘zipper’ like structure.  This interaction is necessary throughout development by 
contributing to the formation of epithelial sheets and structures (reviewed in Baum & 
Georgiou, 2011).  Furthermore, correct AJ interaction is required to maintain epithelial 
cell integrity by preventing epithelial-to-mesenchymal-transitions (EMT) which can lead 
to malignancies and cancer (Shih et al., 2002; Peinado et al., 2004).  The cytoplasmic 
domain of CDH1 interacts with β-catenin, which in turn binds α-catenin, which anchors 
the AJs to the actin cytoskeleton and other actin associated proteins such as actinin, 
vinculin, formin-1, and zona occludin 1(also known as tight junction protein 1 or TJP1) 
(reviewed in Baum and Georgiou, 2011; Patel et al., 2003; Thie et al., 1995; Koch et al.,  
2004). The cadherin-catenin complex mediates several signaling events, including WNT 
signaling through the translocation of the β-catenin complex to the nucleus (Gooding et 
al., 2004; Gottardi & Gumbiner, 2001).  The β-catenin complex is also responsible for AJ 
recycling, which must turnover frequently to allow cells to respond quickly to changes in 
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cell density or proliferation.  Mature AJs must first be established before TJ complexes 
are formed (Gooding et al., 2004; Gottardi & Gumbiner, 2001). 
Components of AJs are detectable throughout preimplantation development from the 1-
cell zygote stage to the blastocyst stage and in both TE and ICM. However, it is not until 
the embryo has reached the late 8-cell stage that AJs are fully assembled into functional 
AJs at opposing cell borders (Figure 1.1) (Peyrieras et al., 1983; Reima, 1990; Ao & 
Erickson, 1992; Clayton et al., 1993; Larue et al,. 1994; Campbell et al., 1995; Collins & 
Fleming, 1995; Riethmacher et al., 1995; Ohsugi et al., 1996; Pey et al., 1998; Kanzler et 
al., 2003; Nganvongpanit et al., 2006). Across several species, CDH1 itself is required for 
compaction and maintenance of the blastocyst cavity, as demonstrated in both deletion 
and depletion studies (Peyrieras et al., 1983; Ao & Erickson, 1992; Larue, et al., 1994; 
Pey et al., 1998; Nganvongpanit et al., 2006).   
Larue et al, 1994 produced Cdh1-/- mouse embryos and demonstrated that Cdh1 -/- mice 
failed to maintain a normal blastocyst cavity and succumbed prior to implantation (Larue 
et al., 1994). Cdh1-/- embryos undergo compaction coincident with, and at the same rate 
as, normal and Cdh1+/- embryos.  Cdh1-/- embryos do not arrest at compaction due to 
maternally contributed CDH1, which is detectable as late as 4.5 days post coitus, or the 
equivalent to the blastocyst stage (Larue et al., 1994). As normal and Cdh1+/- embryos 
become blastocysts and begin to hatch, the Cdh1-/- embryos remain in the zona pellucida, 
and do not hatch from the zona pellucida. If the zona pellucida is removed, Cdh1 -/- 
embryos will undergo compaction, however, they are much less adhesive to one another 
and a less tightly packed morula forms (Larue et al., 1994).   
The role of CDH1 in preimplantation development was also characterized by using 
dsRNA in the mouse embryo and by RNAi in the bovine embryo, resulting in similar 
phenotypes as the mouse CDH1 null model (Wianny & Zernicka-Goetz, 2000; 
Nganvongpanit et al., 2006).  As previously discussed, AJs along with TJs form a seal 
along the apical outer membrane of the embryo, which allows the blastocyst to 
accumulate fluid and expand (Watson et al., 1992; Watson et al., 1999; Watson & 
Barcroft, 2001; Watson et al., 2004).  Taken together, these studies indicate that CDH1, 
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and more generally, AJ formation is critical for proper TE differentiation and polarization 
and absolutely required for blastocyst cavitation.   
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Figure 1.4 Model of the Trophectoderm  
The TE is a polarized epithelial cell type that has both an apical and basolateral 
membrane.  TJs are located between the cells forming a seal that prevents fluid from 
escaping out of the blastocyst cavity.  The TJs regulate the passage of solutes across the 
TE.  The Na/K-ATPase maintains the electrochemical gradient across the cell membrane 
by actively exchanging 3 Na+ molecules to the outside of the cell for 2 K+ molecules to 
the inside of the cell.  The AQPs allow the passage of water (H20) across the TE in the 
presence of a low osmotic gradient created between the blastocyst cavity and the 
extracellular solution.  These molecules fundamentally drive TE differentiation and thus 
blastocyst formation.  
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1.3.5 Tight Junctions and Preimplantation Development 
TJ establish the ‘seal’ surrounding the outer cells of the morula, which allows fluid to 
accumulate within the blastocyst cavity (Figure 1.4) (Watson et al., 2004). Apical-basal 
cell polarity is also established and maintained in epithelial cells by the correct formation 
and localization of TJs. The TJ complex includes numerous proteins such as the zona 
occluden proteins (TJP1, TJP2, TJP2), cingulin, claudins and occludin, that can provide 
either structure, adhesion or both properties to the TJ (Fleming et al., 1989; Fleming et 
al., 1993; Sheth et al., 1997; Sheth et al., 2000; Thomas et al., 2004; Moriwaki et al., 
2007).  TJs are localized to the apical most region of the basolateral cell surface (Figure 
1.3). TJs have two primary functions: 1) to promote and maintain cell-cell adhesion, and 
2) through interaction with the actin cytoskeleton, to provide an intracellular barricade 
defining and separating specialized apical and basolateral plasma membranes, known as 
the ‘fence function’ (reviewed in Niessen, 2007).  
TJ cell-cell adhesion enables the epithelium to act as a physical, protective barrier by 
preventing molecules from passing between intercellular spaces (reviewed in Niessen, 
2007). In preimplantation development, the importance of TJs is made clear as the 
embryo undergoes compaction and blastocyst expansion. TJs help to establish polarity in 
the developing TE and provide cell-cell adhesion points creating a barrier or ‘seal’ 
between the cells (Figure 1.4). This seal allows the compacted embryo to form the fluid 
filled blastocyst cavity, and to expand into the blastocyst (Gualtieri et al., 1992; Fleming 
et al., 2000; Kim et al., 2004).   
The importance of TJs in blastocyst development has been demonstrated by inhibiting 
normal TJ assembly at the 8-cell stage (Wang et al., 2008).  At the 8-cell stage, embryos 
have been treated with Tjp1 siRNA and Tjp1 expression has been depleted (Wang et al., 
2008). Tjp1 deficient embryos are unable to form blastocysts (Wang et al., 2008).  The 
barrier function of TJs has been tested by pharmacologically inhibiting two structural 
components of the TJ, claudin 4 and claudin 6 (Moriwaki et al., 2007). Treated embryos 
are able to compact. However, the blastomeres remained rounded and did not polarize, 
resulting in the embryos failing to form expanded blastocysts (Moriwaki et al., 2007).  
Furthermore, the TJ seal has also been challenged by placing inhibited embryos into 
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medium containing 4.4kDa FITC molecules (known as the FitC assay) which normally 
cannot move across the TJ seal.  Significant accumulation of 4.4 kDa FITC occurred in 
TJ inhibited embryos indicating that loss of claudin 4 and 6 is accompanied by increased 
TJ permeability (Moriwaki, et al., 2007).  These studies indicate that the TJs are an 
essential mediator of TE differentiation, polarization and permeability (Violette et al., 
2006; Madan et al., 2007). 
1.3.6 The Na/K-ATPAse and Preimplantation Development 
The Na/K-ATPase is also important for cavitation and blastocyst formation (Figure 1.4). 
Within the blastocyst, the Na/K-ATPase creates an ionic gradient across the TE by 
pumping out three Na+ for every two K+ molecules pumped into the cell which then 
promotes the movement of fluid into the blastocyst cavity (Figure 1.4) (Taniguchi et al., 
2001; Watson & Barcroft, 2001; Kidder, 2002; Watson et al., 2004).  Completion of 
every ionic transport cycle results in the consumption of a single ATP molecule (Baltz et 
al., 1997; Boldyrev, 2001; Jorgensen & Pedersen, 2001). 
The Na/K-ATPase is an oligomeric protein that maintains the osmotic gradient across the 
plasma membrane of virtually all eukaryotic cells, including the preimplantation embryo 
(Boldyrev, 1993; Boldyrev, 2001; Jorgensen & Pedersen, 2001; Taniguchi et al., 2001).  
It consists of two main subunits, α and β, which provide the enzymatic and structural 
properties to the Na/K-ATPase respectively (Boldyrev, 1993; Boldyrev, 2001; Jorgensen 
& Pedersen, 2001; Taniguchi et al., 2001) 
The α-subunit (ATP1A) is the catalytic subunit of the Na/K-ATPase that maintains the 
Na+ and K+ ion gradient found across all plasma membranes. There are three different 
isoforms of the α-subunit; ATP1A1, ATP1A2, and ATP1A3. ATP1A is properly folded 
and directed to its appropriate membrane domain by its interactions with the β-subunit 
(ATP1B) of the Na/K-ATPase (Ueno, et al., 1997). There are four β-subunits; ATP1B1, 
ATP1B2, ATP1B3, ATP1B4. Together, the ATP1A and the ATP1B form an electrogenic 
ion transporter that regulates the ionic gradient across the cell membrane. A third subunit, 
the γ subunit, is a small single transmembrane protein that increases the α-subunits 
affinity to ATP (Rivard et al., 2005). 
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In the preimplantation embryo, Atp1a1 is expressed from the 2-cell stage onward 
(Watson & Kidder, 1988; Watson et al., 1990). In the 1–cell embryo, maternal transcripts 
of Atp1b1 are abundantly present but rapidly decline until the 8-cell stage when 
embryonic gene expression is activated, and embryonic Atp1b1 is activated (Watson & 
Kidder, 1988; Watson et al., 1990).  At the protein level, ATP1B1, along with the 
ATP1A1, is localized to the cortical domains of each blastomere of the mouse and bovine 
preimplantation embryo from the late 8-cell stage onward (Watson et al., 1990; MacPhee 
et al., 2000).  While the Na/K-ATPase subunits are present throughout preimplantation 
development, the appearance of detectable levels of activity has been reported to occur 
just prior to compaction. Activity levels rise significantly in the late morula stage just 
prior to the onset of cavitation (Biggers, et al., 1977; Wiley, 1984; Houghton et al., 2003). 
The Na/K-ATPase becomes confined to the basolateral cell domain of the TE in 
conjunction with TJ formation and cavitation (Watson & Kidder, 1988). In the ICM, both 
subunits display an apolar distribution.   
The Na/K-ATPase polarized distribution in the TE is consistent with its role as a trans-
trophectodermal fluid regulator (Betts et al., 1998; Watson et al., 1999; Watson et al., 
2004).  Silencing of Atp1b1 expression by microinjection of siRNAs prevents blastocyst 
formation and causes improper localization of TJ proteins, TJP1 and occludin, instead of 
a cortical distribution pattern, these proteins are localized to the cytoplasm (Madan et al., 
2007). Atp1b1 depleted embryos also displayed abnormal ATP1A1 localization (Madan 
et al., 2007).  Similarly, Atp1a1-deficient embryos do not expand and form normal 
blastocysts. However, this occurs only upon culture in vitro (Barcroft et al., 2004).  The 
Na/K-ATPase can also act as a signaling molecule, transmitting extracellular signals 
across the plasma membrane to molecules in the cytoplasm. Na/K-ATPase signaling 
occurs via ATP1A1 and can be activated by various cardiotonic steroids, such as ouabain 
(Xie, 2001; Clausen, 2002; Espineda et al., 2004; Violette et al., 2006).  When stimulated 
with ouabain, the Na/K-ATPase signals via SRC family kinases (SFK), which in turn 
results in a loss of TJ cohesiveness and blastocyst cavity integrity (Violette et al., 2006; 
Giannatselis et al., 2011).  Taken together, these results demonstrate that the Na/K-
ATPase plays a role in regulating polarization of the TE and blastocyst formation, and 
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therefore proper expression and localization of the Na/K-ATPase is critical for normal 
blastocyst development.   
1.3.7 Aquaporins and Preimplantation Development 
Successful blastocyst expansion is dependent on the embryo’s ability to accumulate fluid 
within the blastocyst cavity.  Aqua-glycerol-porins (AQPs) are an essential part of this 
process since they provide the channels through which fluid can move across the TE 
(Figure 1.4).  The Na/K ATPase creates a small osmotic gradient across the TE. 
However, the gradient is not sufficient to induce rapid osmosis into the blastocyst cavity.  
AQPs therefore facilitate the movement of fluid across the TE in the presence of a weak 
osmotic gradient, thereby promoting rapid blastocyst expansion (Baltz et al., 1997; Gade 
& Robinson, 2006; Watson et al., 2004). AQPs are water channels representing a family 
with 13 known members that are expressed in many tissues of the body, including the 
preimplantation embryo (Barcroft et al., 2003; Offenberg & Thomsen, 2005; Agre, 2006; 
Hara-Chikuma & Verkman, 2008).  Of these, mRNAs encoding Aqp1, 3, 5, 6, 7, 8, and 9 
have been detected in the preimplantation embryo (Offenberg et al., 2000). At the protein 
levels, AQPs 3 and 8 are localized to the basolateral surfaces and AQP9 is present on the 
apical surfaces of the trophectoderm (Barcroft et al., 2003).  Together, AQP3, 8 and 9 
facilitate the movement of water, small solutes, glycerol and urea across the epithelial 
barrier and into the blastocoel cavity (Figure 1.4) ( Barcroft et al., 2003; Hara-Chikuma & 
Verkman, 2005; Gade & Robinson, 2006; Hara-Chikuma & Verkman, 2006; Y. Liu et 
al., 2007; Tait et al., 2008).   
During preimplantation embryo development, AQPs contribute to the embryo’s ability to 
respond to hyperosmotic stress.  Blastocysts placed in KSOMaa medium + 10% glycerol 
(1800 milliOsmolarity (mOsm)) initially collapse, but are able to recover their expanded 
shape within 3-5 minutes.  However, blastocysts placed into the same medium with a 
mercuric compound used to block AQP function have reduced ability to regain an 
expanded morphology.  This highlights the important role AQPs play in enabling the 
blastocysts to establish and maintain blastocyst expansion (Barcroft et al., 2003). AQPs 
move glycerol from the external environment to the internal blastocyst cavity reducing 
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the trans-trophectodermal glycerol concentration gradient.  Thus, the embryo is able to 
restore its normal expanded blastocyst morphology. 
AQPs are part of the cellular response to osmotic stress.  Aqp3 and Aqp9 expression are 
up-regulated in response to hyperosmotic stress as indicated in two separate cell lines 
(Sugiyama et al., 2001; Arima et al., 2003).  Osmotic stress up-regulated Aqp3 expression 
in human keratinocytes (Sugiyama et al., 2001).  Arima et al., (2003) used rat astrocytes 
as a model for studying hyperosmotic stress and found that after 6 hours, Aqp9 mRNAs 
were elevated.  Arima et al. (2003) determined that hyperosmotic stress increased p38 
MAPK activity. This indicates that p38 MAPK may be playing a role in Aqp regulation in 
response to hyperosmotic stress (Arima et al., 2003).  Taken together, these studies 
provide convincing evidence that Aqp expression is regulated by osmotic stress and is an 
important molecule to study in regards to preimplantation development.  
1.3.8 MAPK Regulation of Preimplantation Development 
1.3.8.1 Mitogen Activated Protein Kinase (MAPK) 
MAPKs are intracellular signaling pathways that translate extracellular stimuli into 
cellular responses (Cargnello & Roux,  2011; Aouadi. et al., 2006; Bradham. et al., 2006).  
They direct a wide variety of physiological processes through serine/threonine signaling.  
They are ubiquitously expressed in all eukaryotic cells and are involved in such processes 
as regulating gene expression, mitosis, metabolism, motility, survival, apoptosis and 
differentiation (reviewed in Cargnello & Roux, 2011).    MAPK are also present in the 
preimplantation embryo and have both a developmental and adaptive role by directing 
embryonic responses to environmental changes (Natale et al., 2004; Y. Wang et al., 2004; 
Fitzgerald et al., 2005; Madan et al., 2005; Paliga et al.,  2005; Fong et al., 2007; Hickson 
et al., 2007; Maekawa et al., 2007; Lu et al., 2008).  This is particularly important in the 
context of ART where embryos are cultured in vitro and potentially exposed to many 
extracellular signals not usually encountered in the reproductive tract.   
There are two main MAPK pathways, the conventional pathways and the atypical 
pathways (Cargnello & Roux, 2011). The conventional pathways consist of ERK1/2, 
JNK1/2/3 and p38 (α,β,γ,δ), and ERK5, and the atypical pathways consist of ERK3/4, 
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ERK7, and the Nemo-like kinases (Cargnello & Roux, 2011).   The conventional MAPK 
pathways have been characterized throughout preimplantation development and therefore 
my studies focus solely on elucidating the role of the conventional MAPK pathways and 
will therefore be referred to as MAPK. MAPKs are activated through a conserved three 
stage cascade of phosphorylating kinases; a MAPK, a MAPK kinase (MAPKK) and a 
MAPKK kinase (MAPKKK) (Figure 1.5) (Adapted from Bell et al., 2008).  MAPKKK 
are activated by extracellular stimuli through phosphorylation events occurring by 
interacting with small GTP-binding proteins of the Ras/Rho family.  MAPKKK 
subsequently phosphorylates MAPKK, which then phosphorylates MAPK which then 
orchestrates a cellular response (Figure 1.5) (Reviewed in Kyriakis & Avruch, 2001; 
Cargnello & Roux, 2011).  
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Figure 1.5 MAPK Signaling 
The three conventional MAPK pathways are expressed during preimplantation 
development.  They help mediate the embryonic response to environmental stimuli, 
including stress.  Each pathway can be inhibited using specific pharmacological 
inhibitors that act either directly upon the MAPK kinase (such as SB 220025, which acts 
upon p38 MAPK), or upstream mediators of the pathway (such as U0126, which inhibits 
MAPKK from activating ERK) (Reviewed in Cargnello & Roux, 2011; Duncia et al., 
1998; Jackson et al., 1998).   
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1.3.8.2 ERK MAPK and Preimplantation Development 
The mammalian ERK pathway was the first of the MAPK pathways to be characterized 
(Boulton et al., 1991; Cargnello & Roux, 2011).  There are two isoforms of ERK, ERK1 
and ERK2, which share approximately 83% amino acid identity.  They are expressed in 
all tissues, predominantly though in the brain, skeletal muscle, thymus and heart 
(Reviewed in Cargnello & Roux, 2011; Kyriakis & Avruch, 2001). ERK1/2 plays a 
critical role in cell proliferation, from controlling cell-cycle progression to the regulation 
of early response genes (Reviewed in Cargnello & Roux, 2011).  ERK1/2 can be 
activated by various stimuli including growth factors, G protein-coupled receptor 
activation, cytokines, osmotic stress and microtubule disorganization. ERK1/2 are 
localized cytoplasmically; however, upon stimulation, they primarily accumulate in the 
nucleus (Chen et al., 2005).  The ERK pathway can be inhibited using the 
pharmacological agents U0126 and PD98059 (Duncia et al., 1998; Jackson et al., 1998). 
These inhibitors target MAPKK, MEK1 and MEK2 which in turn phosphorylate ERK1/2 
when the pathway is stimulated.  The inhibitors’ mode of action is to interact with the un-
phophorylated species of MEK1 and MEK2, preventing future phosphorylation and thus 
inhibiting the propagation of the signaling cascade (Duncia et al., 1998).  
Although ERK1/2 are present throughout preimplantation development, the role that they 
play is still relatively unclear. The ERK pathway plays a role in implantation and 
trophoblast invasion into the uterine wall by the blastocyst (Reviewed in Fitzgerald et al., 
2005).  Inhibition of the ERK pathway does not prevent blastocyst formation, but it may 
play a role in TE differentiation (Jackson et al., 1998; Paliga et al., 2005; Lu et al., 2008).  
ERK is localized to the apical membrane of each blastomere at the 8-cell stage and 
inhibition of the ERK pathway causes a visible decrease in CDX2 detection, a TF 
required for TE differentiation and maintenance.  After ERK inhibition, blastocyst 
formation was delayed and trophoblast outgrowths were impaired (Lu et al., 2008).  
These results do indicate that the ERK pathway is present throughout preimplantation 
development and warrants further study.  
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1.3.8.3 JNK/SAPKs and Preimplantation Development 
There are three isoforms of JNK/SAPK, JNK1, JNK2, and JNK3 and they are 85% 
identical with each other.  JNK1 and JNK2 are expressed in various tissues, however 
JNK3 is abundantly expressed in testes, neuronal tissues and cardiac myocytes (reviewed 
in Cargnello & Roux, 2011).  The JNK pathway is activated by a number of different 
stresses, including UV radiation, cytokine treatment, heat shock and radiation (reviewed 
in Aouadi et al., 2006).  Activation of the JNK pathway has been studied through the use 
of pharmacological inhibitors such as SP600125 and AS601245 (Bogoyevitch et al., 
2010).   These inhibitors are ATP competitive blockers and have been widely used to 
study the JNK pathway (Bogoyevitch et al., 2010).    
JNK/SAPK is present and active in the preimplantation embryo, and does play a role in 
mediating development in in vivo derived blastocysts (Zhong et al., 2004; Xie et al., 
2006; Xie et al., 2007).  To investigate the effects of culture media on activation of the 
JNK/SAPK pathway, embryos were placed in either “optimized” media (Potassium 
Simplex Optimized Media with amino acids (KSOMaa)) or “poor” media (Ham’s F10) in 
the presence of a JNK/SAPK inhibitor.  It was reported that embryos cultured in 
“optimized” KSOMaa media in the presence of the JNK/SAPK inhibitor had reduced 
apoptosis at the blastocyst stage, and developed at a faster rate than the embryos cultured 
in KSOMaa media alone.  Embryos cultured in the “poor” Ham’s F10 media in the 
presence of the JNK/SAPK inhibitor developed poorly compared to embryos cultured in 
Ham’s F10 alone. This indicates that the JNK/SAPK pathway is required to help maintain 
homeostasis when embryos are cultured in suboptimal media, but not when embryos are 
cultured in optimized media.  The JNK/SAPK MAPK pathway therefore does not 
necessarily play a role during development but does mediate the responses of early 
embryos to environmental stress (Xie et al., 2006).  
1.3.8.4 P38 MAPKs and Preimplantation Development  
The p38 MAPK family consists of 4 isoforms, α (MAPK-14), β (MAPK-11), γ (MAPK-
12), δ (MAPK-13) where MAPK-14 and MAPK-11 isoforms are more ubiquitously 
expressed than the MAPK-12 and MAPK-13 isoforms (Reviewed in Cargnello & Roux, 
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2011).  The four different isoforms affect downstream targets involved in transcription, 
mRNA stability, or translation (Jiang et al., 1996; Sudo et al., 2005; Cargnello & Roux, 
2011). The p38 MAPK pathway is involved in the production of cytokines in response to 
inflammation, as well as in cell proliferation and cell survival (Reviewed in Cargnello & 
Roux, 2011). It is activated by stress from cytokines, osmotic stress, oxidative stress and 
various other environmental cues (Reviewed in Duzgun et al., 2000; Ono & Han, 2000; 
Kyriakis & Avruch, 2001; Arima et al., 2003; J. Liu et al., 2004; Natale, et al., 2004; 
Song et al., 2005; Aouadi et al., 2006; Bradham & McClay, 2006; Fong et al., 2007; 
Hickson et al., 2007; Hara-Chikuma & Verkman, 2008; Cargnello & Roux, 2011).  While 
the pathway is inactive, p38 isoforms are detected in both the cytoplasm and the nuclei. 
However, upon stimulation, these isoforms accumulate in the nuclei (Cargnello & Roux, 
2011).  
There are several inhibitors available that selectively target MAPK-14 and MAPK-11 
(Jackson et al., 1998). These inhibitors include SB 203580 and SB 202190 which are 
ATP-competitors; SB 220025, which binds to the enzymatic site of MAPK-14 and 
MAPK-11, as well as a fourth inhibiter, BIRB079, which indirectly competes with ATP 
binding (reviewed in Jackson et al., 1998; Cargnello & Roux, 2011).  Of these, SB 
220025 has been extensively utilized to elucidate the role of p38 MAPK throughout 
preimplantation development (Natale et al., 2004; Madan et al., 2005; Paliga et al.,  2005; 
Fong et al., 2007; Hickson et al., 2007). SB 220025 (5-(2-Amino-4-pyrimidinyl)-4-(4-
fluorophenyl)-1-(4-piperidinyl) imidazole) belongs to a group of compounds known as 
cytokine suppressive anti-inflamatory drugs (CSAIDs). CSAIDs are ATP-competitors 
that specifically bind to the ATP-active pocket of unphosphorylated or phosphorylated 
forms of p38 MAPK, preventing its ability to phosphorylate downstream targets, or to 
autophosphorylate (Frantz et al., 1998; Wang et al., 1998).  CSAIDs block the p38 
MAPK cascade, which results in decreased production of cytokines, such as TNF-α and 
IL-1β.  SB 220025 inhibits p38 phosphorylation of a downstream target, EGFR.  The IC50 
of SB 220025 was 50 nM using EGFR as a read-out. SB 220025 has a 1000-fold greater 
selectivity for p38 MAPK over ERK MAPK (Jackson et al., 1998). 
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SB 220025 has been used to study the role of p38 MAPK throughout cleavage stage 
development (Natale et al., 2004; Paliga et al., 2005).  Embryos were cultured from the 2-
cell stage in SB 220025 and allowed to develop normally. Treated embryos resulted in a 
reversible, developmental arrest at the 8-16 cell stage, compared to untreated embryos 
which formed blastocysts (Natale et al., 2004). Once the pharmacological inhibitors were 
removed, embryos resumed their developmental program and progressed normally to the 
blastocyst stage. Inhibition of the p38 MAPK pathway resulted in loss of phospho-HSP, 
which is required to stabilize filamentous actin (Natale et al., 2004; Paliga et al., 2005).  
Once the inhibitor was removed, phospho-HSP returned and filamentous actin was 
properly stabilized, resulting in the embryo being able to resume the proper 
developmental program (Natale et al., 2004; Paliga et al., 2005).  These results support 
the hypothesis that p38 MAPK activity is important for blastocyst development.   
Furthermore, p38 MAPK can phosphorylate CDX2 and act as a positive regulator during 
intestinal epithelial cell differentiation (Houde et al., 2001). However, the effect of p38 
MAPK on CDX2 expression in the TE has yet to be investigated. P38 MAPK may also 
play a role in the preimplantation embryo’s ability to respond to stress in the culture 
media.  When embryos are exposed to hyperosmotic stress for 15 minutes, the p38 
MAPK pathway is activated (Fong et al., 2007).  The MAPKAPK2, a downstream target 
of p38 MAPK and an appropriate indicator of p38 MAPK activity, is more highly 
phosphorylated in embryos exposed to hyperosmotic culture medium than embryos 
cultured in KSOMaa.  This elevation in phosphorylation is extinguished when the 
embryos are cultured under hyperosmotic conditions in the presence of SB 220025, 
confirming that p38 MAPK is activated in response to hyperosmotic stress (Fong et al., 
2007; Alizadeh et al., 2005; Bultman et al., 2006; Pennetier et al., 2006; Tang et al., 
2007; Thelie et al., 2007; Bettegowda et al., 2008; Hamatani et al., 2008; Vallee et al., 
2008; Yurttas et al., 2008). 
Additionally, p38 MAPK mediates phosphorylation of EZRIN, a molecule involved in 
apical microvilli length as well as polarization during embryonic compaction, in an 
oncogenic RAF-1-transfected mouse hepatic cell line (Lan et al., 2006).   Upon 
transfection of RAF-1 into the mouse hepatic cell line, EMT was demonstrated by 
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increased Snai1 and decreased Cdh1 expression.  As well, Ezrin was down-regulated and 
there was a loss of microvilli.  Inhibition of p38 MAPK using SB 203580, in RAF-1 
treated cells, restored the normal expression of Cdh1, Snai1, Ezrin and the number of 
microvilli (Lan et al., 2006). 
P38 MAPK is also involved in regulated Cdh1 expression during gastrulation (Zohn et 
al., 2006).  During gastrulation, p38 MAPK is required for Cdh1 down-regulation during 
mesoderm migration. However, this process is independent of SNAI1 regulation of Cdh1.  
Taken together, these results demonstrate some of the multiple ways that p38 MAPK 
signaling can regulate embryonic development and cellular responses to stimuli. 
1.3.9 Downstream Targets of p38 MAPK: Snai1 and Snai2 
The p38 MAPK pathway regulates downstream expression of several TFs, including 
Snai1 and Snai2.  SNAI1 and SNAI2 are two TFs involved in wound repair and in EMT 
(Cho et al., 2007; Dhasarathy et al.,  2007; Hotz et al., 2007).  Aberrant expression of 
Snai1 and Snai2 is linked to metastasis in epithelial cell lines (Batlle et al., 2000; Hotz et 
al., 2007; Moreno-Bueno et al., 2006).  SNAI1 and SNAI2 direct the loss of polarity in 
epithelial cells by down-regulating Cdh1, Tjp1 and Occludin expression, resulting in the 
loss of cell-cell contacts and EMT (Batlle et al., 2000; Bolos et al., 2003; Cano et al., 
2000; Ikenouchi et al.,  2003; Moreno-Bueno et al., 2006).  Once EMT has occurred, and 
a cell is no longer bound to surrounding cells, it can potentially proliferate and become a 
metastasizing cancerous cell. EMT is induced by several growth factors, including 
transforming growth factor beta (TGFβ) and fibroblast growth factor 4 (FGF4), which 
also regulate Snai1 and Snai2 expression (Hotz et al., 2007; Rukstalis & Habener, 2007; 
Yoshino et al., 2007).  
The p38 MAPK pathway is involved in mediating the response to stress in ovarian cancer 
cell lines (Cheng et al., 2010; Strippoli et al., 2010).  The p38 MAPK pathway regulates 
Cdh1 expression in response to EGF stimulation via SNAI1 but not SNAI2 in human 
ovarian cancer cells (Cheng et al., 2010). When ovarian cancer cells are stimulated using 
EGF in the presence of a p38 inhibitor (SB 203580) or p38 α siRNA, there is a decrease 
in expression of Snai1 and Cdh1 (Cheng et al., 2010).  The p38 MAPK pathway also 
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plays a role in EMT.  EMT is induced in human mesothelial cells by using TGF-β 
(Strippoli et al., 2010). Cells pre-treated with the p38 MAPK pharmacological inhibitor, 
SB 203580 prior to EMT induction results in decreased Snai1 expression which indicates 
a role for the p38 MAPK pathway in regulating Snai1 (Strippoli et al., 2010).   
SNAI1 and SNAI2 also regulate Atp1b1 expression in MDCK cells (Espineda et al., 
2004). As SNAI1 increases in MDCK cells, Atp1b1 expression decreased, indicating that 
it is down-regulated by SNAI1. Increased SNAI1 also results in down-regulated Cdh1 
expression and the loss of cell-cell contacts (Espineda et al., 2004). Conversely, increased 
SNAI2 promotes Atp1b1 expression by inhibiting Snai1 expression (Espineda et al., 
2004). Taken together these data indicate the p38 MAPK pathway may play a role in 
regulating blastocyst formation protein through the regulation of Snai1 and Snai2 TFs.   
1.3.10 Culture Effects on Preimplantation Development   
The goal of embryo culture is to produce viable embryos for implantation while 
minimizing the perturbation embryos might encounter during in vitro culture. The 
development of culture media has provided much insight into the susceptibility of the 
preimplantation embryo to perturbation to its environment.  Through the addition and 
elimination of materials in culture media, including serum, proteins, amino acids, as well 
as changes to the culture atmosphere, such as hypoxia, temperature, and pH, research has 
been able to elucidate the windows in which environmental perturbation cause permanent 
changes to the developmental potential of an embryo (Gardner 1992; Gardner et al., 
1993; Gardner et al., 1994).   
The first media component to be identified as contributing to aberrant embryo 
development was the addition of serum to embryo culture media (reviewed in Thompson 
et al., 2007).  Serum is routinely used in cell culture and initially, seemed to have 
beneficial effects to preimplantation embryo development (Reviewed in Thompson et al., 
2007; Walker et al., 1992). However, both sheep and cattle offspring from serum culture 
embryos displayed higher than normal birth weights resulting in the phenomenon known 
as Large Offspring Syndrome (reviewed in Thompson et al., 2007). Sheep produced with 
culture medium containing serum have, on average, 20% higher birth weights and 
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gestation length extended by two days (Walker et al., 1992). Other adverse health 
outcomes in these sheep included higher incidents of neonatal deaths and abnormalities in 
limb development (reviewed in Thompson et al., 2007; Walker et al., 1992).  In the 
mouse, embryos cultured in the presence of serum are born significantly smaller than 
their non-serum cultured counterparts and have increased fetal mortality (Reviewed in 
Bowman & McLaren, 1970; Arny et al., 1987; Khosla et al., 2001).   Observable 
consequences to embryos cultured in the presence of serum occur as early as the 
blastocyst stage with changes in morphology, such as reduced compaction, early embryo 
blastulation and greater cytoplasmic fragmentation, as well as changes in metabolism 
including blastocyst consumption of metabolites, serum lipoprotein accumulation in the 
cytoplasm of the blastomeres, higher rate of glycolysis, a lower level of glucose oxidation 
and increased mitochondrial degeneration  (Reviewed in Thompson et al., 2007; 
Thompson et al., 1991; Walker et al., 1992; Gardner et al., 1994; Rizos et al., 2002; 
Shamsuddin & Rodriguez-Martinez, 1994). Media that could support blastocyst 
development as successfully as serum-supplemented media were then developed and 
several factors for successful embryo development were uncovered (reviewed in 
Thompson et al., 2007; Gardner et al., 2008).  These included a beneficial role of adding 
amino acids and a deleterious role of ammonia, a waste by-product of amino acid 
metabolism (Gardner et al., 1994; Gardner et al., 1993; Lane and Gardner 1992).  
Exposure to ammonia during the cleavage stage of development results in developmental 
abnormalities as well as altered expression of the imprinted gene H19 (Reviewed in Lane 
and Gardner 2001; Thompson et al., 2007). Embryo development blocking at the two-cell 
stage was also an obstacle.  Embryos were able to be cultured from the two cell stage to 
the blastocyst stage, but were unable to be cultured directly from the one-cell stage as 
they would arrest at the two-cell stage. As media improved, the osmolarity was also 
reduced from approximately 300 mOsm to 265mOsm, and organic osmolytes such as 
glycine were added, and the 2-cell block was overcome (Baltz et al., 2010).   Optimizing 
culture media is still an ongoing process.   
Effects to blastocyst development and fetal weight are readily observable consequences 
to culture effects.  Recent studies however have revealed adverse effects in behavior and 
in long term health in cultured embryos as well (Ecker et al., 2004; Watkins et al., 2007). 
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These include raised systolic blood pressure in later adult life in both male and female 
mice and increased anxiety and decreased memory retention in mice derived from 
cultured embryos (Ecker et al., 2004). Consequences of embryo culture on epigenetic 
reprogramming have been proposed as a mechanism that accounts for these permanent 
and long-lasting health effects (reviewed in Khosla et al., 2001; Thompson et al., 2007).    
Epigenetic alterations linked to the addition of serum to culture medium include reduced 
expression of insulin-like growth factor-2-receptor, which is related to Large Offspring 
Syndrome (Powell et al., 2006; Young et al., 2001).  Additionally, human imprinting 
diseases, such as Beckwith-Wiedemann syndrome and Angelmann syndrome, are also 
more prevalent in children produced through ART (Reviewed in Thompson et al., 2007; 
Reviewed in Khosla et al., 2001).   
The culturing of embryos often produces more embryos than required for each round of 
ART.  These embryos are then frozen and stored in liquid nitrogen until they are required, 
at which point they are thawed.  This process exposes embryos to high levels of 
hyperosmotic cryoprotectant media consisting of glycerol and sucrose.  Sucrose acts to 
draw water out of the cells, while glycerol can pass through the cell membrane via the 
AQP, replacing water, and acting as a cryoprotectant against the cellular damages that 
freezing can cause (Leibo et al., 2011).   
Although these studies and technologies reveal some of the initial and long-lasting effects 
of the in vitro environment on embryo development and health, the mechanism of how 
environmental perturbations cause permanent changes have yet to be elucidated.  My 
studies focus on the MAPK pathways, signal transduction pathways that mediate 
embryonic responses to environmental changes, as an important aspect to understanding 
embryonic adaptability to environmental insults.   
1.4 Proposed Model of MAPK Regulation of TE Associated Proteins 
Understanding the molecular mechanism governing blastocyst development and response 
to culture stress is essential.  P38 MAPK has both a developmental role and an adaptive 
role throughout preimplantation development.  Understanding the role of the p38 MAPK 
pathway in the blastocyst will provide further insight into blastocyst formation and 
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adaptability.  I have proposed a model for the roles of MAPK pathways in mediating 
preimplantation development, blastocyst formation and embryonic response to culture 
stress (Figure 1.6).  In this model, the JNK/SAPK pathway regulates apoptosis following 
exposure to hyperosmotic medium during preimplantation development. The p38 MAPK 
pathway also contributes to the regulation of apoptosis, as well as regulating Aqp3 and 
Aqp9 expression.  Finally, the p38 MAPK pathway regulates blastocyst development by 
signaling through known targets, SNAI1 and potentially SNAI2, which in turn regulate 
CDH1, TJP1, OCCLUDIN and ATP1B1 (Figure 1.6). 
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Figure 1.6 Proposed Model of MAPK Regulation of TE Associated Proteins in 
Response to Stress and Development 
This model predicts that the p38 MAPK pathway and the JNK/SAPK pathway regulate 
apoptosis in response to stress.  It predicts that the p38 MAPK pathway also regulates 
Aqp3 and Aqp9 expression in response to stress but not during development.  It predicts 
that the p38 MAPK pathway contributes to blastocyst formation by regulating SNAI1 and 
SNAI2, which in turn regulate the Na+/K+-ATPase, which regulates TJs.  Green arrows 
indicate transcriptional regulation; Purple arrows indicate activation; Red bars indicate 
inhibition; Blue circles represent nuclei.     
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1.5 Objectives and Hypothesis 
My overall hypothesis is that the MAPK pathways regulate TE associated proteins and 
apoptosis in response to culture stress and may regulate other TE associated proteins by 
affecting SNAI1 and SNAI2 expression or localization during blastocyst formation.  
1.5.1 Chapter Two: “MAPK Regulation of Aquaporin (AQP) Expression and 
Embryonic Apoptosis Following Exposure to Hyperosmotic Conditions.” 
Rationale: Previous studies have demonstrated that AQP3 and 9 are present and 
functional in the preimplantation embryo (Barcroft et al., 2003).  Studies have also 
indicated that the p38 MAPK and JNK/SAPK pathways are present and that the p38 
MAPK pathway is activated in response to hyperosmotic stress in the preimplantation 
embryo (Wang et al., 2005; Xie et al., 2006; Xie et al., 2007; Fong et al., 2007).   
Hypothesis: The p38 MAPK and JNK/SAPK pathways regulate Aqp expression and 
apoptosis following exposure to hyperosmotic medium during preimplantation 
development.  
Objectives: Determine (1) the effects of culture medium hyperosmolarity on Aqp gene 
expression and apoptosis, and (2) the role of the MAPK and JNK/SAPK pathways on 
Aqp gene expression and apoptosis using pharmacological inhibitors. 
 
1.5.2 Chapter Three: P38 MAPK Regulates Cavitation and Tight Junction Function in 
the Mouse Blastocyst  
 
Rationale: The p38 MAPK pathway has both a developmental and adaptive role 
throughout preimplantation development.  The preimplantation embryo cannot progress 
beyond the 8-16 cell stage if the p38 MAPK pathway is blocked at the 8-cell stage 
(Natale et al., 2004; Paliga et al., 2005). However, the role of p38 MAPK regulation of 
blastocyst formation and TE maintenance has not been studied.   
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Hypothesis: The p38 MAPK pathway regulates blastocyst expansion, hatching and TE 
differentiation.    
 
Objective: Determine the effects of p38 MAPK inhibition on blastocyst cavitation and 
expansion, hatching frequency and apoptosis levels, TJ permeability, TJP1 localization 
and distribution, TE differentiation and polarization, and Aqp3 expression and AQP3 
localization.  
 
1.5.3 Chapter Four: SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell 
Stage and Become Segregated to the TE in the Mouse Blastocyst. 
Rationale: The p38 MAPK pathways regulate CDH1 and TJP1 in response to stress via 
SNAI1 (Grotegut et al., 2006; Lan et al., 2006).  Furthermore, SNAI1 and SNAI2 are 
involved in regulating the Na/K-ATPase, another blastocyst formation associated protein 
(Espineda et al., 2004). However, little is known about the regulation of Snai1I and Snai2 
during preimplantation development.  
 
Hypothesis: The p38 MAPK pathway regulates blastocyst development by signaling 
through known targets, SNAI1 and potentially SNAI2, which in turn regulate CDH1, 
TJP1, OCCLUDIN and ATP1B1.   
 
Objective: Characterize SNAI1 and SNAI2 expression and localization throughout 
preimplantation development.  
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CHAPTER TWO 
 
MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) 
PATHWAYS MEDIATE EMBRYONIC RESPONSES TO 
CULTURE MEDIUM OSMOLARITY BY REGULATING 
AQUAPORIN 3 AND 9 EXPRESSION AND LOCALIZATION, 
AS WELL AS EMBRYONIC APOPTOSIS. 
 
 
 
A version of this chapter has been published: 
 
Bell, C.E., Lariviere, N.M, Watson, P.H, Watson, A.J. (2009). Mitogen Activated Protein 
Kinase (MAPK) Pathways mediate embryonic responses to culture medium osmolarity 
by regulating Aquaporin 3 and 9 expression and localization and embryo apoptosis. 
Human Reproduction. 24(6):1373-1386 
Reproduced here with permission from Human Reproduction and Oxford University 
Press 
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2.1 Introduction 
Understanding the interactions between the early embryo and its external environment is 
critical to developing optimal culture environments for the production of preimplantation 
embryos and also for understanding the developmental program that controls 
preimplantation development. Assisted reproductive technologies have long sought to 
mimic the environment of the reproductive tract to minimize the environmental stress on 
the preimplantation embryo when cultured in vitro (Diamond et al., 1991; Leese et al., 
1998; Kwong et al., 2000; Bogdarina et al., 2007). Our studies have revealed that up to 
seven members of the Aquaporin (AQP) gene family are expressed throughout 
preimplantation development (Offenberg et al., 2000) and that AQPs are likely to 
function in facilitating the trans-trophectoderm fluid movements that occur during 
cavitation which result in the formation of the fluid-filled cavity of the blastocyst 
(Barcroft et al., 2003). AQPs are water channels and represent a family with 13 known 
members that are expressed in many tissues including the kidneys, lungs and uterus 
(Hoffert et al., 2000; Offenberg et al., 2000; Barcroft et al., 2003; Agre, 2006; Hara-
Chikuma and Verkman, 2008). AQPs, such as AQP 3 and 9 are aquaglyceroporins and in 
addition to water, these transmembrane proteins allow the passage of small solutes such 
as urea and glycerol across the cell membrane (Rivard et al., 2005). 
 
More recently, our studies have investigated p38 mitogen-activated kinase (MAPK11/14) 
pathway expression and function during preimplantation development (Natale et al., 
2004; Paliga et al., 2005; Fong et al., 2007; Hickson et al., 2007; Madan et al., 2007).We 
have discovered that MAPK11/14 is required to support development beyond the 8–16 
cell stage in the mouse and that MAPK11/14 is also activated in response to embryonic 
exposure to hyperosmotic medium (Natale et al., 2004; Paliga et al., 2005; Fong et al., 
2007). Xie et al. (2007) reported increased activation of MAPK11/14 and MAPK8 
(previously known as the JNK/SAPK pathway) pathways in embryos cultured in poor 
media compared with those cultured in optimized media. Xie et al. (2007) also showed 
that embryos cultured in less optimal conditions had higher levels of apoptosis than those 
cultured in optimized media. Culture medium osmolarity is an important parameter that 
must be defined to provide embryos with appropriate environments in which to develop 
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in vitro. Studies conducted primarily in Dr(s) Baltz’ and Gardner’s laboratories have 
demonstrated that in vivo reproductive tract environments expose embryos to what would 
be considered to be hyperosmotic environments for cultured embryos (Gardner and 
Leese, 1990; Collins and Baltz, 1999). It has been determined that amino acid 
concentrations, in particular glycine levels, in the oviduct serve as osmolytes to allow for 
embryo development in 300–350 mOsm environments in vivo (Steeves et al., 2003; 
Steeves and Baltz, 2005). In vitro preimplantation embryos cultured in 300 mOsm culture 
medium do not normally progress to the blastocyst stage. However, we have discovered 
that MAPK11/14 activity is elevated only when embryos are cultured in hyperosmotic 
sucrose medium and not in hyperosmotic glycerol medium (Fong et al., 2007). We 
propose that exposure to hyperosmotic conditions would increase the ionic gradient 
across the plasma membrane and this may provide a stimulus for enhanced expression of 
AQPs in an attempt to alleviate osmotic stress. Since the AQPs expressed during 
preimplantation development include the aquaglyceroporins AQP 3 and 9, we have 
investigated the influences of exposure to hyperosmotic culture medium on AQP mRNA 
levels and protein distribution using either sucrose or glycerol to produce hyperosmotic 
media. Embryos, and somatic cells in general, do not have the ability to transport sucrose 
across the plasma membrane, however, the existence of aquaglyceroporins provides early 
embryos and somatic cells with an avenue for moving glycerol across the plasma 
membrane. In addition, we have investigated the influences of exposure to hyperosmotic 
medium on blastocyst apoptosis and characterized the role of MAPK11/14 and the 
MAPK8 pathways in mediating the responses to hyperosmotic culture media. The early 
mouse embryo provides an ideal model to investigate the effects of environment on the 
regulation of AQP expression and function. This cellular model affords an opportunity to 
define the signaling pathways controlling AQP expression and function. Our results 
indicate that AQPs are important mediators of embryonic adaptive cellular responses to 
hyperosmotic stress. We have determined that AQP expression and localization is 
primarily regulated by the MAPK14/11 pathway, whereas apoptosis is primarily 
controlled by the MAPK8 pathway. 
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2.2 Materials and Methods 
 
2.2.1 Ovulation Induction and Mouse Embryo Collection 
 
Female MF-1 mice (Charles River, Canada; 3–5 weeks old) were injected with 5 IU 
PMSG (Intervet Canada Ltd, Whitby, Ontario, Canada), followed by 5 IU hCG (Intervet) 
47 h later and mated with CD-1 males. Successful mating was determined the following 
morning (Day 1) by the detection of a vaginal plug. Time post-hCG was used to measure 
the developmental age of the embryos. Preimplantation mouse embryos were flushed 
from the reproductive tract using M2 flushing media (Sigma, St Louis, MO, USA) at 65–
68 h (8-cell and compacting 8-cell) post-hCG. Embryos were then washed four to five 
times in 50 ml drops of potassium simplex optimized medium with amino acids 
(KSOMaa, Chemicon, Temecula, CA, USA) and transferred to 20 µl drops of KSOMaa 
(Jones et al., 1997) or hyperosmotic treatment media, under light paraffin oil. They were 
maintained in culture under 5% CO2 in air atmosphere at 37ºC for 3, 6 or 24 h. Animal 
care and treatment followed protocols established by the UWO animal care committee. 
 
2.2.2 Hyperosmotic Media 
 
Hyperosmotic media were prepared by the addition of sucrose or glycerol to KSOMaa 
medium. The treatment groups consisted of (i) KSOMaa (control, 265 mOsm); (ii) 
KSOMaa + 0.023 g/ml sucrose (300 mOsm); (iii) KSOMaa + 0.032 g/ml sucrose (350 
mOsm); (iv) KSOMaa (1 ml) + 0.3 ml (1.26 g/ml) glycerol (300 mOsm) and (v) 
KSOMaa (1 ml) + 0.7 ml (1.26 g/ml) glycerol (350 mOsm). The osmolarity of the 
embryo culture medium was tested by freezing-point depression using an Advanced 
Model 3320 MicroOsmometer (Advanced Instruments Inc., Norwood, MA, USA).  
 
2.2.3 MAPK14/11 and MAPK8 Inhibition 
 
 SP600125, MAPK8 inhibitor negative control inactive analog, SB220025 and SB202474 
were purchased from Calbiochem (La Jolla, CA, USA). All compounds were dissolved in 
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dimethylsulfoxide (DMSO) to make stock concentrations of 10 mM and were stored at -
20ºC. Pools of 20 embryos were cultured for 6 or 24 h in 20 µl drops of either (i) 
KSOMaa plus 0.1% DMSO; (ii) KSOMaa plus 2–10 µM SB220025 (CSAID, active 
MAPK14/11 inhibitor); (iii) 300 mOsm sucrose hyperosmotic media plus 2–10 µM 
SB220025; (iv) 350 mOsm sucrose hyperosmotic media plus 2–10 µM SB220025; (v) 
KSOMaa plus 10 µM SB202474 (CSAID, inactive analog) (Natale et al., 2004; Paliga et 
al., 2005; Fong et al.,2007); (vi) KSOMaa plus 10 µM SP600125 (active MAPK8 
inhibitor) (Xie et al., 2006) or (vii) 300 mOsm sucrose hyperosmotic media plus 10 µM 
SP600125; (viii) 350 mOsm sucrose hyperosmotic media plus 10 µM SP600125; (ix) 
KSOMaa plus 10 µM MAPK8 inhibitor negative control inactive analog (CSAID, 
MAPK8 negative control inactive analog).  
 
2.2.4 RNA Extraction  
 
Total RNA was extracted from the pools of 20 embryos or from positive control tissue 
(mouse heart, liver and kidney; 1 mg). Samples were frozen and stored at -80ºC in 5 µl of 
lysis buffer and processed as outlined in a Microeasy RNA isolation Kit protocol 
(Qiagen, Mississauga, Ontario, Canada) following collection. In samples used for real-
time reverse transcription and polymerase chain reaction (RT–PCR) analysis, 0.025 
pg/embryo of exogenous Luciferase control RNA (Promega
 
Corporation, Madison, WI, 
USA) containing a 30-base poly(A)
 
tail was added to each pool of embryos prior to RNA 
extraction. This was done to be able to compare mRNA level between pools of embryos 
at different stages.   
 
2.2.5 Reverse Transcription and Polymerase Chain Reaction 
 
Embryo total RNA was reverse transcribed (RT) using Random Primers
 
(Invitrogen Life 
Technologies, Burlington, ON, Canada) and RNaseOUT
TM 
Ribonuclease Inhibitor 
(Invitrogen Life Technologies) along
 
with Sensiscript RT (Qiagen) according to the 
manufacturer's
 
suggested protocol. Following 1 h incubation, the sample was
 
diluted to a 
concentration of one embryo equivalent per microliter
 
(embryo/µl) and subjected to PCR 
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amplification of Luciferase,
 
to determine the efficiency of the RNA extraction and 
reverse
 
transcription prior to investigation of expression of the target
 
genes by real-time 
PCR amplification.
  
 
2.2.6 Custom TaqMan
®
 Gene Expression Assay Design for Real-Time PCR 
 
The Custom TaqMan
®
 primer and probe sets for Luciferase
 
were designed using the 
Assays-by-Design File Builder program
 
(Applied Biosystems, Foster City, CA, USA). 
The probe sequence
 
for luciferase was directed against a target site 550 bp into
 
the full-
length sequence used to generate the Luciferase Control
 
RNA (Promega Corporation). 
The target site specifies an approximate
 
location for the generation of a TaqMan
®
 probe, 
and each
 
target site was verified to be unique by performing the BLAST
® 
analysis. Dual-
labeled probes were synthesized (Applied Biosystems)
 
to contain the reporter dye 6-
carboxyfluorescein (6-FAM) at
 
the 5' end and a non-fluorescent quencher dye at the 3' 
end.
 
 
2.2.7 Real-time RT–PCR Analysis     
Real-time RT–PCR was performed using the ABI PRISM® 7900HT sequence detection 
system (Applied Biosystems) and TaqMan
® 
gene expression assays (Applied 
Biosystems). Pre-designed and
 
pre-optimized commercially available TaqMan
®
 gene 
expression
 
assays for Aqp 3 (Assay ID: mm01208559_m1), and 9 (Assay ID: 
mm00508094_m1),
 
were used along with the Custom TaqMan
®
 gene expression
 
assays 
described above for Luciferase. The PCR mixture (50 µl)
 
contained 25 µl of TaqMan
®
 
Universal PCR Master Mix
 
(2x concentration, containing AmpliTaq Gold
®
 DNA 
Polymerase,
 
AmpErase
®
 UNG, dNTPs with dUTP, Passive Reference 1 and
 
optimized 
buffer components; Applied Biosystems), 2.5 µl
 
of the appropriate 20x TaqMan
®
 gene 
expression assay (see
 
above), 10 µl of embryo cDNA (at a diluted concentration
 
of 0.1 
embryo/µl) corresponding to one embryo equivalent
 
per reaction and 12.5 µl of 
HyPure
TM
 Molecular Biology
 
Grade Water (HyClone, Logan, UT, USA). Thermal 
cycling conditions
 
were 50°C for 2 min and 95°C for 5 min, followed by
 
up to 60 cycles 
of 95°C for 15 s, and a combined annealing
 
extension stage, 60°C for 1 min. Each 
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reaction was performed
 
in triplicate on ABI PRISM
®
 96-well optical reaction plates
 
(Applied Biosystems). Relative quantification of target gene
 
expression levels was 
performed using the comparative CT (threshold
 
cycle) method (ABI PRISM
®
 sequence 
detection system, version
 
2.1, Applied Biosystems). The quantification was normalized
 
to 
the control luciferase RNA levels (Li et al., 2005). Within
 
the log linear phase region of 
the amplification curve, the
 
difference between each cycle was equivalent to a doubling 
of
 
the amplified product of the PCR. The CT value was determined
 
by subtracting the 
control CT value for each sample from the
 
target gene CT value of the sample. Calculation 
of CT used KSOMaa
 
control treatment as the standard for determining fold-changes
 
in the 
relative mRNA expression of the target gene using the
 
formula 2
–C
T. 
2.2.8 Antisera 
Immunolocalization of AQP 3 and 9 in treated 8-cell embryos
 
was determined by using 
proven commercially available primary
 
antibodies from Alpha Diagnostic Int. (San 
Antonio, TX, USA)
 
consisting of: (i) rabbit polyclonal anti-rat AQP 3, directed
 
against a 
15-amino-acid sequence from the C terminus of rat
 
AQP 3 and (ii) rabbit polyclonal anti-
rat AQP 9, raised against
 
a 19-amino-acid synthetic peptide from the rat AQP 9 C-
terminal
 
domain. The antisera were employed at a dilution of 1:100 in
 
combination with a 
goat anti-rabbit whole secondary antibody
 
(Jackson ImmunoResearch, West Grove, PA, 
USA). Each antibody
 
has been extensively characterized in western blot and 
immunolocalization
 
studies on mouse and rat tissues, and established as specific
 
for their 
target proteins (Ishibashi et al., 1994; Ma et al.,
 
1994; Ecelbarger et al., 1995; Echevarria 
et al., 1996; Ishibashi
 
et al., 1997; Koyama et al., 1997; Ishibashi et al., 1998 ; Barcroft
 
et 
al., 2004).
  
2.2.9 Indirect Immunofluorescence Detection of AQP 3 and 9 
Mouse embryos were collected from the reproductive tracts of
 
superovulated female MF-
1 mice as described above. Embryo pools
 
were washed in 1x PBS (GIBCO) and fixed for 
indirect immunofluorescence
 
in 2% paraformaldehyde in PBS at room temperature for 30 
min.
 
Fixed embryos were washed once in 1x PBS and either used immediately
 
or stored 
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at 4°C in embryo storage buffer (1x PBS + 0.9%
 
sodium azide) for up to 1 week before 
processing for whole-mount
 
indirect immunofluorescence as previously described (Jones 
et
 
al., 1997; Betts et al., 1998; MacPhee et al., 2000; Barcroft
 
et al., 2003, 2004). Fixed 
embryos were permeabilized in blocking
 
buffer (0.01% Triton X-100 + 5% normal goat 
serum in 1x PBS)
 
at room temperature for 30 min followed by two washes in fresh
 
PBS. 
Embryos were incubated with primary antibody for AQP 3
 
or 9 at a 1:100 dilution in 
antibody dilution/wash buffer (ADB;
 
0.005% Triton X-100 + 1% normal goat serum in 
1x PBS) at 4°C
 
overnight. Negative controls included embryos incubated in ADB
 
alone 
without the addition of the primary antibody in order
 
to determine the levels of non-
specific fluorescence. Embryos
 
were then washed three times for 20 min in ADB at 37°C 
and
 
incubated with fluorescein isothiocyanate (FITC)-conjugated
 
secondary antibody 
(1:200 in ADB) at 4°C overnight, followed
 
by three washes for 20 min in ADB at 37°C. 
Fully processed
 
embryos were mounted onto glass slides in 20 µl of FluoroGuard
 
anti-
fade reagent (BioRad) under elevated 22 x 22 mm glass coverslips
 
(No. 1 thickness), and 
slide preparations were sealed with nail
 
polish. Slides were stored for up to 2 days at 4°C 
in a
 
light tight box prior to immunofluorescence imaging employing
 
a BioRad MRC600 
Confocal Laser Scanning Microscope. In total,
 
20–30 embryos for each treatment were 
examined for each
 
of the two primary antisera. 
2.2.10 Hyperosmotic Treatment of Embryos for Apoptosis Assessment 
Embryos were collected as described above. They were then placed
 
in KSOMaa or 
hyperosmotic sucrose or glycerol media, with or
 
without inhibitors, for 6 h. They were 
then washed in fresh
 
50 µl KSOMaa drops and placed into fresh 20 µl KSOMaa
 
drops 
and culture as described above.
 
 
2.2.11 TUNEL Apoptosis Assay 
Cleavage of genomic DNA during apoptosis yields single strand
 
breaks in high molecular 
weight DNA, which can be identified
 
by labeling the free 3'-OH terminal with modified 
nucleotides
 
in an enzymatic reaction (Saraste and Pulkki, 2000; Huerta et
 
al., 2007). Once 
the blastocyst stage was reached, embryo pools
 
were fixed for 1 h in 2% 
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paraformaldehyde in PBS and washed
 
in PBS. Fixed embryos were then permeabilized 
and blocked by
 
room temperature incubation for 1 h in permeabilization solution
 
(1% 
sodium citrate + 0.01% Triton X-100). The first negative
 
controls did not undergo 
permeabilization. The embryos were
 
then placed into a humidified chamber and placed at 
4°C
 
for 2 min. They were then washed again in PBS, and a
 
positive control group was 
removed from the treatment groups
 
and treated with 100 µl DNAse solution (10 µl 
DNAse1
 
in 990 µl 50 mM Tris-HCl) for 10 min at room temperature.
 
This was done to 
induce strand breaks, allowing for the assessment
 
of maximal DNA fragmentation during 
analysis. A second group
 
of embryos was removed from the treatment groups to serve as
 
the second negative control for fixed embryos. Both groups of
 
negative control embryos 
were put into 50 µl TUNEL label
 
solution (nucleotide mixture in reaction buffer). The 
positive
 
control and the treatment groups were placed in 50 µl
 
TUNEL reaction mixture 
(terminal deoxynucleotidyl transferase
 
from calf thymus, recombinant in Escherichia 
coli, in storage
 
buffer + nucleotide mixture in reaction buffer). The TUNEL reaction
 
mixture-labeled DNA strand breaks through terminal deoxynucleotidyl
 
transferase, which 
catalyzes polymerization of labeled nucleotides
 
to the free 3'-OH DNA ends in a 
template-independent manner,
 
and by incorporating fluorescein labels in nucleotide 
polymers
 
(Byrne et al., 1999; Saraste and Pulkki, 2000). The fluorescein
 
label was 
detected by epifluorescence microscopy. The two negative
 
controls, the positive control 
and the treatment groups were
 
incubated for 60 min in a humidified chamber at 37°C. 
Upon
 
removal from the chamber, the groups were washed in 0.5 µl
 DAPI (4’,6-
diamidino-2-phenylindole dihydrochloride; Sigma-Aldrich;
 
diluted 1:2000 from 1 mg/ml 
stock solution) + 200 µl PBS
 
for 30 min, to stain the DNA within the nuclei. The groups 
were
 
washed twice more in 200 µl PBS, leaving 15 min between
 
the washes. Fully 
processed embryos were mounted onto glass
 
slides in a drop of FluoroGuard
TM
 anti-fade 
reagent (BioRad
 
Laboratories Canada Ltd., Mississauga, ON, Canada). Fluorescence
 
imaging was conducted on a Zeiss Axiovert 100 inverted microscope
 
equipped with 
epifluorescence optics and digital image analysis
 
software (Carl Zeiss Inc., Thornwood, 
NY, USA).
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2.2.12 Caspase-3 Assay for Apoptosis 
Activated caspase-3 in preimplantation embryos was detected
 
using the PhiPhilux G1D2 
kit (OncoImmunin Inc., College Park,
 
MD, USA). 10–15 embryos from each treatment 
were incubated with 30 µl
 
caspase-3 substrate under oil for 1 h at 37°C in air with
 
5% 
CO2. After three washes in dilution buffer, embryos were
 
fixed with 2% 
paraformaldehyde in PBS for 30 min at 4°C
 
in the dark. After three washes in PBS, the 
first of which contained
 
DAPI, fully processed embryos were mounted onto glass slides
 
in 
a drop of FluoroGuard
TM
 anti-fade reagent (BioRad). Fluorescence
 
imaging was 
conducted on a Zeiss Axiovert 100 inverted microscope
 
equipped with epifluorescence 
optics and digital image analysis
 
software (Carl Zeiss Inc.).
 
 
2.2.13 Apoptotic Fluorescence Image Analysis 
Apoptotic fluorescence was assessed by first counting the number
 
of DAPI-stained (blue) 
nuclei, visualized by an excitation wavelength
 
of 450–500 nm, representing the total 
number of cells
 
in the early embryo. Then, the FITC-positive (green signal), apoptotic
 
nuclei were counted, visualized by an excitation wavelength
 
of 515–565 nm. To obtain 
the percent of apoptotic cells,
 
the number of FITC-stained cells was divided by the DAPI-
stained
 
cells. All microscope and image capture settings remained constant
 
during the 
digital capture of micrographs between embryos and
 
between treatment groups. Acquired 
micrographs were saved in
 
TIFF image format and processed using Adobe Photoshop 
CS2 (Adobe
 
Systems Inc., San Jose, CA, USA) for recognition, selection
 
and separation 
of the desired chromogen signal. Qualitative
 
analysis was done by separation of the blue 
channels (representing
 
DAPI-stained nuclei) and the green channels (representing FITC
 
fluorescence of fragmented DNA).
 
 
2.2.14 Statistical Analysis 
Statistical analysis of data was carried out using SPSS
®
,
 
version 12.0 (SPSS Inc., 
Chicago, IL, USA) software package.
 
TUNEL assay and Caspase-3 assay results are 
presented as the
 
mean ± SEM for percent apoptosis from three independent
 
replicates. All 
data were tested for homogeneity of variances
 
by independent sample t-tests for equality 
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of variances. In
 
instances of equal variance, data were subjected to one-way
 
analysis of 
variance (ANOVA), and followed by Tukey’s multiple comparison test. When equal 
variances were not observed, data
 
were arcsine-transformed and then subjected to 
ANOVA, followed
 
by Tukey’s multiple comparison test. For all data analysis, p≤ 0.05 
was considered statistically significant.
  
2.3 Results 
2.3.1 Experimental Design 
Our first objective was to define the experimental parameters for treating embryos with 
hyperosmotic media.
 
Eight-cell mouse embryos were cultured in normal KSOMaa (265
 
mOsm), and KSOMaa made hyperosmotic with either sucrose or glycerol
 
to 300 and 350 
mOsm. Embryos were cultured for 3, 6 and 24 h
 
and examined and fixed or frozen for 
immunofluorescence or real-time
 
RT–PCR. Figure 2.1 shows representative phase 
contrast
 
images of embryos cultured under the above described conditions.
 
Embryos 
cultured in KSOMaa for 24 h progressed normally to the
 
blastocyst stage. Embryos 
cultured in 300 mOsm sucrose medium
 
compacted, but were unable to progress to the 
blastocyst stage.
 
Embryos cultured in 350 mOsm sucrose medium were delayed 
developmentally
 
and did not compact or proceed to the blastocyst stage. In contrast,
 
embryos cultured in glycerol hyperosmotic media at both 300
 
and 350 mOsm compacted 
and progressed normally to the blastocyst
 
stage (Figure 2.1). 
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Figure 2.1 Culture Stress Affects Blastocyst Formation 
Phase contrast images of embryos cultured in hyperosmotic media using sucrose or 
glycerol. Phase contrast images of embryos cultured in 265 (normal KSOMaa), 300 
(KSOMaa + sucrose or glycerol) or 350 mOsm (KSOMaa + sucrose or glycerol). 
Embryos were cultured for 3, 6 or 24 h before development was assessed based on 
morphology. Embryos cultured in KSOMaa, KSOMaa + 300 mOsm glycerol and 
KSOMaa + 350 mOsm glycerol were all able to develop to the blastocyst stage in normal 
proportions. Embryos cultured in 300 mOsm sucrose compacted, but did not cavitate. 
Embryos cultured in 350 mOsm did not compact and arrested at the 8–16 cell stage; Scale 
bar = 20 microns. 
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2.3.2 Aqp 3 mRNA Levels After Hyperosmotic Treatment Using Sucrose or Glycerol 
There was no significant difference in Aqp 3 mRNA abundance
 
after 3 h in hyperosmotic 
media (data not shown). Aqp 3 expression
 
after 6 h (Figure 2.2A) in 350 mOsm sucrose 
media was significantly
 
elevated undergoing a 2.14-fold increase over KSOMaa control
 
mRNA levels. After 24 h, Aqp 3 (Figure 2.2B) mRNA levels were
 
significantly elevated 
by 2.64-fold in 300 mOsm sucrose over
 
control levels, but were not significantly elevated 
in embryos
 
cultured in 350 mOsm sucrose. Interestingly, after 6 and 24
 
h in glycerol 
treatment, Aqp 3 mRNA levels were significantly
 
decreased (P >0.05) in embryos 
cultured in 350 mOsm glycerol
 
medium (Figure 2.2 C and D). Aqp 3 mRNA levels were 
decreased
 
by 80% compared with KSOMaa control levels after 6 h and 60%
 
from 
KSOMaa control levels after 24 h in 350 mOsm glycerol hyperosmotic
 
treatment. 
2.3.3 Aqp 9 mRNA Levels After Hyperosmotic Treatment Using Sucrose or Glycerol 
There was no significant difference in Aqp 9 mRNA abundance
 
after 3 h in hyperosmotic 
media (data not shown). Aqp 9 mRNA
 
expression underwent a 1.97-fold increase after 6 
h (Figure 2.2 E)
 
in 300 mOsm sucrose media over KSOMaa control levels and a 2.73-fold
 
increase in 350 mOsm sucrose media over control levels. By 24
 
h, Aqp 9 mRNA 
expression was significantly (P >0.05) increased
 
by 4.3-fold in 300 mOsm sucrose and 8-
fold in 350 mOsm sucrose
 
over control levels (Figure 2.2 F). Figure 2.2 G and H indicate
 
that in contrast to the sucrose hyperosmotic treatment results,
 
Aqp 9 mRNA levels were 
not significantly increased in any of
 
the glycerol medium treatment groups at either time 
point. 
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Figure 2.2 Relative Aqp 3 and 9 mRNA Levels Following Treatment.  
Real-time RT–PCR was used to determine the relative mRNA levels of Aqp 3 after 6 (A) 
or 24 h (B) in sucrose hyperosmotic media. Aqp 3 mRNA was significantly elevated after 
(A) 6 h in 350 mOsm and (B) 24 h in 300 mOsm; n = 3, mean ± SE, P ≤ 0.05. Real-time 
RT–PCR was used to determine the relative mRNA levels of Aqp 3 following (C) 6 or 
(D) 24 h exposure to glycerol hyperosmotic medium treatment. There were no significant 
increases in Aqp 3 mRNA levels between glycerol medium treatments and KSOMaa (265 
mOsm) control. Real-time RT–PCR was used to determine the relative mRNA levels of 
Aqp 9 after 6 (E) or 24 h (F) in sucrose hyperosmotic media. Aqp 9 mRNA was 
significantly elevated in embryos cultured for (E) 6 and (F) 24 h in 300 and 350 mOsm 
treatment media. In contrast, treatment for (G) 6 and (H) 24 h exposure to glycerol 
hyperosmotic medium did not result in a significant change in mRNA levels for Aqp 9 
between glycerol medium treatments and KSOMaa (265 mOsm) (G,H).  
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Figure 2.3 AQP 3 and 9 Protein Localization Following Treatment with Sucrose or 
Glycerol Hyperosmotic Medium.  
Representative images of AQP 3 after 6 (A–C) or 24 h (D–F) exposure and AQP 9 after 6 
(G–I) or 24 h (J–L). AQP 3 and 9 protein localization pattern varied by 6 (B,C; H,I) and 
24 h (E,F; K,L) in sucrose hyperosmotic medium from normal distribution patterns in 
KSOMaa (A,D; G,J), showing enhanced cytoplasmic components of normal AQP 3 and 9 
localization. Glycerol treatment did not affect AQP 3 and 9 localization compared with 
untreated controls. n = 20–30 embryos in each group; scale bar = 20 microns. No primary 
antibody negative control (M).  
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2.3.4 AQP 3 and 9 Protein Localization After Hyperosmotic Treatment Using 
Sucrose or Glycerol 
AQP protein localization was next investigated using whole-mount
 
immunofluorescence 
for AQP 3 and 9 polypeptides. Figure 2.3
 
displays representative images of normal 
distribution of AQP
 
3 (Figure 2.3A and D) and 9 (Figure 2.3G and J) and abnormal
 
distribution of AQP 3 and 9 after exposure to hyperosmotic conditions.
 
These images 
represent the range of morphologies observed after
 
exposure to hyperosmotic media. 
There were no visible changes
 
in AQP 3 or 9 localization after 3 h in hyperosmotic media 
(data
 
not shown). Both polypeptides maintained the cortical, apolar
 
localization patterns 
reported by Barcroft et al. (2003). After
 
6 h, however, AQP 3 localization shifted from 
the cortical distribution
 
to become primarily cytoplasmic under 300 and 350 mOsm 
sucrose
 
medium conditions (Figure 3B and C). After 24 h in sucrose
 
hyperosmotic media, 
the AQP 3 distribution became predominantly
 
cytoplasmic (Figure 3E and F). 
Localization of AQP 9 underwent
 
a more dramatic change to become predominantly 
cytoplasmic in
 
both 300 and 350 mOsm sucrose medium treatments at 6 h, although
 
some 
cortical localization was observed (Figure 3H and I).
 
AQP 9 distribution remained 
cytoplasmic in both 300 and 350
 
mOsm at 24 h, although some cortical expression was 
observed
 
(Figure 3K and L). AQP 3 and 9 protein localization was not
 
affected by culture 
in glycerol medium in any of the treatment
 
groups or at any time point (data not shown). 
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Figure 2.4 Relative Aqp 3 and 9 mRNA Levels Following Treatment in the Presence 
of Either a MAPK14/11 or MAPK8 Inhibitor.  
Real-time RT–PCR was used to determine the relative mRNA levels of Aqp 3 after (A) 6 
or (B) 24 h exposure to sucrose hyperosmotic medium treatment + SB220025 (a 
MAPK14/11 inhibitor). No significant increases in Aqp 3 mRNA levels were observed 
after (A) 6 h but after (B) 24 h exposure to sucrose hyperosmotic media Aqp 3 mRNA 
levels significantly declined in the presence of SB220025. The Aqp mRNA levels of Aqp 
9 after (E) 6 or (F) 24 h exposure to sucrose hyperosmotic medium treatment + 
SB220025 did not vary significantly between any treatments after (E) 6 or (F) 24 h. The 
relative mRNA levels of Aqp 3 were measured after (C) 6 or (D) 24 h exposure to sucrose 
hyperosmotic medium treatment + SP600125 (a MAPK8 inhibitor). There was a 
significant increase in Aqp 3 mRNA after 6 (C) and 24 h (D) in embryos exposed to 350 
mOsm sucrose hyperosmotic medium treatment + SP600125; n = 3, mean ± SE, P ≤ 0.05. 
The Aqp 9 mRNA levels after (G) 6 or (H) 24 h exposure to sucrose hyperosmotic 
medium treatment + SP600125 were significantly increased compared with control 
values; n = 3, mean ± SE, p ≤ 0.05.  
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2.3.5 Aqp 3 and 9 mRNA Levels After Hyperosmotic Treatment Using Sucrose in 
the Presence of a MAPK14/11 Inhibitor 
Our next objective was to define the signaling pathways regulating
 
the sucrose 
hyperosmotic treatment induction of AQP mRNA expression.
 
We first examined the 
effects of blocking MAPK14/11 on Aqp mRNA
 
levels. To address this, embryos were 
cultured in sucrose hyperosmotic
 
media as described above with the addition of 2 µM 
SB220025
 
(Natale et al., 2004). The 3 h time point was not included (nor
 
the glycerol 
treatments) in these experiments because Aqp 3
 
and 9 mRNA expression did not vary 
from controls under these
 
conditions. In contrast to what was observed with sucrose 
hyperosmotic
 
media alone (Figure 2A), after 6 h of treatment with sucrose
 
media in the 
presence of MAPK14/11 inhibitor, we did not detect
 
a significant increase in Aqp 3 
mRNA levels (Figure 2.4A) compared
 
with KSOMaa control levels. However, after 24 h, 
we observed
 
a significant decrease in the Aqp 3 mRNA levels (Figure 2.4B).
 
In contrast to 
what was observed with sucrose hyperosmotic media
 
alone, in the presence of the 
MAPK11/14 inhibitor, Aqp 9 mRNA
 
levels did not significantly increase in sucrose 
media after
 
6 (Figure 2.4E) or 24 h (Figure 2.4F) compared with KSOMaa
 
control levels. 
AQP 3 and 9 protein localization following sucrose
 
hyperosmotic treatment and 
MAPK14/11 inhibitor did not vary
 
from that observed in untreated controls, indicating 
that MAPK14/11
 
blockade negated the transition to a predominantly cytoplasmic
 
distribution observed following sucrose hyperosmotic medium
 
treatment (data not 
shown). 
2.3.6 Aqp 3 and 9 mRNA Levels After Hyperosmotic Treatment Using Sucrose in 
the Presence of a MAPK8 Inhibitor 
We next investigated whether the MAPK8 pathway may also regulate
 
Aqp 3 and 9 
mRNAs following exposure to hyperosmotic media.
 
To address this, embryos were 
cultured in sucrose hyperosmotic
 
media as described above with the addition of 10 µM 
SP600125
 
(Xie et al., 2006, 2007). The 3 h time point was not included
 
(nor the glycerol 
treatments) in these experiments because Aqp
 
3 and 9 mRNA expression did not vary 
from controls under these
 
conditions (see above). After 6 h of treatment with 350 mOsm
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sucrose hyperosmotic medium in the presence of MAPK8 inhibitor,
 
we still observed 
significant increases in Aqp 3 (Figure 2.4C)
 
and 9 (Figure 2.4G) mRNA levels compared 
with KSOMaa control
 
levels. After 24 h, we also observed significant increases in
 
Aqp 3 
(Figure 2.4D) and 9 (Figure 2.4H) mRNA levels in 350
 
mOsm sucrose hyperosmotic 
medium compared with the KSOMaa control.
 
In the presence of a MAPK8 inhibitor, 
AQP 3 and 9 protein distribution
 
predominantly consisted of the expected cortical 
distribution
 
observed in untreated controls but also included a cytosolic
 
component in the 
presence of hyperosmotic media and the MAPK8
 
blocker (data not shown). These data 
suggest that the MAPK8
 
pathway is not a primary mediator of the variations in level
 
and 
expression in AQP 3 and 9 in response to hyperosmotic stress. 
2.3.7 Apoptosis in Embryos Cultured in KSOMaa, 300 and 350 mOsm Sucrose or 
Glycerol Media 
Our results to this point indicate that sucrose hyperosmotic
 
treatment affects AQP mRNA 
and protein distribution, and these
 
effects are primarily mediated via the MAPK14/11 
pathway and
 
not the MAPK8 pathway. We next investigated whether hyperosmotic
 
treatment would affect the incidence of cell death or apoptosis.
 
We hypothesized that the 
presence of aquaglyceroporins would
 
reduce the incidence of apoptosis in the presence of 
glycerol
 
hyperosmotic treatment. Eight-cell mouse embryos were treated
 
with the 
respective medium for 6 h and then placed into normal
 
KSOMaa medium for assessment 
of apoptosis at the blastocyst
 
stage (24 h in culture total time). Analysis of apoptosis by
 
TUNEL in blastocysts after 6 h in KSOMaa, 300 or 350 mOsm KSOMaa
 
using glycerol 
or sucrose revealed that there was a significant
 
increase (p≤ 0.05) in apoptotic nuclei in 
embryos treated with
 
350 mOsm sucrose medium when compared with normal KSOMaa 
or
 
hyperosmotic glycerol medium (Figure 2.5A). Comparison of means
 
by independent 
sample t-tests and one-way ANOVA indicated that
 
there was no significant difference in 
apoptotic cells between
 
KSOMaa controls, 300 mOsm glycerol, 300 mOsm sucrose and 
350
 
mOsm glycerol-treated groups (Figure 2.5A). To validate this
 
finding further, we also 
measured apoptosis using a caspase-3
 
assay. The caspase-3 assay revealed that embryos 
treated for
 
6 h in 350 mOsm sucrose medium also displayed a significant
 
increase in 
apoptosis (p≤ 0.05) when compared with KSOMaa or hyperosmotic glycerol medium. 
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Figure 2.5B depicts representative
 
images of TUNEL and caspase-3-labeled apoptotic 
cells in embryos
 
cultured for 6 h in KSOMaa and 350 mOsm KSOMaa sucrose 
treatments.  
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Figure 2.5 Apoptosis Following Hyperosmotic Media Treatment for 6 h.  
(A) TUNEL and caspase-3 assays were used to assess the level of apoptosis in blastocysts 
after having been exposed to hyperosmotic media for 6 h and then allowed to develop to 
the blastocyst stage in normal KSOMaa media. Embryos cultured in glycerol 
hyperosmotic media displayed the same level of apoptosis as control embryos cultured in 
KSOMaa. Embryos cultured in 350 mOsm sucrose medium displayed a significant 
increase in apoptosis compared with controls; mean ± SE, p ≤ 0.05.  
(B) Representative images of embryos displaying TUNEL or caspase-3 positive cells; n = 
20–30 embryos in each group. Embryos cultured in 350 mOsm sucrose hyperosmotic 
medium displayed a greater incidence of apoptotic nuclei than embryos cultured in the 
control KSOMaa or 300 mOsm groups; scale bar = 20 microns.  
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Figure 2.6 Apoptosis in Hyperosmotic Media-Treated Embryos Plus MAPK14/11 
Inhibitor 
(A)  TUNEL and caspase-3 assays were used to assess apoptosis in blastocysts following 
exposure of 8-cell stage embryos to hyperosmotic medium treatment for 6 h in the 
presence of SB220025. Blockade of the MAPK14/11 pathway did not affect the 
appearance of normal elevated apoptosis levels following exposure to sucrose 
hyperosmotic media; mean ± SE, p ≤ 0.05.  
(B) Representative images of TUNEL or caspase-3-treated embryos exposed to 350 
mOsm hyperosmotic media (sucrose or glycerol) + SB220025 or 350 mOsm 
hyperosmotic media (sucrose or glycerol) + SB202474. Embryos cultured in 350 mOsm 
sucrose hyperosmotic + SB220025 medium displayed a greater incidence of apoptotic 
nuclei than embryos cultured in the control KSOMaa + SB220025 or 350 mOsm glycerol 
+ SB220025. There was no significant difference in apoptosis levels between embryos 
cultured in the presence of SB220025 or SB202474; scale bar = 20 microns. n = 20–30 
embryos in each group.  
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2.3.8 Apoptosis Following Culture in KSOMaa and 350 mOsm Sucrose or Glycerol 
Medium in the Presence of MAPK14/11 or MAPK 8 Blocker 
We next investigated whether inhibition of the MAPK14/11 pathway
 
would affect 
apoptosis after embryos were cultured in hyperosmotic
 
medium. Figure 2.6 illustrates that 
embryos cultured in the
 
350 mOsm sucrose medium in the presence of the MAPK14/11 
inhibitor
 
displayed similar levels of apoptosis using both the TUNEL and
 
caspase-3 
assays as did embryos cultured in the MAPK14/11 inactive
 
analog SB202474 and 
DMSO. Figure 2.6 B depicts representative
 
images of TUNEL and caspase-3-labeled 
apoptotic cells in embryos
 
cultured for 6 h in KSOMaa, 350 mOsm KSOMaa using 
glycerol or
 
sucrose treatments in the presence of SB220025. We next characterized
 
whether inhibition of the MAPK8 pathway would affect apoptosis
 
following embryo 
culture in hyperosmotic medium. Apoptosis was
 
not affected by blocking MAPK8 
activity in control (KSOMaa)
 
culture embryos or in embryos cultured in glycerol 
treatment
 
media (Figure 2.7). However, for embryos cultured in the 350
 
mOsm sucrose 
treatment medium, blockade of MAPK8 activity resulted
 
in a significant decrease in 
apoptosis as assessed by both TUNEL
 
and caspase-3 assays (p ≤ 0.05) (Figure 2.7). 
Figure 2.7B
 
depicts representative images of TUNEL and caspase-3-labeled
 
apoptotic 
cells in embryos cultured for 6 h in KSOMaa, 300 and
 
350 mOsm KSOMaa using 
glycerol or sucrose treatments. 
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Figure 2.7 Apoptosis in Hyperosmotic Media-Treated Embryos Plus MAPK8 
Inhibitor. 
(A) TUNEL and caspase-3 assays were used to assess apoptosis in blastocysts following 
exposure of 8-cell stage embryos to hyperosmotic medium treatment for 6 h in the 
presence of SP600125; mean ± SE, p ≤ 0.05. MAPK8 pathway inhibition completely 
blocked apoptosis following treatment with 350 mOsm sucrose hyperosmotic media.  
(B) Representative images of TUNEL or caspase-3-treated embryos exposed to 350 
mOsm hyperosmotic media (sucrose or glycerol) + SP600125 or 350 mOsm 
hyperosmotic media (sucrose or glycerol) + MAPK8 inactive inhibitor. Embryos cultured 
in 350 mOsm sucrose hyperosmotic + SP600125 medium displayed no incidence of 
apoptotic nuclei compared with embryos cultured in the control KSOMaa + SP600125 or 
350 mOsm glycerol + SP600125. There was a significant difference in apoptosis levels 
between embryos cultured in the presence 350 mOsm sucrose hyperosmotic + SP600125 
and embryos cultured in 350 mOsm sucrose hyperosmotic + MAPK8 inactive inhibitor; 
scale bar = 20 microns. n = 20–30 embryos in each group.  
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2.4 Discussion 
In this study, we have demonstrated that preimplantation embryos
 
may be cultured at 
physiological osmolarities if the culture
 
medium is supplemented with glycerol instead of 
sucrose. In
 
addition, AQP 3 and 9 gene expression and protein localization
 
are regulated 
by osmotic treatment, indicating that AQPs are
 
important components of the adaptive 
mechanisms that preimplantation
 
embryos employ in response to a changing 
environment. Interestingly,
 
Aqp 3 and 9 mRNA levels and protein distribution were only 
affected
 
by sucrose treatment and not by glycerol treatment, indicating
 
that AQP 3 and 9 
function to alleviate cellular stress imposed
 
by the external environment. This conclusion 
was validated by
 
our observations that glycerol treatment did not result in elevated
 
apoptosis, unlike the sucrose treatment. Thus, AQP 3 and 9 also
 
participate in regulating 
apoptosis by reducing cellular stress.
 
Furthermore, we have demonstrated by the use of 
specific and
 
potent MAPK inhibitors that the regulation of AQP expression
 
and 
localization primarily occurs by the MAPK14/11 pathway,
 
whereas apoptosis is primarily 
regulated by the MAPK8 pathway.
 
Taken together, these outcomes support the overall 
conclusion
 
that AQP 3 and 9 function in part to alleviate cellular osmotic
 
stress and 
indicate that the MAPK14/11 and MAPK8 pathways are
 
important stress-activated 
pathways that have distinct roles
 
to play in regulating embryonic responses to stress.
 
 
AQPs act as water channels, allowing water and solutes to cross
 
the plasma membrane in 
the absence of a steep osmotic gradient.
 
Their physiological role has been defined as 
regulating near
 
iso-osmotic water transport (Ishibashi et al., 2000; Agre and
 
Kozono, 
2003; Barcroft et al., 2003; Agre, 2006). Exposure to
 
hyperosmotic conditions would 
increase the ionic gradient across
 
the plasma membrane and this may provide a stimulus 
for enhanced
 
expression of AQPs in an attempt to alleviate the stress. The
 
shift in AQP 
protein distribution from a primarily cortical
 
to a cytoplasmic distribution may reflect the 
progression of
 
newly synthesized protein en route to the plasma membrane. This
 
finding 
would be consistent with our prediction that the alterations
 
in AQP expression that occur 
following exposure to hyperosmotic
 
medium reflect an adaptive cellular response to 
culture-induced
 
stress.
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The MAPK14/11 pathway is activated in response to hyperosmotic
 
treatment in the 
embryo and in other cell types (Arima et al.,
 
2003; Fong et al., 2007). In addition, MAPK 
signaling is implicated
 
in the regulation of AQP 3 and 9 (Arima et al., 2003; Cao et
 
al., 
2006) and other AQPs (Hoffert et al., 2000; Umenishi and
 
Schrier, 2003; Hansen and 
Galtung, 2007). These studies noted,
 
however, that the total protein levels for the MAPK 
pathway
 
did not increase in response to hyperosmotic stress and that
 
signaling occurred 
via increased phosphorylation of the MAPK
 
pathway constituents. Our results certainly 
support the conclusion
 
that the hyperosmotic treatment-induced influences on AQP 
expression
 
and distribution are primarily regulated by MAPK14/11 in the
 
preimplantation 
embryo. Of interest, embryos cultured in normal
 
KSOMaa + MAPK14/11 inhibitor did 
not show any changes in Aqp
 
3 and 9 mRNA expression or protein localization. 
Therefore,
 
MAPK14/11 regulation of AQP 3 and 9 may be primarily directed
 
during 
responses to hyperosmotic stress and is not a component
 
of the normal regulatory 
mechanisms controlling basal AQP expression
 
during preimplantation development.
 
 
In complete contrast to the results obtained following sucrose
 
hyperosmotic treatment, 
embryos cultured in 350 mOsm glycerol
 
hyperosmotic medium were morphologically 
identical to embryos
 
cultured in KSOMaa. As well, they did not demonstrate any changes
 
in mRNA expression or protein localization for Aqp 9. We did,
 
however, observe a 
decrease in the mRNA expression of AQP 3
 
after 6 and 24 h in embryos treated with 
hyperosmotic glycerol
 
media. This could be indicative of the embryo attempting to
 
regulate the accumulation of glycerol within the blastomeres
 
by decreasing the expression 
of an aquaglyceroporin such as
 
AQP 3. This result would indicate that Aqp 3 mRNA is 
responsive
 
but Aqp 9 mRNA is not, demonstrating that these AQPs are differentially
 
regulated and can respond independently to environmental changes
 
that the embryo 
experiences. Offenberg et al. (2005) examined
 
the expression of Aqp 3 and Aqp 9 in 
blastocysts cultured from
 
the 8-cell compacted embryo in hyperosmotic conditions for 40
 
h and did not report any changes in mRNA levels. Our studies
 
examined effects over a 
much shorter time period (3, 6 and 24
 
h). We predict that our results and those of 
Offenberg et al.
 
(2005) suggest that the influences on AQP expression occur fairly
 
rapidly 
following exposure to hyperosmotic medium and then may
 
return to basal levels by 40 h 
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after exposure to hyperosmotic
 
medium. Offenberg et al. (2005) did, however, show 
increases
 
in Aqp 3 and 9 mRNA expression after blastocyst puncture, which
 
supports our 
observation that AQP 3 and 9 expression is regulated
 
under stressful conditions.
 
 
The ability of treated embryos to progress in normal numbers
 
to the blastocyst stage in 
the 350 mOsm glycerol medium is intriguing.
 
We would propose that this occurrence is 
due in part to the
 
presence of AQP 3 and 9 and their role as aquaglyceroporins
 
to promote 
the movement of glycerol into the cell down the glycerol
 
concentration gradient (Zelenina 
et al., 2004; Hara-Chikuma
 
and Verkman, 2005; Karlgren et al., 2005; Hara-Chikuma and 
Verkman,
 
2006; Liu et al., 2007; Rojek et al., 2007). The presence of
 
AQP 3 and 9 could 
alleviate the osmotic gradient, establishing
 
equilibrium with the external medium and thus 
eliminating the
 
presence of osmotic stress on the embryo in the 350 mOsm glycerol
 
medium. Barcroft et al. (2003) demonstrated that AQPs were present
 
and functional in 
the preimplantation embryo by exposing blastocysts
 
to an 1800 mOsm glycerol solution. 
Under these conditions, the
 
blastocysts initially collapse but then recover completely 
within
 
3 min to restore their original shape and volume (Barcroft et
 
al., 2003). In this 
example, normal expression of aquaglyceroporins
 
allowed the embryos to transport 
glycerol across the blastocyst
 
membrane quickly and restore normal blastocyst volume, 
however,
 
when the same experiment was conducted using sucrose instead
 
of glycerol, 
embryos were not able to regain their expanded
 
form (Barcroft et al., 2003). In 
conclusion, our outcomes would
 
suggest that culture in 350 mOsm glycerol medium does 
not impair
 
development to the blastocyst stage in vitro, does not activate
 
the MAPK14/11 
pathway or alter AQP expression, thus it does
 
not appear to evoke a cellular stress 
response.
 
 
Apoptosis is an important mechanism linked to the cellular response
 
to stress (Kurzawa et 
al., 2002; Esfandiari et al., 2005; Zander
 
et al., 2006; Esfandiari et al., 2007; Oh et al., 
2007; Xie
 
et al., 2007). Apoptotic mechanisms are well defined during
 
preimplantation 
development, and this developmental event is
 
normally first observed at the blastocyst 
stage (Pierce et al.,
 
1989; Hardy, 1997, 1999; Warner et al., 1998; Byrne et al.,
 
1999; 
Huppertz et al., 1999; Pampfer, 2000; Levy et al., 2001).
 
Both MAPK14/11 and MAPK8 
pathways mediate cellular apoptosis
 
and it is for this reason that we investigated the 
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effects of
 
exposure to hyperosmotic medium treatment on apoptosis. Our
 
results indicate 
that hyperosmotic stress using sucrose treatment
 
will increase the levels of apoptosis. 
However, 350 mOsm glycerol
 
medium does not elicit a similar apoptotic response. Xie et
 
al. (2007) demonstrated that the MAPK8 pathway regulates apoptosis
 
during 
preimplantation development. Interestingly, our results
 
support those of Xie et al. (2007) 
and suggest that the MAPK8
 
pathway is the primary mediator of osmotic stress-induced 
apoptosis.
 
Our outcomes support our assertion that the exposure to glycerol
 
hyperosmotic 
medium does not elicit a cellular stress response
 
due to the action of AQP 3 and 9, which 
alleviate the osmotic
 
stress by allowing glycerol to cross the cell membrane. Thus,
 
AQP 3 
and 9 may also function to regulate the occurrence of
 
apoptosis in cell systems. Clearly, 
blockade of the MAPK14/11
 
pathway had no effect on hyperosmotic treatment-induced 
apoptosis,
 
whereas blockade of the MAPK8 pathway completely negated the
 
increased 
apoptosis observed following treatment with hyperosmotic
 
sucrose medium. Treatment 
with either the MAPK14/11 or MAPK8
 
inhibitor applied to normal KSOMaa media 
control embryos had
 
no effect on reducing embryonic apoptotic levels, indicating
 
that 
basal apoptotic levels are unlikely to be under the control
 
of either pathway. Thus, our 
experiments have also shed light
 
on the roles of two MAPK pathways, MAPK14/11 and 
MAPK8 in regulating
 
apoptosis, and also their roles in response to embryonic exposure
 
to 
hyperosmotic treatment. Each pathway has a distinct but important
 
contribution to the 
mechanisms controlling preimplantation development.
 
 
We therefore conclude that the changes in Aqp 3 and 9 mRNA levels
 
and protein 
distribution are the components of a rapid adaptive
 
response that the embryo employs to 
alleviate cellular stress.
 
The sucrose treatment exceeds the adaptive capacity of the 
preimplantation
 
embryo, resulting in the activation of apoptosis and induced
 
cell death. 
MAPK14/11 activation is therefore, in this context,
 
a component of the rapid adaptive 
stress response mechanism,
 
whereas the MAPK8 pathway regulates apoptosis. Our results 
indicate
 
that culture in 350 mOsm KSOMaa + glycerol medium is not detrimental
 
for 
preimplantation development and this may allow early embryo
 
culture at more 
physiological osmolarities. These outcomes improve
 
our understanding of the embryonic 
adaptive mechanisms to environmental
 
stress and indicate that AQPs are critical 
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components of the
 
embryo's response to stressful environments. They may also lead
 
to 
further developments in the optimization of culture media
 
for the production of 
mammalian preimplantation embryos in vitro.
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3.1 Introduction 
Mammalian preimplantation development extends from fertilization to implantation and 
culminates in the formation of a blastocyst, a fluid filled structure that emerges from the 
zona pellucida and implants into the uterine wall to maintain pregnancy (Watson et al., 
2004; Bell et al., 2008). The early blastocyst consists of two cell types, the inner cell 
mass (ICM) and the trophectoderm (TE) (Watson et al., 2004; Bell et al., 2008).  The 
ICM is an undifferentiated mass of cells that will become the embryo proper. The TE is a 
polarized epithelial cell layer which surrounds the ICM.  The TE mediates implantation 
to the uterine wall, contributes to the embryonic portion of the placenta and is 
characterized by the expression of transcription factors (TF), such as caudal homeobox 
two (Cdx2) (Strumpf et al., 2005).  Functional adherens junctions (AJ) and tight junctions 
(TJ) form a seal between the cells of the TE, which is essential for fluid accumulation and 
formation of the blastocyst cavity (McLaren et al., 1977; Fleming et al., 1989; Fleming et 
al., 1993; Kim et al., 2004; Violette et al., 2006; Hartsock et al., 2007; Niessen, 2007; 
Bell et al., 2008; Giannatselis et al., 2011).   
The Na/K ATPase is also a critical mediator of blastocyst formation as it establishes a 
trans-trophectoderm osmotic gradient that directs fluid movement across the TE 
epithelium (Watson et al., 1990; Baltz et al., 1997; Betts et al.,  1998; MacPhee et al., 
2000; Kidder et al., 2005; Madan et al., 2007).  The Na/K ATPase is comprised of two 
main subunits; the alpha (ATP1A) and the beta (ATP1B).  Loss of Atp1a during 
preimplantation development does not impede the initial formation of a blastocyst, but 
shortly after results in an embryonic lethality during peri-implantation development 
(Barcroft et al., 2003).  In contrast, loss of Atp1b1 results in a developmental arrest at the 
morula stage, and blastocyst expansion does not occur (Madan et al., 2006).   
Additionally, the Na/K ATPase acts as an ouabain mediated signaling molecule that 
regulates TJ formation and function in the TE (Violette et al., 2006; Giannatselis et al., 
2011).  Fluid movement across the TE is facilitated by the presence of aquaporins (AQP) 
3 and AQP 9 in the TE membrane (Barcroft et al., 2003).  AQP 9 is localized to the apical 
surface of the TE and AQP 3 is localized to the baso-lateral surface of the TE, and 
together they facilitate fluid movement from the ‘outside’ to the ‘inside’ of the blastocyst 
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cavity, along the osmotic gradient maintained by the Na/K ATPase (Barcroft et al., 2003).  
Together, the AJs, TJs, Na/K ATPase and AQPs, are critical gene products that 
coordinate blastocyst expansion and blastocyst cavity formation (reviewed in Bell et al., 
2008). Although the cell biology of blastocyst formation is well documented, the 
molecular signaling events, particularly the intracellular signaling events, governing 
blastocyst formation are unclear (reviewed in Yamanaka et al., 2006; Bell et al., 2008).  
The p38 MAPK pathway is an intracellular signaling pathway that translates extracellular 
stimuli into cellular responses (Cargnello et al., 2011). This intracellular signaling 
pathway directs a wide variety of physiological processes through Serine/Threonine 
phosphorylation (Cargnello et al., 2011).  p38 MAPK is ubiquitously expressed in all 
eukaryotic cells and regulates gene expression, mitosis, metabolism, motility, survival, 
apoptosis and differentiation (Natale et al., 2004; Wada et al., 2004; Zohn et al., 2006; 
Bell et al., 2009; Cargnello et al., 2011).  Each component of the p38 MAPK pathway is 
present throughout preimplantation development and the p38 MAPK pathway plays both 
developmental and adaptive roles during preimplantation development (Natale et al., 
2004; Paliga et al., 2005; Fong et al., 2007; Bell et al., 2009).  Our previous studies have 
demonstrated that p38 MAPK is both an important mediator of early preimplantation 
development and is also a component of the adaptive mechanism the embryo can employ 
to adjust to environmental influences during development (Natale et al., 2004; Paliga et 
al., 2005; Fong et al., 2007; Bell et al., 2009).  P38 MAPK is a gene family consisting of 
four different isoforms,  and  Reviewed in Cargnello & Roux, 2011) Our 
previous studies focusing on the role of p38 MAPK during preimplantation development 
demonstrated that treatment of 2-, 4- and uncompacted 8-cell embryos with the cytokine 
suppressive anti-inflammatory drugs (CSAIDs
TM
; SB203580 and SB220025 active 
forms; SB202474 inactive form control) all result in a reversible developmental blockade 
that suspends development at the 8-16 cell stage (Natale et al., 2004; Paliga et al., 2005).  
CSAIDs
TM
, SB203580 and SB220025, are potent and specific pharmacological agents 
that are routinely and reliably used to investigate p38 MAPK function in cell systems 
(reviewed in Jackson et al., 1998; Cargnello & Roux et al., 2011).  We also demonstrated 
that the p38 MAPK inhibited blockade is accompanied by a downstream loss of 
MAPKAPK2/3 phosphorylation, then loss of HSP25/27 phosphorylation and finally a 
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disassembly of filamentous actin (Natale et al., 2004; Paliga et al., 2005). 8-16 cell stage 
drug free embryos resume their developmental program and progress normally to the 
blastocyst stage following treatment with an accompanying delay consistent with the 
original CSAID treatment time (Natale et al., 2004; Paliga et al., 2005).  
In addition, the p38 MAPK pathway directs preimplantation embryonic responses to 
environmental stress (Fong et al., 2007; Bell et al., 2009).  Fong et al., 2007 reported that 
MAPKAPK2, a downstream target of p38 MAPK, displayed enhanced phosphorylation 
in embryos exposed to hyperosmotic culture medium. This elevation in MAPKAPK2 
phosphorylation was extinguished when the embryos were cultured under hyperosmotic 
conditions in the presence of SB 220025, demonstrating that p38 MAPK was activated in 
response to hyperosmotic stress (Fong et al., 2007).  Bell et al., 2009 demonstrated that 
the p38 MAPK pathway up-regulated Aqp3 and Aqp9 mRNA expression in response to 
hyperosmotic stress in 8-cell embryos but did not regulate blastocyst apoptosis levels 
resulting from hyperosmotic stress (Bell et al., 2009).  Taken together, these results 
demonstrate that p38 MAPK signaling regulates both the developmental program of 
preimplantation development and embryonic adaptations to environmental stress.  
The present study was conducted to investigate the role of p38 MAPK in regulating 
cavitation and blastocyst formation. Embryos were cultured from the early blastocyst 
stage for 12 h or 24 h in the presence of a p38 MAPK inhibitor, SB 220025.  Blastocyst 
expansion, zona hatching, TE formation and function, and apoptosis levels were assessed.  
We have demonstrated that the p38 MAPK pathway is required for blastocyst expansion 
and hatching and for regulating TJ function.  Furthermore, suppression of p38 MAPK 
signaling resulted in a significant increase in apoptosis levels. These results demonstrate 
that p38 MAPK also exerts its influences on blastocyst formation and suggests that it is 
an important mediator of blastocyst formation gene family expression, function and thus 
coordination of the overall events that regulate blastocyst formation.   
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3.2 Materials and Methods 
3.2.1 Ovulation Induction and Mouse Embryo Collection 
 
Female MF-1 mice (Charles River, Canada; 3–5 weeks old) were injected with 5 IU 
Pregnant Mare’s Serum Gonadotropin (PMSG)(Intervet Canada Ltd, Whitby, Ontario, 
Canada), followed by 5 IU human Chorionic Gonadotropin (hCG) (Intervet) 48 h later 
and mated with CD-1 males. Successful mating was determined the following morning 
(Day 1) by the detection of a vaginal plug. Time post-hCG was used to measure the 
developmental stage of the embryos. Preimplantation mouse embryos were flushed from 
the reproductive tract using M2 flushing media (Sigma, St Louis, MO, USA) at 89 h 
(early blastocyst) post-hCG.  
 
3.2.2 Embryo Culture and Treatment 
 
3.2.2.1 Concentration Response Experiments: 
Embryos were washed four to five times in 50 µl drops of either potassium simplex 
optimized medium with amino acids (KSOMaa, Chemicon, Temecula, CA, USA) + 0.2%  
dimethylsulfoxide (DMSO), KSOMaa + 20 µM SB 202474 (inactive analogue control), 
KSOMaa + 2 µM SB 220025, KSOMaa + 5 µM SB 220025, KSOMaa + 10 µM SB 
220025 or KSOMaa + 20 µM SB 220025 and transferred to 20 µl drops of the respective 
treatment under light paraffin oil. They were maintained in culture under 5% CO2 in air 
atmosphere at 37ºC for 24 h. Embryos were imaged at 4 h, 8 h, 12 h and 24 h post 
collection. After 12 h or 24 h of treatment, embryos from each group were washed in 
fresh KSOMaa (minimum of 3 times) and placed in fresh KSOMaa 20 µl culture drops 
for recovery experiments.  Embryos were imaged at time points equivalent to 24 h, 28 h 
and 36 h post embryo collection.  These time points are equivalent to 12 h, 16 h and 24 h 
of recovery for 12 h treated embryos and 4 h and 12 h recovery for 24 h treated embryos 
respectively (Appendix A: Supplemental Figure 2). Embryo diameter was used to assess 
blastocyst expansion.  Diameter of each blastocyst was measured in two different 
directions (using Image Pro analysis 6.2 software; Appendix A: Supplemental Figure 1) 
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and then averaged and the volume was calculated based on the calculated radius. To 
confirm expansion results from embryos treated with SB 220025, embryos were also 
treated with 5 µM SB 203580, another potent p38 inhibitor, for 24 h and measured.     
Animal care and treatment followed protocols established by the UWO animal care 
committee conforming to the Canadian Council for Animal Care (CCAC) guidelines. 
 
3.2.2.2 Assessment of Zona Hatching In Vitro 
 
Embryos were washed four to five times in 50 µl drops of treatment and transferred to 20 
µl drops of the respective treatment under light paraffin oil. They were maintained in 
culture under 5% CO2 in air atmosphere at 37ºC for 12 h or 24 h. Embryo hatching was 
assessed at 24 h and 48 h post collection.  An embryo was consider to be  “hatching”  if 
any part of the embryo protruded from the zona pellucida or  “hatched” if the embryo was 
completely free of the zona pellucida.  Four replicates were performed.  
 
3.2.3 Quantitative RT-PCR 
Quantitative RT-PCR was conducted to determine the effects of p38 MAPK inhibition on 
the mRNA levels of TE associated proteins. Total RNA was extracted from pools of 20 
embryos using the PicoPure kit (Arcturus, Molecular Device, Sunnyvale, CA). Reverse 
Transcription (RT) reaction was carried out using Sensiscript reverse transcriptase 
(Qiagen, Mississauga, ON). The samples were incubated in 10x buffer, RNAse inhibitor, 
dNTPs and random primers at 37°C for 1 h. Quantitative PCR reactions were performed 
using the BioRad Chromo4 detection system (BioRad, Mississauga, ON). PCR was 
carried out in 20 µl reactions containing 10 µl SYBR Green (Invitrogen, Burlington, 
ON), 0.2 µl of primer sets provided by Biosearch Technologies (Novado, CA), 1 µl of 
appropriate dilution of cDNA (1 embryo/µl), and 8.8 µl of water. To confirm the 
specificity of each quantitative RT-PCR product, amplicons were extracted from gels and 
purified using a QIAquick gel extraction kit (Qiagen, Mississauga, ON) and submitted for 
nucleotide sequencing (DNA Sequencing Facility, Robarts Research Institute, London, 
ON, Canada). The nucleotide sequences were then compared with sequences available in 
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GenBankTM nucleotide sequence data base, and in all cases the specificity of each PCR 
product was confirmed. Aqp3 and Aqp9 were obtained from Applied Biosystems 
(Aqp3Assay ID: mm01208559_m1; Aqp 9 Assay ID: mm00508094_m1). All other sequences 
can be found in Appendix A: Supplemental Figure 7. Three to six replicates were 
performed.   
3.2.4 Antisera 
Antibodies used in whole mount immunofluorescence procedures were obtained from 
commercial sources: CDH1 and TJP1 (Upstate Cell Signaling Solutions, Charlottesville, 
VA), CDX2 (Aviva Systems Biology, San Diego, CA), AQP3 and 9 (Alpha Diagnostic 
Int. (San Antonio, TX, USA)), ERK and p-ERK (Cell Signalling Technologies (Danvers, 
MA, USA). 
3.2.5 Indirect Immunofluorescence  
Mouse embryos were collected from the reproductive tracts of
 
super ovulated female MF-
1 mice as described above. Embryo pools
 
were washed in 1x PBS (GIBCO) and fixed for 
indirect immunofluorescence
 
in 2% paraformaldehyde in PBS at room temperature for 30 
minutes.
 
Fixed embryos were washed once in 1x PBS and either used immediately
 
or 
stored at 4°C in embryo storage buffer (1x PBS + 0.1%
 
sodium azide) for up to 1 week 
before processing for whole-mount
 
indirect immunofluorescence as previously described 
(Betts et al., 1998; MacPhee et al., 2000; Barcroft et al., 2004; Fong et al., 2007; Madan 
et al., 2007).  Fixed embryos were permeabilized in blocking
 
buffer (0.01% Triton X-100 
+ 5% normal donkey serum in 1x PBS)
 
at room temperature for 1 h followed by two 
washes in fresh
 
PBS. Embryos were incubated with primary antibody in a 1:100 dilution 
in antibody dilution/wash buffer (ADB;
 
0.005% Triton X-100 + 0.5% normal donkey 
serum in 1x PBS) at 4°C
 
overnight. Negative controls included embryos incubated in 
ADB
 
alone without the addition of the primary antibody in order
 
to determine the levels 
of non-specific fluorescence. Embryos
 
were then washed three times for 30 minutes in 
ADB at 37°C and
 
incubated with fluorescein isothiocyanate (FITC)-conjugated
 
secondary 
antibody (1:200 in ADB) at 4°C overnight, followed
 
by three washes for 30 minutes in 
ADB at 37°C. 4',6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich;
 
diluted 1:2000 from 
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1 mg/ml stock solution), a nuclear stain, along with Rhodamine phalloidin (diluted 1:20 
into ADB), a filamentous actin (F-actin) stain, were added to the first wash step.  Fully 
processed
 
embryos were mounted onto glass slides in 20 µl of Vectashield
 
mounting 
medium (Vector, Burlingame, CA) under elevated 22 x 22 mm glass cover slips
 
(No. 1 
thickness), and slide preparations were sealed with nail
 
polish. Slides were stored for up 
to 2 days at 4°C in a
 
light tight box prior to immunofluorescence imaging.  Embryos were 
examined by confocal microscopy using an Olympus Fluoview 1000 laser scanning 
Confocal Microscope (Olympus, Canada). In total,
 
10-15 embryos for each treatment 
were examined for each
 
of the primary antisera.   
3.2.6 Assessment of TJ Function by FITC-Dextran Uptake Assay 
To investigate the effects of p38 MAPK inhibition on TJ permeability, embryos were 
cultured for 12 h or 24 h in KSOMaa, SB 202474, SB 220025 or for 30 minutes in 2 mM 
EGTA (ethylene glycol Bis- (β-aminoethyl ether) N,N,N,N -tetraacetic acid).  After 
treatment, blastocysts were cultured in drops containing 40 kDa FITC-Dextran in 
KSOMaa for 30 minutes. Following this incubation, blastocysts were immediately 
washed in three 50 µL wash drops of KSOMaa and placed in a fourth clean KSOMaa 
drop for immediate assessment of FITC-dextran accumulation employing an epi-
fluorescent microscope (Olympus). Three replicates were performed for each time point.   
3.2.7 TUNEL Apoptosis Assay 
Cleavage of genomic DNA during apoptosis yields single strand
 
breaks in high molecular 
weight DNA, which can be identified
 
by labeling the free 3'-OH terminal with modified 
nucleotides
 
in an enzymatic reaction (Saraste & Pulkki, 2000; Huerta et al., 2007). After 
24 h of treatment, embryo pools
 
were fixed for 1 h in 2% paraformaldehyde in PBS and 
washed
 
in PBS. Fixed embryos were then permeabilized and blocked for 3 minutes in 
permeabilization solution
 
(1% sodium citrate + 0.01% Triton X-100) at 4°C. Embryos 
were then washed in PBS, and a
 
positive control group was removed from the treatment 
groups
 
and treated with 100 µl DNAse solution (10 µl DNAse1
 
(Invitrogen)
 
in 990 µl 50 
mM Tris-HCl) for 13 minutes at room temperature.
 
This was done to induce strand 
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breaks, allowing for the assessment
 
of maximal DNA fragmentation during analysis. A 
group
 
of embryos was removed from the treatment groups to serve as
 
the negative control 
group.  The positive
 
control and the treatment groups were placed in 50 µl
 
TUNEL 
reaction mixture (terminal deoxynucleotidyl transferase
 
from calf thymus, recombinant in 
Escherichia coli, in storage
 
buffer + nucleotide mixture in reaction buffer). The TUNEL 
reaction
 
mixture labeled DNA strand breaks through terminal deoxynucleotidyl
 
transferase, which catalyzes polymerization of labeled nucleotides
 
to the free 3'-OH DNA 
ends in a template-independent manner,
 
and by incorporating fluorescein labels in 
nucleotide polymers
 
(Byrne et al., 1999; Saraste & Pulkki, 2000). Negative control 
embryos were put into 50 µl TUNEL label
 
solution (nucleotide mixture in reaction 
buffer) only.  Embryos were
 
incubated for 60 minutes in a humidified chamber at 37°C. 
The groups were then washed in 0.5 µl
 
DAPI (Sigma-Aldrich;
 
diluted 1:2000 from 1 
mg/ml stock solution) + 200 µl PBS
 
for 30 minutes, to stain the DNA. The groups were
 
washed twice more in 200 µl PBS, for 15 minutes at 37°C. Fully processed embryos were 
mounted onto glass
 
slides in a drop of Vectashield
 
mounting medium.  Three replicates 
were performed for each time point.   
3.2.8 Apoptotic Fluorescence Image Analysis 
Embryos were examined by confocal microscopy using an Olympus Fluoview 1000 laser 
scanning Confocal Microscope (Olympus, Canada). Z-stack images were taken of the 
embryos and used to count total cell number and FITC positive cell number.  Apoptotic 
fluorescence was assessed by first counting the number
 
of DAPI-stained (blue) nuclei, 
representing the total number of cells
 
in the early embryo followed by counting the FITC-
stained (green) apoptotic
 
nuclei. To obtain the percent of apoptotic cells,
 
the number of 
FITC-stained cells was divided by the number of DAPI-stained
 
cells. All microscope and 
image capture settings remained constant
 
during the digital capture of micrographs 
between embryos and
 
between treatment groups.  10-15 embryos were assessed for each 
treatment group. 
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3.2.9 Statistical Analysis  
 
The results from the concentration response and recovery experiments were first 
subjected to Normality tests and once passed analyzed by a repeated measure ANOVA 
test followed by a Student-Newman-Keuls post hoc test.   All other experiments were 
also first subjected to Normality tests and once passed analyzed a one-way ANOVA test 
followed by a Student-Newman-Keuls post hoc test.  All error bars represent standard 
error mean (SEM). Significant p value ≤ 0.05.  Data was analyzed using the SigmaStat® 
3.5 (Jandel Scientific Software, San Rafael, CA, USA). 
3.3 Results 
3.3.1 p38 MAPK Regulation of Blastocyst Expansion is SB 220025 Concentration 
Dependent 
We first defined the concentration and time course effects of treating early blastocysts 
with the p38 MAPK inhibitor SB 220025 (Figure 3.1). Embryos cultured in all tested 
concentrations of SB 220025 did not display a significant difference from control 
embryos following 4 h and 8 h of treatment (data not shown).  After 12 h of treatment, 
embryos cultured in 5 µM SB 220025 (volume, 494875 ± 44778 microns
3
), 10 µM SB 
220025 (516938 ± 21180 microns
3
) or 20 µM SB 220025 (505363 ± 23317) displayed a 
significant reduction in blastocyst cavity expansion compared to control groups: 
KSOMaa + 0.2 % DMSO (712395 ±46015 microns
3
), KSOMaa + 20 µM SB 202474 
(inactive analogue of SB 220025) (638006 ± 84041 microns
3
).  After 24 h of culture, 
embryos cultured in 2 µM SB 220025 (617718 ± 69820 microns
3
), 5 µM SB 220025 
(601282 ± 40766  microns
3
),  10 µM SB 220025 (547158 ± 71035 microns
3
) or 20 µM 
SB 220025 (425879 ± 23317 microns
3
) all displayed a significant reduction in blastocyst 
volume compared to control groups: KSOMaa + 0.2 % DMSO (811406 ± 31382 
microns
3
), KSOMaa + 20 µM SB 202474 (1100180 ± 28571 microns
3
) (Figure 3.1; 
Appendix A: Supplemental Figure 3).  From this data, we selected 5 µM SB 220025 as 
the lowest effective concentration for investigating the effects of p38 MAPK inhibition 
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on blastocyst formation and used this concentration in all subsequent experiments. To 
validate the specificity and reproducibility of these outcomes, we repeated this 
experiment using a second p38 MAPK inhibitor, SB 203580. Our outcomes employing 5 
µM SB 203580 for 24 h were identical to the SB 220025 outcomes in that we observed a 
significant reduction in blastocyst volume in the presence of SB 203580 (Appendix A: 
Supplemental Figure 5).  To ensure the effects we were observing were not being 
mediated by inadvertently affecting the ERK MAPK pathway, we probed embryos 
treated for 24 h with 5 µM SB 220025 for total-ERK and phospho-ERK levels by 
immunofluorescence. Treatment with SB 220025 had no observable influence on total or 
phospho-ERK fluorescence levels (Appendix A: Supplemental Figure 6).    
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Figure 3.1 SB220025 Concentration Response and Blastocyst Expansion 
Embryos were cultured for 24 h in control media (KSOMaa and SB 202474) or in 
KSOMaa + increasing doses of SB 220025 (2 µM, 5 µM, 10 µM and 20 µM) and imaged 
at 0 h, 12 h, and 24 h of treatment.  The diameter of each embryo was measured as 
described in Appendix A: Supplemental Figure 1 and volume was calculated from the 
radius. After 12 h and 24 h embryos cultured in KSOMaa + SB 220025 were significantly 
less expanded than controls. Three replicates were performed and 30-35 embryos were 
measured in each group. SEM p≤0.05 
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3.3.2 Embryo Recovery After p38 MAPK Inhibition 
After 12 h and 24 h of treatment, embryos were washed extensively in fresh, drug free 
medium and then placed into fresh culture drops for a treatment recovery period. 
Embryos treated for 12 h and then placed into recovery medium remained significantly 
less expanded than controls, however, they did resume expansion and continued to 
expand for the full recovery period (Figure 3.2A). Embryos treated for 24 h with SB 
220025 did not resume blastocyst expansion following this treatment (Figure 3.2B).   
 
3.3.3 p38 MAPK Activity is Required for In Vitro Zona Hatching  
As we established that p38 MAPK signaling regulates blastocyst expansion, we next 
investigated the role of p38 MAPK signaling in blastocyst hatching in vitro.  Zona 
hatching was assessed at 24 h and 48 h post collection. Blastocysts treated for 12 h with 
SB 220025 blocked zona hatching  (4% ± 4%) compared to KSOMaa (20% ± 15%) and 
SB 202474 (24% ± 10%) controls at 24 h post collection. Blastocysts treated for 24 h 
with SB 220025 (0%) displayed a significant (p ≤ 0.05) reduction in zona hatching 
compared to controls; KSOMaa (22% ± 12%) or SB 202474 (31% ± 10%) (Figure 3.3). 
Extending the experimental period to 48 h post collection (i.e. 12 h or 24 h treatment 
followed by 36 h or 24 h recovery respectively), had no benefit as embryos treated with 
SB 220025 remained enclosed by the zona pellucida (data not shown).   
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Figure 3.2 Embryo Recovery After 12 h (A) and 24 h (B) of Treatment 
Embryos were washed in fresh KSOMaa after 12 h (A) and allowed to recover until 24 h, 
28 h, and 36 h post collection.  The diameter of each embryo was measured as described 
in Appendix A: Supplemental Figure 1 and volume was calculated from the radius.   
(A) Embryos treated with SB 220025 for 12 h remained significantly less expanded 
compared to controls, however, they were still able to expand.   
(B) Embryos treated with SB 220025 for 24 h remained significantly less expanded 
compared to controls, and were not able to expand.  
Three replicates were performed and 30-35 embryos were measured in each group. SEM 
p≤0.05 
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Figure 3.3 Inhibition of the p38 MAPK Pathway Prevents Embryo Hatching 
(A) Embryos were cultured in KSOMaa, SB 202474 or SB 220025 for 12 h and then 
washed in fresh KSOMaa and cultured until 24 h post collection (12 additional 
hours) and then assessed for hatching.   
(B) Embryos were cultured in KSOMaa, SB 202474 or SB 220025 for 24 h and then 
assessed for hatching.   
Embryos that had begun to hatch were counted as positive.  (SEM; p≤ 0.05; n=4) 
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3.3.4 p38 MAPK Signaling, TE Differentiation, AJs and TJs 
We next investigated whether TE differentiation or polarization was affected due to p38 
MAPK inhibition after 24 h of treatment.  To assess TE differentiation, we investigated 
the expression of CDX2, a TF that is required for TE linage specification (Strumpf et al., 
2005). CDX2 localization was maintained and confined to the outer cells (yellow arrows) 
of both control (KSOMaa Figure 3.4A; SB 202474 Figure 3.4B) and SB 220025 treated 
blastocysts (Figure 3.4C).  To investigate TE polarization, we characterized the 
localization of CDH1, which is localized to the basolateral membranes of the TE 
(reviewed in Yamanaka et al., 2006; Bell et al., 2008).  CDH1 displayed a normal 
basolateral cell margin distribution pattern in the TE cells in each treatment group (Figure 
3.5).  We next investigated effects of SB 220025 treatment on TJ permeability using a 
standard FITC-dextran assay (Violette et al., 2006; Giannatselis et al., 2011). Blastocyst 
expansion is dependent upon the formation of a TJ permeability seal in the TE (reviewed 
in Yamanaka et al., 2006; Bell et al., 2008). Changes in the permeability of this TJ seal 
can be precisely assessed by applying a sensitive FITC-Dextran assay (Sheth et al., 2000; 
Violette et al., 2006; Giannatselis et al., 2011).  Following 12 h (Figure 3.6A) and 24 h 
(Figure 3.6B) SB 220025 treatment, we observed a significant increase in FITC-dextran 
accumulation into the blastocyst cavity compared to controls. This indicates that p38 
MAPK activity regulates TE TJ permeability. We then analyzed the effects of blocking 
p38 MAPK activity on blastocyst formation gene family expression by applying  RT-
PCR to investigate the effects of SB 220025 treatment on zonula occludens (Tjp1), 
Occludin (Ocln), and the Na/K ATPase beta 1-subunit (Atp1b1) mRNA levels (Kim et al., 
2004; Violette et al., 2006; Madan et al., 2007; Giannatselis et al., 2011). No significant 
difference in Tjp1, Ocln, or Atp1b1 mRNA levels was observed among treatment groups 
(data not shown).  Finally we assessed effects of treatment on TJP1 localization. 
Blastocysts treated for 12 h (Figure 3.7 A-F) with SB 220025 displayed abnormal TJP1 
cortical staining compared with control embryos.  TJP1 is normally distributed along the 
basolateral membrane in a smooth, continuous pattern (KSOMaa Figure 3.7A; merged 
image 3.7D; SB 202474 Figure 3.7B; merged image 3.7E).  TJP1 also co-localizes with 
the cytoskeleton, which can be seen as yellow signal in the merged images of both 
KSOMaa and SB 202474 treated embryos (KSOMaa Figure 3.7A; merged image 3.7D; 
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SB 202474 Figure 3.7B; merged image 3.7E).  In p38 MAPK inhibited embryos, TJP1 
appears in tight foci at cell-cell contacts with punctate staining and there is a loss of 
yellow signal to predominantly red signal indicating a loss of TJP1 co-localization with 
actin (Figure 3.7C; merged image 3.7F).  The same punctate distribution along the 
basolateral membrane and loss of yellow signal was observed in embryos treated after 24 
h (Figure 3.8 A-F) of p38 MAPK inhibition. After 24 h, TJP1 localization was more 
punctate (Figure 3.7C; merged image 3.7F; white arrows) along adjacent cell borders in 
SB 220025 treated embryos compared to 12 h of treatment and compared to control 
embryos (KSOMaa Figure 3.8A; merged image 3.8D; SB 202474 Figure 3.8B; merged 
image 3.8E; yellow arrows).  This punctate distribution was observed in 70% of embryos 
treated for 12 h and 85% of embryos treated for 24 h with SB 220025 as scored by two 
independent observers.     
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Figure 3.4 TE Differentiation is not Affected by p38 MAPK Inhibition 
CDX2 protein localization following treatment with KSOMaa, SB 202474, or SB 
220025. Representative images of CDX2 after 24 h of treatment in KSOMaa (A), SB 
202474 (B) or SB 220025 (C).  CDX2 protein localization pattern did not vary after 24 h 
(A-C).  White arrows indicate ICM; Yellow arrows indicate TE.  Blue = nucleus; Red = 
F-actin; Green = CDX2; n=10-15 embryos in each group; scale bar = 10 microns.  
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Figure 3.5 TE Polarization is not Affected by p38 MAPK Inhibition 
CDH1 protein localization following treatment with KSOMaa, SB 202474, or SB 
220025. Representative images of CDH1 after 24 h of treatment in KSOMaa (A), SB 
202474 (B) or SB 220025 (C).  CDH1 protein localization pattern did not vary after 24 h 
(A-C; Merge images D-F).    Blue = nucleus; Red = F-actin; Green = CDH1;  n=10-15 
embryos in each group; scale bar = 10 microns.  
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Figure 3.6 p38 MAPK Pathway Regulates TJ Permeability 
To test TJ permeability, embryos were treated in KSOMaa. SB 202474, or SB 220025 
then exposed to 40 kDa FITC-dextran. (A) After 12 h of treatment, a significant 
difference was observed in the number of embryos displaying 40 kDa FITC-dextran 
fluorescence within the blastocyst cavity between SB 220025 and control groups 
(p≤0.05) n=3.   (B) After 24 h of treatment, a significant difference was observed in the 
number of embryos displaying 40 kDa FITC-dextran fluorescence within the blastocyst 
cavity between SB 220025 and control groups (p≤0.05) n=3.  Representative images of 
embryos following 12 h or 24 h treatment of treatment with (C) 2 mM EGTA (positive 
control), (D) KSOMaa, (E) SB 202474 or (F) SB 220025 using 40kDa FITC-dextran.  
SEM; scale bars = 10 microns. n=3.  
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Figure 3.7 Inhibition of p38 MAPK Affects TJP1 Distribution at 12h 
TJP1 protein localization following treatment with KSOMaa, SB 202474, or SB 220025. 
Representative images of TJP1 after 12 h (A–F) treatment.  SB 220025 treatment affected 
TJP1 localization after 12 h (A-C; Merged images (D-F), white arrows indicate punctate 
staining of TJP1 along adjacent cell borders instead of the even distribution pattern 
normally observed in control embryos (yellow arrows).  Blue = nucleus; Red = F-actin; 
Green = TJP1; n=10-15 embryos in each group; scale bar = 10 microns.  
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Figure 3.8 Inhibition of p38 MAPK Affects TJP1 Distribution at 24h 
TJP1 protein localization following treatment with KSOMaa, SB 202474, or SB 220025. 
Representative images of TJP1 after 24 h (A–F) treatment.  SB 220025 treatment affected 
TJP1 localization after 24 h (A-C; Merged images (D-F), white arrows indicate punctate 
staining of TJP1 along adjacent cell borders instead of the even distribution pattern 
normally observed in control embryos (yellow arrows).  Blue = nucleus; Red = F-actin; 
Green = TJP1 n=10-15 embryos in each group; scale bar = 10 microns.  
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3.3.5 Inhibition of p38 MAPK Signaling Reduces Aqp3 mRNA Expression and 
Protein Detection 
To complete our analysis of the effects of p38 MAPK inhibition on blastocyst formation 
gene families, we investigated the effects of SB 220025 treatment on Aqp3 and Aqp9 
mRNA levels.  After 12 h of SB 220025 treatment, there was no significant difference in 
Aqp3 or Aqp9 mRNA levels between treated and control groups (Figure 3.9A).  After 24 
h, Aqp9 mRNA levels were unaffected, however, Aqp3 mRNA levels were significantly 
reduced in embryos treated with SB 220025 compared to controls (Figure 3.9B). 
Protein staining as observed using confocal microscopy also revealed a similar pattern.  
Embryos treated for 12 h had little or no difference in AQP3 detection (Figure 3.10 A-C).  
However, embryos treated for 24 h displayed an obvious and consistent reduction in 
AQP3 immunofluorescence intensity in p38 MAPK inhibited embryos (Figure 3.10 D-F).  
AQP9 staining did not reveal any visible difference after either 12 h or 24 h time point 
(data not shown).   
 
3.3.6 Inhibition of p38 MAPK Signaling Increases Apoptosis in the Blastocyst 
The results indicate that p38 MAPK regulates blastocyst expansion, zona hatching in 
vitro, TJ permeability and Aqp3 mRNA levels. The timing of p38 MAPK inhibition is 
critical as 12 h treated embryos recovered from treatment as demonstrated by their 
resumption of cavitation following treatment and placement in drug free culture medium, 
while 24 h treated embryos do not recover from treatment. For these reasons we 
investigated whether p38 MAPK inhibition affected apoptosis in SB 220025 treated 
embryos. Blastocysts treated for 12 h with SB 220025 displayed no significant difference 
in apoptosis levels between groups (Figure 3.11A).  However, embryos cultured for 24 h 
in SB 220025 displayed a significant increase in apoptotic cells (11% ± 1%, Figure 
3.11B) over that observed for controls (KSOMaa (6% ± 1%) and SB 202474 (6% ± 2%).   
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Figure 3.9 Inhibition of p38 MAPK Affects Aqp3 mRNA Expression 
Relative Aqp 3 and 9 mRNA levels following treatment. Quantitative RT–PCR was used 
to determine the relative mRNA levels of Aqp 3 after 12 h (A) or 24 h (B) in SB 220025. 
Aqp 3 and Aqp 9 mRNA were not significantly affected after (A) 12 h; n = 3, mean ± 
SEM, P ≤ 0.05. Aqp 9 mRNA was not significantly affected after (B) 24 h; however, Aqp 
3 mRNA was significantly decreased after 24 h. n = 3, mean ± SEM, P ≤ 0.05. 
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Figure 3.10 AQP3 Immunofluorescence After 12 h and 24 h of p38 MAPK 
Inhibition 
AQP3 protein localization following treatment with KSOMaa, SB 202474, or SB 220025. 
Representative images of AQP3 after 12 h (A–C) of p38 inhibition.  No apparent 
difference in AQP3 immunofluorescence was observed between treated and control 
embryos after 12 h.  However, embryos treated with SB 220025 for 24 h (D-F) displayed 
a clear and consistent reduction in AQP3 immunofluorescence compared to controls. 
Green = AQP3; n=10-15 embryos in each group; scale bar = 10 microns.  
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Figure 3.11 Inhibition of p38 MAPK Pathway Affects Apoptosis 
Apoptosis following KSOMaa, SB 202474 or SB 220025 treatment for 12 h (A) and 24 h 
(B). TUNEL was used to assess the level of apoptosis in blastocysts after having been 
cultured in KSOMaa, SB 202474 or SB 220025 media for 12 h or 24 h. Embryos cultured 
in KSOMaa, SB 202474 or SB 220025 for 12 h (A) displayed the same level of 
apoptosis. Embryos cultured in SB 220025 for 24 h (B) displayed a significant increase in 
apoptosis compared with controls; mean ± SEM, P ≤ 0.05. (C-G) Representative images 
of embryos from TUNEL assay; (C) Negative control; (D) Positive control; (E) 
KSOMaa; (F) SB 202474; (G) SB 220025; n = 4 replicates; 15-20 embryos in each 
group.  
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3.4 Discussion 
Preimplantation development is the most vulnerable period of mammalian development 
with the majority of human preimplantation embryos failing to reach the blastocyst stage 
or implant  (Ellish et al., 1996). With the increasing reliance on fertility clinics and 
Assisted Reproductive Technologies (ARTs) to provide patients with an opportunity to 
have children (Mesrogli et al., 1991; Sebastiani et al., 2009; Lee et al., 2010), research 
focusing on understanding the mechanisms controlling preimplantation development and 
also on how the environment affects that developmental program is increasingly needed.  
Previous studies have demonstrated that Na/K-ATPase subunits, AJs, TJs and AQPs 
contribute directly to the mechanism that enables the TE to oversee cavitation and 
blastocyst formation (reviewed in Bell et al., 2009; Giannatselis et al., 2011). It is 
necessary to define the intracellular signaling mechanisms that regulate the functions of 
these gene products so that we can develop a comprehensive understanding of how 
cavitation and blastocyst formation are coordinated. We have recently demonstrated that 
the Na/K-ATPase, in addition to its well known ion transport function can also serve as a 
mediator of ouabain induced Src activation that regulates TJ function and blastocyst 
formation (Giannatselis et al., 2011). The present study, with its focus on p38 MAPK, 
probed the role of pathways that may be downstream of Src and investigated their 
contributions to cavitation and blastocyst formation.  
In the present study we have demonstrated that p38 MAPK regulates cavitation and 
overall blastocyst formation. More importantly we have uncovered several components of 
the p38 MAPK mediated role by demonstrating that p38 MAPK inhibition in early 
blastocysts is accompanied by an increase in TE tight junction permeability, shifts in 
TJP1 localization, down regulation of Aqp3 mRNA levels, reduced AQP3 detection and 
increased apoptosis. Together these outcomes place p38 MAPK as a likely intracellular 
signaling mediator that coordinates the function of the blastocyst formation family genes 
in regulating cavitation and blastocyst formation. The consistency of outcomes observed 
regarding the effects to blastocyst cavity expansion for both CSAID treatments employed 
in this study, and the absence of observable effects to the ERK MAPK pathway during 
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these treatments, support our conclusion that the effects we have observed are attributable 
to a blockade of p38 MAPK activity.   
We were concerned that the outcomes on blastocyst expansion following CSAID 
treatment may be related to effects on TE differentiation or TE polarity. CDX2 activity is 
regulated by p38 MAPK phosphorylation in intestinal epithelial cell differentiation 
(Houde et al., 2001) and additionally, p38 MAPK regulates Cdh1 expression during 
gastrulation, a process that occurs immediately following implantation (Rossant et al., 
1997; Rossant, 2004; Behr et al., 2005).  We therefore sought to determine if p38 MAPK 
regulated CDX2 and CDH1 localization or detection in the blastocyst.  Our outcomes 
demonstrated no effect of CSAID treatment on CDX2 or CDH1 localization suggesting 
that TE differentiation and polarity were already well established and likely unaffected by 
the CSAID treatment used in this study. We applied our studies exclusively to cavitating 
blastocysts (89 hr post-hCG) so that we could focus specifically on investigating the role 
of p38 MAPK on blastocyst cavitation. It may be possible that p38 MAPK does affect TE 
differentiation and TE polarity but to determine this, experiments would have to be 
directed to earlier stages of development prior to the onset of cavitation. Thus, the 
maintenance of TE differentiation and polarity as indicated by normal CDX2 and CDH1 
localization patterns ensure that the outcomes observed in our study pertain specifically 
to p38 MAPK regulation of cavitation and are not due to secondary or indirect influences 
due to disruption of TE differentiation or polarity.   
From these experiments, we were also able to conclude that F-actin was present and 
properly localized in p38 MAPK inhibited embryos.  Our studies did not observe any 
changes in staining intensity of F-actin in p38 MAPK inhibited blastocyst unlike those 
reported by Natale et al. 2004 and Paliga et al., 2005.  Natale et al., 2004, and Paliga et 
al., 2005, demonstrated that p38 MAPK signaling was required at the 8-16 cell stage for 
normal blastocyst development through its regulation of heat-shock protein 25/27 which 
stabilizes F-actin.  F-actin stability was restored after p38 MAPK inhibition was removed 
and embryos were placed in new culture drops and allowed to progress to the blastocyst 
stage (Natale et al., 2004; Paliga et al., 2005).  The differences we have observed between 
our two studies could be indicative of a stage specific role that p38 MAPK plays at the 8-
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16 cell stage versus the blastocyst stage.  This result supports the hypothesis that p38 
MAPK signaling regulates different cellular responses at the 8-16 cell stage from the 
blastocyst stage of preimplantation development and this may represent an important 
process of signaling maturation that the preimplantation embryo acquires as it advances 
towards the blastocyst stage and prepares for implantation. Gene deletion studies have 
demonstrated that p38 MAPK is required for successful development with knockout 
mice suffering a developmental lethality by day 10.5 of pregnancy (reviewed in Aouadi 
et al., 2006).  Each CSAID compound targets both p38 MAPK  and  forms and thus 
while preimplantation embryos may be able to complete this developmental interval in 
the absence of p38 MAPK we would suggest that our collective results demonstrate 
that targeting both p38 MAPK and using CSAID treatment results in a cessation of 
preimplantation development and erosion of the adaptive mechanisms that early embryos 
use to adjust to the environment (Jackson et al., 1998, Natale et al., 2004; Paliga et al., 
2005; Fong et al., 2008; Bell et al., 2009).  These results indicate that p38 MAPK is an 
important mediator of preimplantation embryo development and environmental adaptive 
responses (Natale et al., 2004; Paliga et al., 2005; Fong et al., 2008; Bell et al., 2009). 
We observed a considerable effect of CSAID treatment time on blastocyst cavitation and 
zona hatching in this study. Clearly both a 12 h and 24 h treatment time had a significant 
negative effect on blastocyst cavitation and zona hatching in vitro. The effects of 12 h 
treatment were less severe than the 24 h treatment. Embryos treated for 12 h displayed an 
ability to resume expansion after treatment while those treated for 24 h did not. In 
addition, both treatment times resulted in a blockade of zona hatching in vitro even after 
placement in fresh culture drops and allowed to recover. Our interpretation of these 
outcomes is that the 12 h treatment simply slowed down the developmental program 
sufficiently to prevent the treated embryos from fully catching up to their untreated 
controls during the recovery period. The majority of the controls had advanced to become 
fully expanded, zona hatched blastocysts by the end of the experimental and the treatment 
recovery periods. This outcome mirrors our observations of the effects of CSAID 
treatment on cleavage stage embryos, where we observed that they proceeded to the 
blastocyst stage in normal frequencies once CSAID treatment was halted but this advance 
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was accompanied with a substantial time delay (Natale et al., 2004; Paliga et al., 2005). 
The 12 h treated blastocysts in the present study were clearly advancing following 
CSAID treatment, but the recovery period was not long enough to allow them to become 
synchronized once again with their control counterparts (Natale et al., 2004; Paliga et al., 
2005).  The 24 h treated blastocysts displayed a very different outcome as they were 
unable to resume expansion following CSAID treatment.  Our interpretation of this 
outcome is based upon our knowledge of the duel function that p38 MAPK plays during 
preimplantation development. We would suggest that the 24 h treatment was sufficiently 
long enough to deprive the embryo of a key component of its adaptive mechanism to 
environmental stress resulting in an inability of the embryo to recover following 
treatment (Reviewed in  Cargnello et al., 2011;  Fong et al., 2007; Aouadi et al., 2006; 
Natale et al., 2004; Bell et al., 2009).  This interpretation is supported by our results, for 
apoptosis was unaffected by the 12 h CSAID treatment period, but the 24 h treatment 
period was accompanied by a significant increase in apoptosis. Studies have clearly 
demonstrated that it is the JNK/SAPK pathway that regulates apoptosis in the 
preimplantation embryo, especially following environmental stress (Xie et al., 2003; 
Wang et al., 2005; Xie et al., 2006; Bell et al., 2009). We would propose that the 
extended 24 h CSAID treatment time and its accompanying failure to resume cavitation 
and increased apoptosis are reflective of the effects of environmental stress on the 
embryo due to the prolonged inhibition of a key component of the embryo’s stress 
response adaptive mechanisms (Fong et al., 2008; Bell et al., 2009). The down regulation 
of Aqp3 mRNA levels and reduced AQP3 detection observed only at the 24 h treatment 
time is certainly consistent with this interpretation of our results. A decline in Aqp3 
mRNA levels and reduced AQP3 detection are suggestive that facilitated fluid movement 
across the TE may be impeded by 24 h CSAID treatment. If so, this would certainly 
contribute to the inability of 24 h CSAID treated embryos to resume expansion following 
treatment and this outcome is consistent with our earlier report that demonstrated that p38 
MAPK regulates Aqp mRNAs levels in cleavage stage embryos (Bell et al., 2009). 
Finally, the increased FITC-dextran permeability we observed following 12 h and 24 h 
CSAID treatment is consistent with our earlier studies (Violette et al., 2006; Giannatselis 
et al., 2011). Strippoli et al., 2010 investigated the role of p38 MAPK during epithelial-
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to-mesenchymal transition (EMT) and demonstrated that loss of p38 MAPK signaling 
during EMT resulted in disorganized and loss of expression of TJP1 in human 
mesothelial cells (Strippoli et al., 2010). Collectively, these studies provide an 
understanding of the mechanisms that control TJ function during cavitation and reinforce 
our understanding of the role the TJ permeability seal plays in regulating cavitation and 
blastocyst formation (Violette et al., 2006; Madan et al., 2007; Giannatselis et al., 2011). 
Our recent studies have demonstrated that the Na/K-ATPase is an upstream regulator of 
TE TJ permeability and this mechanism is modulated by Src phosphorylation (Violette et 
al., 2006; Madan et al., 2007; Giannatselis et al., 2011).  The present study has implicated 
p38 MAPK as a likely downstream intermediary from Na/K-ATPase and Src regulation 
of TE TJ function.  In conclusion, our results support an important role for p38 MAPK in 
mediating cavitation and blastocyst expansion and suggest that it is an important mediator 
of blastocyst formation gene family expression, function and thus coordination of the 
overall events that regulate blastocyst formation.   
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CHAPTER FOUR 
SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell 
Stage and Become Segregated to the TE in the Mouse 
Blastocyst 
 
 
A version of this chapter has already been published: 
  
Bell, C. E., & Watson, A. J. (2009). SNAI1 and SNAI2 are asymmetrically expressed at 
the 2-cell stage and become segregated to the TE in the mouse blastocyst. PLoS ONE, 
4(12) 
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4.1 Introduction 
Preimplantation development is characterized by the differentiation of two distinct cell 
types, inner cell mass (ICM) which will form the embryo proper and the trophectoderm 
(TE) which will contribute to the embryonic portion of the placenta (Yamanaka et al., 
2006). The TE is a polarized, epithelial cell type and the development of the TE is the 
first differentiation event to occur throughout mammalian development. The cell polarity 
model proposes that TE differentiation is initiated at the 8-cell stage and that TE cell fate 
occurs through the establishment of cell polarity along the length of each blastomere 
forming an apical and basolateral membrane (Yamanaka et al., 2006). If a blastomere 
undergoes symmetric division, each daughter cell inherits equally the apical and 
basolateral membrane, will remain polarized, and contribute to the TE (Yamanaka et al., 
2006). If a blastomere undergoes asymmetric division, each daughter cell inherits a 
distinct portion of the polarized membrane, either apical and basolateral or just 
basolateral, resulting in the differentiation of a TE cell and an ICM cell respectively 
(Yamanaka et al., 2006). Prior to the compacted 8-cell stage in the mouse however, 
blastomeres are totipotent and can contribute to all cell types of the blastocyst (Rossant et 
al., 1976). The outer embryonic blastomeres that do go on to form the TE acquire several 
critical gene products such as Na/K-ATPase (Watson & Kidder 1988; Violette et al., 
2006; Madan et al., 2007), tight junctions (Flemming et al., 1989) and adherens junction, 
aquaporins (Johnson & McConnell JM 2004), and several transcription factors, such as 
caudal homeobox 2 (CDX2) (Strumpf et al., 2005) which define the TE cell lineage and 
orchestrate its function during blastocyst formation. 
Recently, Na/K-ATPase β1 subunit expression has been shown to be regulated in cell 
lines by the two TFs, SNAI1 (previously known as SNAIL) and SNAI2 (previously 
known as SLUG) (Espineda et al., 2004). SNAI1 expression was increased in MDCK 
cells resulting in the down-regulation of the Na/K-ATPase β1. E-cadherin expression was 
also down-regulated resulting in the loss of cell-cell contacts (Espineda et al., 2004). 
Conversely, SNAI2 expression promoted Na/K-ATPase β1 subunit expression by 
inhibiting SNAI1 expression (Espineda et al., 2004). Aberrant expression of SNAI1 
(Carver et al., 2001; Hotz et al., 2007; Peinado et al., 2007) and SNAI2 (Rukstalis & 
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Habener, 2007; Yoshino et al., 2007) is also linked to cancer metastasis in epithelial cell 
lines through its role in directing epithelial-to-mesenchymal cell transition (EMT). 
SNAI1 and SNAI2 direct the loss of polarity in epithelial cells by down-regulating E-
cadherin expression resulting in EMT. Once EMT has occurred, a cell is no longer 
adherent to its neighbors and re-engages cell proliferation and metastasis programs 
(Rukstalis & Habener, 2007). Snai1 knock-out studies in mice have revealed a role for 
SNAI1 in neural crest differentiation (Carver et al., 2001). Snai2 knock-out mice do not 
display an embryonic lethality and survive to birth (Jiang et al., 1998). Since SNAI1 and 
SNAI2 are important mediators of E-cadherin and Na/K ATPase β1 subunit expression, 
(necessary components for TE differentiation and maintenance), we have characterized 
Snai1 and Snai2 expression throughout mouse preimplantation development and TE 
differentiation. Our results have revealed a novel and unexpected protein localization 
pattern for SNAI1 and SNAI2 in the 2-cell and 4-cell embryo and have demonstrated that 
SNAI1 and SNAI2 become confined solely to the outer cells, TE cell lineage of the early 
embryo and are not present in the inner cell, ICM lineage of the embryo.  
4.2 Materials and Methods 
4.2.1 Collection of Preimplantation Embryos 
Mouse embryos were obtained from random-bred MF1 females super ovulated with 
Pregnant Mare's Serum Gonadotropin (PMSG) and human Chorionic Gonadotropin 
(hCG), and mated with CD1 males. Successful mating was determined the next morning 
(day 1) by the presence of a vaginal plug. Embryos were collected at specified times 
following hCG injection, which correspond to appropriate cleavage stages: 1-cell 
inseminated zygotes, 18-hr post-hCG; 2-cell, 48 hr; 4-cell, 60 hr; 8-cell, 65–68 hr; 
compacted embryo, 80–85 hr and blastocysts, 90 hr. Embryos were then washed in 50 µl 
M2 media and frozen in groups of 20 for quantitative RT-PCR analysis or fixed for whole 
mount immunofluorescence detection of SNAI1 and SNAI2 proteins. 
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4.2.2 Mouse Fibroblast NIH 3T3 Cell Culture 
NIH 3T3 cells were plated in 6-well culture dishes at a density of 5×10
3
 cells/cm
2
. Cells 
were cultured in complete medium supplemented with 10% fetal bovine serum (Sigma, St 
Louis, MO), 1% Antibiotics (Sigma) in DMEM. Cells were trypsinized with 1X trypsin 
for 1 min at 37°C, harvested in 3–5 ml complete medium and centrifuged for 5 min at 
4000×g. Cells were re-suspended in 10 ml complete medium and plated on chamber 
slides for immunofluorescence analysis or on 15 cm plates for protein analysis. Cells 
were cultured for 2 days until they reached confluence and fixed for immunofluorescence 
or lysed for whole cell lysate collection. 
4.2.3 Quantitative RT-PCR 
Quantitative RT-PCR was conducted to determine the mRNA profile of Snai1 and Snai2 
at the 1-cell, 2-cell, 4-cell, 8-cell, compacted embryo and blastocyst stages. Prior to RNA 
extractions, Luciferase mRNA, an exogenous control, was added to the samples. Total 
RNA was extracted from pools of 20 embryos using the PicoPure kit (Arcturus, 
Molecular Device, Sunnyvale, CA). Reverse Transcription reaction was carried out using 
Sensiscript reverse transcriptase (Qiagen, Mississauga, ON). The samples were incubated 
in 10x buffer, RNAse inhibitor, dNTPs and random primers at 37°C for 1 hr. Quantitative 
PCR reactions were performed using the BioRad Chromo4 detection system (BioRad, 
Mississauga, ON). PCR was carried out in 25 µl reactions containing 12.5 µl Multiplex 
Universal PCR Master Mix (2X concentration solution optimized for multiplex reactions, 
BioRad), 1.25 µl of SNAI1 and SNAI2 primer/probe sets provided by Biosearch 
Technologies (Novado, CA), or SYBR Green (Invitrogen, Burlington, ON) and 5 µl of 
appropriate dilution of cDNA (0.1 embryo/µl), and 6.25 µl of water. Snai1 primer 
sequence 5′-CATCCTCGCTGGCATCTTCC-3′; 3′-GAGAGCCAAGCAGGAACCAG-
5′; Snai2 primer sequence 5′-CTTTACCCAGTGGCCTTTCTC-3′; 3′-
CCACAGATCTTGCAGACACAA-5′. 
4.2.4 Whole-Mount Immunofluorescence 
Protein localization was investigated using whole-mount immunofluorescence methods 
for both SNAI1 and SNAI2 throughout preimplantation development. Embryos were 
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fixed in 2% paraformaldehyde in PBS and then incubated in primary rabbit polyclonal 
anti-SNAI1 (ab 17732, Abcam, Cambridge, MA and gift from Dr. Paul Wade and Dr. 
Archana Dhasarathy) or rabbit polyclonal anti-SNAI2 antibodies (ab27568, Abcam). 
Negative controls were incubated in antibody dilution buffer alone. NIH 3T3 cells were 
fixed in 4% paraformaldehyde in PBS for 20 min. Cells were then washed and incubated 
with primary SNAI1 or SNAI2 antibody. Negative control cells were incubated in 
antibody dilution buffer alone. Antibody specificity was determined by conducting 
immuno-pre-absorption assays with either a SNAI1 peptide (Abcam) for the SNAI1 
antiserum or a SNAI2 peptide (Abcam) for the SNAI2 antiserum. Fixed embryos were 
then incubated in either SNAI1 or SNAI2 antisera alone, or in the pre-absorption 
antibody solution. Embryos and cells were examined by confocal microscopy using an 
Olympus Fluoview 1000 laser scanning Confocal Microscope (Olympus, Canada). Z-
stack images were taken of the embryos and used to count total cell number and SNAI1 
or SNAI2 positive cells. 
4.2.5 Western Blot 
NIH 3T3 cells were lysed, on ice, using RIPA buffer with Protease inhibitors. Cells were 
then scraped into the RIPA buffer and homogenized by repeated pipetting. Cell lysate 
was removed and placed into a 1.5 ml tube and centrifuged at 4000×g for 5 min. The 
supernatant was removed and stored at −80°C. Protein Quantification was performed 
using DC Protein Assay kid (BioRad) and a spectrophotometer. A 12% acrylamide 
stacking gel was used and 40 mg of protein was loaded into each lane. Antiserum 
dilutions employed included SNAI1 anti-serum (1:1000); SNAI2 antiserum (1:2000); and 
secondary antibody (Anti-Rabbit IgG HRP-linked (Cell Signalling, Danvers, MA) at 
1:10000). Antiserum pre-absorption assay was performed prior to membrane incubation. 
4.2.6 Microinjection of siRNAs 
Microinjection was performed under an inverted microscope using a mechanical 
micromanipulator (Leica, Richmond Hill, ON, CA) attached to Picoinjector PLI-100 
(Harvard Apparatus, Saint-Laurent, PQ, CA). 1-cell embryos were injected with either 
negative control (Invitrogen) or siRNA duplexes targeting Snai1 or Snai2. Microinjection 
149 
 
 
 
of embryos was performed according to a standard procedure. One-cell embryos were 
placed on a concave watch glass and into KSOMaa medium under light mineral oil. A 
holding pipette (Conception Technologies, San Diego, CA) was used to keep the one-cell 
embryos stationary during manipulation. An injection pipette loaded with siRNA solution 
was inserted into the cytoplasm of each zygote followed by the microinjection of 
approximately 20 pl of 20 µM of dsRNA. After microinjection, embryos were cultured in 
KSOMaa medium as described above for 48 hours and fixed at the 4–8 cell stage and 
used for whole-mount immunofluorescence as described above. 
4.2.7 Statistics 
Quantitative RT-PCR and whole-mount immunofluorescence were performed in 
triplicate using pools of embryos at each stage collected from 3 groups of mice. Data was 
analyzed using the SigmaStat® 3.5 (Jandel Scientific Software, San Rafael, CA, USA). 
Upon acceptance of normality tests, the data was analyzed using a One-way ANOVA 
followed by a Bonferroni multiple comparison test. If the data failed the normality test, it 
was analyzed using an ANOVA on ranks, followed by a Dunn's multiple comparison test. 
4.3 Results 
4.3.1 Quantitative RT-PCR of Snai1 and Snai2 Throughout Preimplantation 
Development 
When quantitative RT-PCR was performed on each developmental stage (1-cell, 2-cell, 
4-cell, 8-cell, compacted embryo, blastocyst), it revealed that Snai1 and Snai2 transcripts 
were differentially regulated throughout preimplantation development (Figures 4.1A and 
4.1B respectively). Snai1 transcripts were detected as early as the 1-cell stage, and then 
Snai1 was significantly up-regulated at the 2-cell stage followed by down regulation at 
the 8-cell stage and return to baseline levels at the blastocyst stage (Figure 4.1A). 
Detection of Snai1 throughout preimplantation development confirms previously reported 
detection by Veltmaat et al., 2000; however, here we report relative levels of Snai1. 
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Figure 4.1 Characterization of Snai1 and Snai2 Expression 
(A) Snai1 transcripts were detected using quantitative RT-PCR using pools of 20 freshly 
flushed embryos, at each stage of development (1-cell, 2-cell, 4-cell, 8-cell, compacted 
embryo and blastocyst); n = 3, p ≤ 0.05 ±S.E.M. (B) Snai2 transcripts were detected 
using quantitative RT-PCR using pools of 20 freshly flushed embryos, at each stage of 
development (1-cell, 2-cell, 4-cell, 8-cell, compacted embryo and blastocyst); n = 3, p ≤ 
0.05 ± S.E.M. 
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 4.3.2 Whole Mount Immunofluorescence of SNAI1 and SNAI2 Throughout 
Preimplantation Development 
As revealed by Snai1 knock-out studies, SNAI1 plays a role in neural crest differentiation 
during mouse development (Carver et al., 2001). Snai2 knock-out mice, alternatively, are 
able to survive to birth (Jiang et al., 1998). Although there is no preimplantation lethality 
in the Snai1 or Snai2 knock-out, the potential does exist that oogenetic proteins are 
sufficient to maintain viability past the preimplantation stage in the Snai1 and Snai2 
nulls. Whole-mount immunofluorescence and confocal microscopy were used to 
investigate freshly flushed embryos at each preimplantation developmental stage and 
revealed a unique distribution pattern. SNAI1 localization appears in discrete fluorescent 
foci in cortical regions throughout the zygote (Figure 4.2A). SNAI2 localization is 
symmetrical however; there are areas with increased intensity throughout the zygote 
(Figure 4.2B). SNAI1 and SNAI2 protein immunofluorescence revealed a variety of 
distribution patterns at the 2-cell stage including an asymmetrical localization within 
individual blastomeres. In 6% of 2-cell embryos, SNAI1 was not detectable, while in 
94% of 2-cell embryos SNAI1 was detectable but displayed variable localization patterns 
that consisted of either symmetrical or asymmetrical localization patterns within one or 
both blastomeres of a 2-cell embryo (Figure 4.3A). 16% of 2-cell embryos displayed a 
pattern where SNAI1 was asymmetrical in one blastomere and not expressed in the 
second blastomere, 9% displayed symmetrical distribution in one blastomere and no 
detection in the second, 16% displayed an asymmetrical and symmetrical pattern, 25% 
both asymmetrical and 28% where both blastomeres displayed symmetrical distribution 
(Figure 4.3A). Furthermore, SNAI1 was consistently detectible in the cytoplasm, 
however although SNAI1 is a transcription factor, nuclear localization was not commonly 
observed. 
In contrast, SNAI2 was localized to both the cytoplasm and nucleus in positive 
blastomeres throughout preimplantation development. SNAI2 also displayed both 
asymmetrical and symmetrical distribution patterns at the 2-cell stage (Figure 4.3B). 16% 
of 2-cell embryos displayed symmetrical cytoplasmic localization in both blastomeres, in 
40% both blastomeres were asymmetrical and 36% where both blastomeres displayed 
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symmetrical distribution and weak localization to the nuclei. 8% of 2-cell embryos 
displayed a pattern where in one blastomere SNAI2 was asymmetrical, localized to one 
pole of the blastomere but not expressed in the nucleus or in the second blastomere 
(Figure 4.3B) 
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Figure 4.2 Localization of SNAI1 and SNAI2 in the 1-cell Zygote. 
(A) SNAI1 localization appears in discrete fluorescent foci in cortical regions throughout 
the zygote; n = 9. (B) SNAI2 localization is symmetrical however, there are areas with 
increased intensity throughout the zygote; n = 10. Red = Filamentous Actin; Blue = 
Nuclei; Green = SNAI1 or SNAI2. Scale bars = 10 microns. 
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Detection of SNAI1 and SNAI2 at the 4-cell stage also revealed a variety of distribution 
patterns, including asymmetrical localization within individual blastomeres (Figures 4.4A 
and 4.4B). Localization patterns included 4-cell embryos expressing SNAI1 in all 
blastomeres, 3 of the 4 blastomeres, or only 2 blastomeres (Figure 4.4A). 
 SNAI1 and SNAI2 were detected in the majority of blastomeres at the 8-cell stage 
(Figures 4.5A and 4.5B respectively). SNAI1 was either asymmetrically expressed or 
symmetrically expressed within an individual 8-cell blastomere, however this pattern was 
consistent across all 8-cell embryos. Asymmetrical expression of SNAI2 was also 
observed within an individual 8-cell stage blastomere, however symmetrically distributed 
SNAI2 was the most common pattern observed (Figure 4.5B). In the compacted embryo, 
SNAI1 and SNAI2 proteins become confined to the outer cells only and the inner cells no 
longer displayed SNAI1 or SNAI2 immunofluorescence (Figures 4.5A and 4.5B). This 
localization pattern of SNAI1 and SNAI2 persists throughout development resulting in 
the detection of SNAI1 and SNAI2 only in the TE of the blastocyst (Figures 4.5A and 
4.5B). Cell counts performed at the 8-cell, compacted embryo and blastocyst stage 
revealed the percentage of SNAI1 and SNAI2 positive cells significantly decreased as 
embryos progressed to the blastocyst stage. As the blastocyst matures and becomes fully 
expanded, SNAI1 and SNAI2 were decreasingly detected in all TE cells (filled yellow 
arrow indicates positive staining for SNAI1 (Figure 4.5A) and SNAI2 (Figure 4.5B); 
filled red arrow indicates negative SNAI1 TE cell (Figure 4.5A) and negative SNAI2 TE 
cell (Figure 4.5B). 
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Figure 4.3. Representative Images of SNAI1 and SNAI2 Localization at the 2-cell 
stage. 
(A) Embryos were categorized based on SNAI1 localization; n = 32, three replicates.  
(B) Embryos were categorized based on SNAI2 localization; n = 25, three replicates.  
Red = Filamentous Actin; Blue = Nuclei; Green = SNAI1 (A) or SNAI2 (B). Scale bars = 
10 microns. 
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Figure 4.4 Representative Images of SNAI1 and SNAI2 Localization at the 4-cell 
Stage. 
(A) Embryos were categorized based on SNAI1 localization; n = 15, three replicates.  
(B) Embryos were categorized based on SNAI2 localization; n = 18, three replicates.  
Red = Filamentous Actin; Blue = Nuclei; Green = SNAI1 (A) or SNAI2 (B). Scale bars = 
10 microns.  
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Figure 4.5 Representative Images of SNAI1 and SNAI2 Localization at the 8-cell, 
Compacted Embryo and Blastocyst Stage 
(A) SNAI1 protein expression pattern at the 8-cell, compacted embryo, and blastocyst 
stages. The number of blastomeres expressing SNAI1 versus the total number of 
blastomeres at each stage was counted. 8-cell (n = 16); Compacted embryo (n = 10); 
Blastocyst (n = 13); * = p≤ 0.05; *** = p≤ 0.001, ±S.E.M. Red = Filamentous Actin; 
Blue = Nuclei; Green = SNAI1. Scale bars = 10 microns.   
(B) SNAI2 protein expression pattern at the 8-cell, compacted embryo, and blastocyst 
stages. The number of blastomeres expressing SNAI2 versus the total number of 
blastomeres at each stage was counted. 8-cell (n = 20); Compacted embryo (n = 12); 
Blastocyst (n = 10); * = p≤ 0.05, ±S.E.M. Red = Filamentous Actin; Blue = Nuclei; 
Green = SNAI2. Scale bars = 10 microns.  
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4.3.3 Validation of SNAI1 and SNAI2 Antisera 
Due to the unique nature of the protein localization patterns we report in our study, we 
were especially vigilant regarding the specificity of the antisera employed in this study. 
Antibody peptide pre-absorption controls were conducted using preimplantation embryos. 
Detection of SNAI1 and SNAI2 was lost in embryos incubated with peptide pre-absorbed 
antisera compared to embryos incubated in non-pre-absorbed antisera alone (Appendix B: 
Supplemental Figures 1A and 1B, respectively). In addition, we knocked down SNAI1 
and SNAI2 by microinjecting siRNA into 1-cell embryos targeting either Snai1 or Snai2. 
SNAI1 and SNAI2 were distinctly knocked down but were still weakly detectable in the 
siRNA injected embryos. This reduction of SNAl1 and SNAI2 fluorescence further 
verifies the specificity of the antisera employed in this study (Appendix B: Supplemental 
Figures 1C and 1D). We next confirmed the localization patterns of these antisera in 
published cell models using the same antisera. SNAI1 and SNAI2 immunofluorescence 
applied to NIH 3T3 cells demonstrated a normal (i.e. nuclear and cytoplasmic 
distribution) SNAI1 and SNAI2 localization compared to previously published data 
(Appendix B: Supplemental Figures 2A and 2B respectively; (Appendix B: Supplemental 
Figure 1C is the negative control)) (Franci et al., 2006). We also applied Western Blot 
analysis, which revealed single and appropriate sized bands for SNAI1 and SNAI2 
(Appendix B: Supplemental Figure 2D). Furthermore, a peptide pre-absorption assay was 
also performed for the Western blot analysis revealing that the SNAI1 and SNAI2 bands 
were no longer detectible using pre-absorbed antisera (Appendix B: Supplemental Figure 
2D). These experiments conclusively show that the SNAI1 and SNAI2 antisera employed 
in this study are specific for SNAI1 and SNAI2, respectively. 
4.4 Discussion 
This study sought to characterize the expression of the Snai1 and Snai2 throughout 
preimplantation development. Our results have revealed a novel, asymmetrical protein 
distribution of SNAI1 and SNAI2 within the early preimplantation embryo. Snai1 and 
Snai2 transcripts are detectible throughout preimplantation development. SNAI1 and 
SNAI2 have variable expression at the 2-cell and 4-cell stage including asymmetrical and 
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symmetrical localization within individual blastomeres. SNAI1 and SNAI2 are detected 
in the majority of blastomeres at the 8-cell stage, however, protein localization varies 
between blastomeres within a single embryo. SNAI1 and SNAI2 are then localized to the 
outer cells in the compacted embryo and are localized only in TE cells of the blastocyst. 
The Snai1 pattern of mRNA accumulation does not follow the general pattern of mRNA 
transcript expression throughout mouse preimplantation development where oogenetic 
transcripts are largely degraded by the 2-cell stage and then replaced by embryonic 
expression that drives transcript accumulation after the maternal-to-zygotic transition 
occurs (Bell et al., 2008). This expression pattern supports a novel role for SNAI1 during 
the maternal-to-zygotic transition (MET), as its expression is linked closely with the 
onset of the MET. This is further supported by studies conducted in zebrafish that 
demonstrate an increase in Snai1 transcript during the onset of MET (Hammerschmidt & 
Nüsslein-Volhard, 1993). Snai2 transcripts do decrease at the 2-cell stage and therefore 
more closely follow the typical MET pattern of mRNA transcript abundance during 
mouse preimplantation development. 
Asymmetrical protein localization in early embryonic blastomeres has been reported by 
Antczak and Blerkhome, 1997. They reported that Leptin and STAT3 were both 
asymmetrically expressed in the oocyte and after fertilization, were subsequently 
distributed unevenly to daughter blastomeres at the 4-cell and 8-cell stage. Consequently, 
Leptin and STAT3 became distributed in outer cells of the compacted embryo and then in 
select cells of the TE, leading to the hypothesis that Leptin and STAT3 distribution may 
contribute to lineage segregation. SNAI1 and SNAI2 are also asymmetrically localized; 
however, unlike Leptin and STAT3, SNAI1 and SNAI2 are expressed in all cells of the 8-
cell stage and are not asymmetrically expressed in the outer cells of the compacted 
embryo or TE of the blastocyst. One similarity is that SNAI1 and SNAI2, like STAT3 
and Leptin are expressed in certain cells of the TE in the expanded blastocyst, but not all. 
It would be interesting to determine if STAT3 and Leptin expression coincided with 
SNAI1 and SNAI2 expression in the blastocyst (Antczak & Van Blerkom, 1997). In other 
vertebrates and invertebrates asymmetrical protein expression is more common (ex. 
Xenopus) (Chan & Etkin, 2001). Asymmetrical expression of proteins in other species 
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plays a role in differentiation by the allocation of that protein to distinct cell lineages 
through subsequent cellular divisions (Chan & Etkin, 2001). Lineage tracing studies 
would have to be performed to determine segregation of SNAI1 and SNAI2 between the 
2-cell to 4-cell division in the mouse embryo. Furthermore, it has been demonstrated that 
each blastomere at the 8-cell stage retains the ability to contribute to all cell lineages of 
the early embryo and thus is referred to as being “totipotent” (Yamanaka et al., 2006). 
Our results indicate that blastomeres at the 2-cell, 4-cell and 8-cell stages do not all 
localize SNAI1 or SNAI2 equally and thus while all early blastomeres may display 
totipotence, they are not all equivalent. This variable pattern of SNAI1 and SNAI2 
localization may be regulated by the cell cycle as early blastomeres undergo 
asynchronous cell divisions. However, the asymmetrical SNAI1 and SNAI2 localization 
patterns within individual blastomeres cannot result from cell cycle variation between 
blastomeres and likely results from cytoskeletal based mechanisms within the cell. 
Our data do not allow us to conclude that SNAI1 or SNAI2 are active contributors to cell 
fate decisions during preimplantation development, but certainly SNAI1 and SNAI2 are 
markers of cell fate decisions as their distribution patterns reflect the cell lineage 
decisions that occur during the first week of development. It is intriguing to propose that 
blastomeres displaying variable SNAI1 and SNAI2 localization patterns may divide in 
varying planes, which would produce an uneven inheritance of SNAI1 or SNAI2 to the 
daughter blastomeres, and thus contribute to cell fate decisions in the early embryo. 
Alternatively, blastomeres that have symmetrical distribution of SNAI1 or SNAI2 may 
divide radially, where both daughter blastomeres would inherit SNAI1 or SNAI2. Our 
studies will pursue the determination of the role(s) that SNAI1 and SNAI2 play in 
preimplantation development and possible cell fate decisions. 
It has been proposed that blastomeres at the 2-cell stage are fated to contribute to the 
embryonic or abembryonic portion of the embryo (Bischoff et al., 2008). Furthermore, 
studies have suggested that 4-cell blastomeres are not equally pluripotent due to the 
manner in which 2-cell blastomeres cleave resulting in an uneven distribution of products 
across the blastomeres (Torres-Padilla et al., 2007). Our results demonstrate that SNAI1 
and SNAI2 are unevenly distributed at the 2-cell stage and the 4-cell stage, however, 
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careful analysis has demonstrated that SNAI1 and SNAI2 can be found in all blastomeres 
at the 4-cell stage regardless of blastomere position. Furthermore, SNAI1 and SNAI2 are 
expressed in all blastomeres at the uncompacted 8-cell stage and are expressed in all 
outer cells of the compacted embryo and in both the abembryonic and embryonic portions 
of the TE in the expanded blastocyst. 
This study reveals asymmetrical distribution of SNAI1 and SNAI2 as early as the 2-cell 
and 4-cell stage of preimplantation development, far earlier than previously thought. Not 
only are SNAI1 and SNAI2 asymmetrically distributed within early cleavage stage 
blastomeres but their expression is lost in the ICM coincident with cell lineage 
specification and the formation of outer and inner cell lineages in the early embryo. This 
may indicate that SNAI1 and SNAI2 may contribute to cell polarization and epithelial 
cell differentiation. Collectively, this study provides novel insight into the potential role 
of SNAI1 and SNAI2 in development and cancer metastasis. 
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CHAPTER FIVE 
 
GENERAL DISCUSSION 
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5.1 General Discussion 
The morphological events characterizing preimplantation development are well 
documented, however the molecular events governing preimplantation development must 
be further elucidated. In this thesis, I have endeavored to further elucidate the adaptive 
and developmental role that MAPK pathways play throughout preimplantation 
development.  The specific objectives were:  
Chapter 2: Determine (1) the effects of culture medium hyperosmolarity on Aqp gene 
expression and apoptosis and (2) the role of the MAPK and JNK/SAPK pathways on Aqp 
gene expression and apoptosis using pharmacological inhibitors. 
Chapter 3: Determine the effects of p38 MAPK inhibition on blastocyst cavitation and 
expansion, hatching frequency and apoptosis levels, TJ permeability, TJP1 localization 
and distribution, TE differentiation and polarization, and Aqp3 expression and AQP3 
localization.  
Chapter 4: Characterize SNAI1 and SNAI2 expression and localization throughout 
preimplantation development.  
The objective of study one was to determine how MAPK pathways governed the 
preimplantation embryo’s response to osmotic stress.  Preimplantation embryos were 
cultured in hyperosmotic media from the 8-cell stage for 3h, 6h and 24h and expression 
and localization of Aqp3 and Aqp9 were assessed.  I demonstrated that in response to 
hyperosmotic stress, Aqp3 and Aqp9 expression was elevated and AQP3 and AQP9 
localization was affected.  To determine if p38 or JNK/SAPK, two MAPK pathways that 
are activated in response to hyperosmotic stress, were affecting Aqp3 or Aqp9 expression, 
we cultured embryos in hyperosmotic media in the presence of a p38 MAPK inhibitor 
(SB 220025), or a JNK/SAPK MAPK inhibitor (SP 600125). In the presence of the p38 
MAPK inhibitor, Aqp3 and Aqp9 expression was no longer elevated in response to 
hyperosmotic media.  The JNK/SAPK inhibitor had no effect on Aqp3 and Aqp9 
expression in response to hyperosmotic media.  I then investigated whether hyperosmotic 
media induced apoptosis at the blastocyst stage. 8-cell embryos were cultured for 6h in 
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hyperosmotic media and then placed in normal osmotic media for 24h until they 
developed into blastocysts.  Apoptosis was assessed by TUNEL and Caspase 3 staining.  
Embryos cultured in hyperosmotic media demonstrate increased levels of apoptosis 
compared to control embryos.   To determine if the MAPK pathways p38 or JNK/SAPK 
contribute to the increased levels of apoptosis in response to hyperosmotic media, I 
exposed embryos to hyperosmotic media in the presence of the p38 MAPK inhibitor or 
the JNK/SAPK MAPK inhibitor.  Apoptosis levels in response to hyperosmotic stress are 
attenuated in embryos exposed to JNK/SAPK MAPK inhibitor but not in embryos that 
were p38MAPK inhibited.    
Conclusion 2.1   Aqp3 and Aqp9 expression is elevated in response to hyperosmotic 
stress.   
Conclusion 2.2 The p38 MAPK pathway, but not the JNK/SAPK MAPK pathway, 
regulates Aqp3 and Aqp9 expression in response to hyperosmotic 
stress.  
Conclusion 2.3 Hyperosmotic stress causes increased levels of apoptosis at the 
blastocyst stage. 
Conclusion 2.4  The JNK/SAPK MAPK pathway, but not the p38 MAPK pathway, 
regulates apoptosis in response to hyperosmotic stress. 
 
It has already been demonstrated that p38 MAPK is required for preimplantation 
development at the onset of compaction.  Thus, the objective of study two was to 
determine if p38 MAPK is required at a later stage of preimplantation development—
blastocyst formation.   I determined that inhibition of the p38 MAPK pathway at the early 
blastocyst stage limits blastocyst expansion and prevents blastocyst hatching.  Embryos 
cultured in p38 MAPK inhibitor were less expanded after 12h and 24h and failed to 
recover after the inhibitor was removed.  P38 MAPK inhibited embryos also failed to 
hatch.  Embryos treated with the p38 MAPK inhibitor displayed normal localization of 
CDX2 and CDH1.  p38 MAPK inhibited embryos have increased TJ permeability, 
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disrupted localization of TJP1 after 12h and 24h of treatment and reduced Aqp3 mRNA 
expression and AQP3 detection after 24h of treatment. P38 MAPK inhibited embryos 
also display higher levels of apoptosis than controls.   
Conclusion 3.1 The p38 MAPK pathway is required for embryo expansion and 
hatching. 
Conclusion 3.2 Inhibition of the p38 MAPK pathway results in increased TJ 
permeability. 
Conclusion 3.3 Inhibition of the p38 MAPK pathway results in aberrant cortical 
distribution of TJP1.  
Conclusion 3.4 Inhibition of the p38 MAPK pathway results in reduced Aqp3 
mRNA expression and AQP3 detection after 24h of treatment. 
Conclusion 3.5 Inhibition of the p38 MAPK pathway results in greater apoptosis 
after 24h of treatment.     
The objective of study three was to characterize the mRNA expression and protein 
localization of one target of p38 MAPK, Snai1, and a related family member, Snai2, 
throughout preimplantation development.  Quantitative RT-PCR and whole mount 
immunofluorescence at each stage of preimplantation development (1-cell, 2-cell, 4-cell, 
8-cell, morula and blastocyst) were applied to characterize Snai1 and Snai2 expression.  I 
demonstrated that Snai1 and Snai2 were present at each stage of embryo development 
and that Snai1 expression is elevated at the 2-cell stage, potentially indicating a role for 
Snai1 in MET.  I also demonstrated that SNAI1 and SNAI2 localization is polarized in 
the cytoplasm of individual blastomeres at the 2-cell, 4-cell and 8-cell stage, subsequently 
becoming segregated to the outer cells of the morula, with variable expression in TE cells 
at the blastocyst stage.   
Conclusion 4.1 Snai1 and Snai2 are expressed throughout preimplantation 
development. 
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Conclusion 4.2 SNAI1 and SNAI2 are expressed throughout preimplantation 
development and have a unique polarized distribution from the 2-
cell stage to the 8-cell stage. 
Conclusion 4.3 SNAI1 and SNAI2 are expressed in the outer cells of the morula 
and variable expression of SNAI1 and SNAI2 in the TE cells of the 
blastocyst could indicate a role in TE differentiation.   
I have therefore revised Figure 1.6 Proposed Model of MAPK regulation of TE 
associated proteins in response to Stress and Development and have developed a new 
model incorporating the conclusions outlined in this thesis (Figure 5.1). 
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Figure 5.1 Revised Model of MAPK Regulation of TE Associated Proteins in 
Response to Stress and Development (Figure 1.6) 
This model is a revision of the prediction based on the literature. The JNK/SAPK 
pathway regulates apoptosis in response to stress. The p38 MAPK pathway regulates 
embryonic responses to culture stress through Aqp3 and Aqp9 expression but does not 
regulate apoptosis (red ‘x’). The p38 MAPK pathway contributes to blastocyst formation 
by regulating blastocyst expansion, hatching and TJs, but does not regulate CDX2 
localization (red ‘x’).  SNAI1 and SNAI2 are detectible in the TE, however their role in 
the preimplantation embryo requires further investigation. Green arrows indicate 
transcriptional regulation; purple arrows indicate activation; red bars indicate inhibition; 
blue circles indicate nuclei.     
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5.2 SIGNIFICANCE OF RESEARCH 
The MAPK pathways are involved in many cellular processes, including those involved 
in housekeeping and stress response.  The MAPK pathways also play both a 
developmental role and an adaptive role throughout embryonic development.  My studies 
have provided new knowledge on what the developmental role and the adaptive role of 
the MAPK pathways are in the preimplantation embryo.   
5.2.1 MAPK REGULATION OF BLASTOCYST ASSOCIATED PROTEINS 
5.2.1.1 Aqp3 and Aqp9 
Blastocyst expansion is dependent on several proteins working in concert to accumulate 
fluid within the blastocyst cavity in preparation for implantation (Watson et al., 2004).  
TJ, AJ, the Na/K ATPase and the AQPs each play an important role in fluid accumulation 
within the blastocyst cavity (Watson et al., 2004). The AQPs, in particular, are present 
and functional in the preimplantation embryo and facilitate the movement of fluid across 
the TE (Barcroft et al., 2003; Offenberg et al., 2000). It was therefore important to 
elucidate the mechanism by which Aqps are regulated in the preimplantation embryo.  
My first and second study elucidated the role of p38 MAPK, in response to culture stress 
and blastocyst expansion, in regulating Aqp3 and Aqp9.  In my first study, I demonstrated 
that Aqp3 and Aqp9 expression is elevated in response to hyperosmotic stress (Bell et al., 
2009). This is consistent with other studies that demonstrate an increase in Aqp 
expression in the preimplantation embryo in response to hyperosmotic stress (Offenberg 
& Thomsen, 2005).  I then investigated how the elevated Aqp3 and Aqp9 expression was 
regulated.  Fong et al., 2007, had reported that the p38 MAPK pathway is active in 
response to hyperosmotic stress; however the downstream targets of p38 MAPK were 
still unknown.   This led me to investigate p38 MAPK as a possible regulator of Aqp3 and 
Aqp9.  My results showed that, indeed, the elevated expression of Aqp3 and Aqp9 were 
being regulated by the p38 MAPK pathway. These results are consistent with what has 
previously been reported by Arima et al., 2003 regarding the regulation of Aqp 
expression in response to hyperosmotic conditions.  Using pharmacological inhibitors for 
the conventional MAPK pathway, Arima et al., 2003 determined that the p38 MAPK 
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pathway, but not the JNK/SAPK or ERK MAPK pathways, regulated Aqp expression in 
response to hyperosmotic stress in cultured rat astrocytes  (Arima et al., 2003).  This is 
also consistent with what we have reported regarding JNK/SAPK, that this pathway does 
not regulate Aqp expression in response to hyperosmotic stress (Bell et al., 2009).  The 
ERK MAPK pathway has, however, been implicated in regulating Aqp expression in 
response to hyperosmotic stress in a rat SV40 immortalized submandibular acinar cell 
line and future studies investigating the role of the ERK pathway in cellular volume 
regulation in response to hyper- or hyposmotic stress should be conducted (Hansen & 
Galtung, 2007). In my second study, I investigated the p38 MAPK pathway during 
blastocyst cavitation.  I demonstrated that by inhibiting the p38 MAPK pathway, Aqp3 
expression, but not Aqp9 expression, is significantly reduced.  Taken together, these 
results indicate that the p38 MAPK pathway regulates Aqp3 expression in response to 
stress as well as during normal development.  This also indicates that Aqp9 is differently 
regulated than Aqp3 by the p38 MAPK pathway since it only regulated Aqp9 in response 
to culture stress and not during blastocyst cavitation.  These results have provided insight 
into the role of the p38 MAPK pathway which does indeed regulate the expression of 
Aqp3 in the blastocyst and contributes to blastocyst expansion as well as regulating the 
embryonic response to stress.  
5.2.1.2 Tight Junctions and Adherens Junctions 
In study two, I showed that inhibition of p38 MAPK pathway signaling results in 
compromised TJ permeability.  The TJ seal surrounding the outer cells of the TE is 
required to promote cavitation and maintain blastocyst expansion (Fleming et al., 1993; 
Denker & Nigam, 1998; Kim et al., 2004; Moriwaki et al., 2007).  At a significantly 
higher frequency, p38 MAPK inhibited embryos allow 40 kDa molecules to pass through 
the TJs into the blastocyst cavity compared with control embryos.  This may be due to 
aberrant localization of TJP1 along the cortical membrane.  The p38 MAPK pathway 
does regulate TJP1 in response to culture stress and this is mediated by the TF Snai1 
(Strippoli et al., 2010).  In study three, I have demonstrated that both SNAI1 and SNAI2 
are present throughout preimplantation development and are segregated to the TE.  It is 
possible that the p38 MAPK pathway regulates proteins involved in blastocyst expansion 
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through the TFs localized to the TE, SNAI1 and SNAI2. These results, along with the 
results from study one, indicate that the p38 MAPK pathway plays both an adaptive and 
developmental role in regulating fluid accumulation in the blastocyst.  
The p38 MAPK pathway is required for normal preimplantation development as 
demonstrated by Natale et al., 2005 and Paliga et al., 2006.  Inhibition of the p38 MAPK 
pathway results in a reversible, developmental arrest at the 8-cell stage.  This is primarily 
contributed to by the loss of HSP and actin cytoskeleton (Paliga et al., 2005).  Our studies 
have revealed that p38 MAPK is also required at the blastocyst stage by regulating 
blastocyst expansion and embryo hatching.  p38 MAPK inhibited embryos have reduced 
expansion compared with control embryos and do not hatch.  These results compliment 
knock-out studies that have indicated a role for p38-α during placentation. During 
development, p38-α-/- embryos arrest at embryonic day 10.5 due to placental defects 
(Adams et al., 2000).   Unlike the role p38 MAPK plays in regulating the actin 
cytoskeleton at the 8-cell stage, inhibition of the p38 pathway at the blastocyst stage in 
contrast did not affect the actin cytoskeleton (Natale et al., 2004; Paliga et al., 2005).  
Rhodamine phalloidin staining of the actin cytoskeleton remained consistent between 
control and p38 MAPK inhibited embryos.  These results highlight the different roles that 
the MAPK pathway plays during different stages of embryonic development.    This is 
especially made clear in the role that the p38 MAPK pathway plays in regulating Cdh1 
during gastrulation (Zohn et al., 2006). During gastrulation, p38 MAPK down-regulates 
Cdh1 expression resulting in normal mesoderm migration (Zohn et al., 2006).  Loss of 
p38 MAPK signaling results in misexpression of Cdh1 leading to gastrulation defects 
(Zohn et al., 2006). Inhibition of p38 MAPK during blastocyst formation, however, did 
not affect Cdh1 localization.   
In my first study, embryos were treated for 24h in the presence of the p38 MAPK 
inhibitor SB 220025.  However, embryos were treated from the 8-cell stage and allowed 
to cavitate and progress to the blastocyst stage for 24h. Therefore, unlike my second 
study, where embryos were treated at the blastocyst stage and allowed to cavitate for 24h, 
embryos treated in my first study would not have yet been mature enough to hatch.  I 
therefore did not observe a hatching defect in embryos cultured in KSOMaa + SB 220025 
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in my first study.  This does reveal an important limitation of my studies.  Using the 
formation of a blastocyst as a metric for embryo health does not necessarily indicate 
future embryo health, potential for implantation, ability to maintain a successful 
pregnancy or produce healthy offspring at the time of birth or later into adulthood.  These 
results however do provide greater insight into the mechanisms available to the embryo in 
responding to changes in culture stress and environment during blastocyst formation.   
5.2.2 MAPK REGULATION OF APOPTOSIS 
I have demonstrated that 8-cell embryos exposed for 6h to hyperosmotic stress display 
increased levels of apoptosis at the blastocyst stage compared to controls.  This is 
consistent with what has been reported by Xie et al. 2007, regarding embryos cultured in 
hyperosmotic media at the blastocyst stage.  Xie et al. 2007, cultured embryos in 
hyperosmotic KSOMaa media and demonstrated that the JNK/SAPK pathway was 
activated in response to hyperosmotic media.  Furthermore, culture in hyperosmotic 
media in the presence of the JNK/SAPK inhibitor prevented increased apoptosis (Xie et 
al., 2007). Our studies also demonstrated that the JNK/SAPK MAPK pathway regulated 
apoptosis in response to hyperosmotic stress in the preimplantation embryo.  Embryos 
cultured in the presence of hyperosmotic stress and JNK/SAPK inhibitor do not display 
any apoptotic nuclei compared with embryos treated by hyperosmotic stress alone (Bell 
et al., 2009). This is consistent with the role JNK/SAPK plays many different tissue types 
in response to hyperosmotic stress (Chen et al., 2008; Xie et al., 2006; Xie et al., 2007; 
Zhong et al., 2004). 
Alternatively, the p38 MAPK pathway does not regulate apoptosis in response to 
hyperosmotic stress.  Embryos exposed to hyperosmotic stress in the presence of a p38 
MAPK inhibitor displayed the same level of apoptosis as embryos cultured in 
hyperosmotic medium alone (Bell et al., 2009).  Xie et al., 2006 also reported that 
embryos cultured in KSOMaa in the presence of a JNK/SAPK inhibitor developed faster 
and demonstrated reduced apoptotic levels compared to control embryos cultured in 
KSOMaa alone (Xie et al., 2006; Xie et al., 2007).   However, our studies revealed that 
the JNK/SAPK MAPK and the p38 MAPK pathway did not play a role in basal levels of 
apoptosis at this stage of development.  Embryos cultured in KSOMaa in the presence of 
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the p38 MAPK or the JNK/SAPK inhibitor display the same levels of apoptosis as 
embryos cultured in KSOMaa alone (Bell et al., 2009).  Individual knock-out mice of 
each member of the JNK/SAPK pathway are viable and demonstrate few deformities 
(reviewed in Aouadi et al., 2006) .  However, double knock-out mice of JNK1 and JNK2 
are embryonic lethal and arrest at embryonic stage 11 due to malformation in the neural 
tube and reduced apoptosis in the hind brain indicating a developmental regulation of 
apoptosis by the JNK/SAPK MAPK pathway (reviewed in Aouadi et al., 2006). In study 
two, we demonstrate that inhibition of the p38 MAPK pathway results in increased 
apoptosis, where embryos cultured for 24h in the presence of a p38 inhibitor demonstrate 
increased apoptosis compared to embryos cultured in KSOMaa or SB 202474 alone.  
However, the interpretation of this result is that prolonged inhibition of p38 MAPK 
activity results in a considerable stress response by the embryo that extends well beyond 
the adaptive capacity of the embryo and therefore triggers apoptotic pathways.  My 
hypothesis is that the p38 MAPK pathway is not playing a role in regulating apoptosis 
directly; however inhibiting the p38 MAPK pathway causes stress and apoptosis results.  
This is consistent with our results from study one where p38 MAPK did not affect 
apoptosis levels in hyperosmotic embryos (Bell et al., 2009).    
These results highlight the important differences between the adaptive and developmental 
roles that the MAPK pathways play throughout embryogenesis. Knock-out studies 
demonstrate the developmental role that the MAPK play throughout gestation; however 
they do not necessarily provide insight into the adaptive role these pathways play in 
response to environmental factors.  Further study into the adaptive roles of the MAPK 
pathways throughout gestation is warranted.   
My studies have therefore added to the growing body of knowledge investigating the 
molecular mechanisms that regulate blastocyst formation.   
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5.3 Future Studies 
My studies have revealed a distinct role for the p38 MAPK pathway at the blastocyst 
stage from the 8-16 cell stage of preimplantation development.  These results reiterate 
that the MAPK pathways play unique roles within specific tissues and at certain points 
throughout development.  A detailed analysis of the role of the ERK pathway and the 
JNK/SAPK pathway should be undertaken at each cleavage stage of development and the 
blastocyst stage.   
Additionally, the protein localization of SNAI1 and SNAI2 is very exciting at each stage 
of preimplantation development.  Asymmetrical expression of a protein in the cytosol as 
early as the 2-cell stage has not been previously reported and leads to many questions 
such as: Why are these TFs being produced and sequestered to the cytoplasm?  Do these 
TFs retain their localization from the 2-cell stage throughout subsequent cleavages?  
What could Snai1 and Snai2 be doing in the embryo? Do they play a role in TE 
differentiation? These questions are important future directions to elucidate the 
mechanisms the embryo utilizes to determine which blastomere will contribute to the TE 
versus the ICM.   
 5.4 Summary 
The preimplantation embryo represents the most vulnerable period of embryonic loss 
throughout pregnancy.  It is therefore imperative that we elucidate the mechanisms 
involved in regulated preimplantation embryonic response to stress and mechanisms that 
govern development.  The MAPK pathways are involved in both responding to 
environmental stress and regulating development throughout embryogenesis.  Therefore 
the MAPKs are good candidates to study in order to elucidate the mechanisms involved 
in preimplantation embryonic adaptation to stress and development.  I have demonstrated 
that the p38 MAPK plays an integral role in the preimplantation embryo by regulating 
blastocyst formation family genes in response to stress and during blastocyst cavitation.  I 
have also demonstrated that two TFs, Snai1 and Snai2, which are downstream targets of 
the p38 MAPK pathway, are present throughout preimplantation development.  SNAI1 
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and SNAI2 also have a unique asymmetric distribution pattern from the 2-cell to 8-cell 
stage, and are then segregated to the TE of the blastocyst.  These results suggest that 
SNAI1 and SNAI2 may be involved in TE differentiation or regulation.  Taken together, 
these results have further elucidated the role for the p38 MAPK pathway in the 
preimplantation embryo and have revealed an exciting new set of TFs that are associated 
with the TE.   
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APPENDIX A 
 
 
Supplemental Figures From: 
P38 MAPK Regulates Cavitation and Tight Junction Function in the Mouse 
Blastocyst 
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Supplemental Figure 1: Method of Measuring Blastocyst Expansion 
Embryo diameters were measured for dose response and recovery experiments. Embryos 
were measured in two different directions and then the measurement was averaged. 
Volume was then calculated based on the calculated radius.    
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Supplemental Figure 2: Timeline of Experiments 
Timeline for embryo collection, treatment time, and recovery time for all experiments. 
Embryos were collected at 89h post hCG and cultured for 12h or 24h.  Embryos were 
imaged and measured at 0h, 4h, 8h, 12h, and 24h post hCG, and again following 
recovery, at 24h, 28h and 36h post hCG.  Embryos were collected at 12h or 24h and 
either analyzed for RT-PCR, FITC assay, TUNEL assay or immunofluorescence or 
placed into fresh culture drops and allowed to recover.  Hatching was assessed at 24h 
post hCG.   
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Supplemental Figure 3: Representative Images of Blastocyst Expansion 
Representative images of embryos from each treatment group at each time point during 
the concentration response experiment. Scale bar = 20 microns. 
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Supplemental Figure 4: Representative Images of Blastocyst Expansion During 
Recovery 
Representative images of embryos from each treatment group at each time point during 
the recovery experiment. Scale bar = 20 microns. 
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Supplemental Figure 5: Embryo Expansion After SB203580 Treatment 
Embryos were cultured for 24 h in control media (KSOMaa and SB 202474) or in 
KSOMaa + SB 203580 and imaged at 0 h, 12 h, and 24 h of treatment.  The diameter of 
each embryo was measured as described in Supplemental Figure 1 and volume was 
calculated from the radius. After 24 h embryos cultured in SB 203580 were significantly 
less expanded than controls. Three replicates were performed and 15-20 embryos were 
measured in each group. SEM; p≤0.05. 
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Supplemental Figure 6: ERK and Phospho ERK Expression in p38 MAPK 
Inhibited Embryos 
Total-ERK and phospho–ERK protein following treatment with KSOMaa, SB 202474, or 
SB 220025 using immunofluorescence. Representative images of total-ERK after 24 h of 
treatment  KSOMaa (A), SB 202474 (B) or SB 220025 (C) and phospho-ERK after 24 h 
of treatment  KSOMaa (D), SB 202474 (E) or SB 220025 (F). There was no visible 
difference between total-ERK or phospho-ERK between the treatment groups.  Green = 
total-ERK (A-C); Green = phosphor-ERK (D-F); No primary (G) n=10-15 embryos in 
each group; scale bar = 10 microns.  
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Supplemental Figure 7: Quantitative RT-PCR Primer Sets 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Real-time primer sets
Ocludin 5' AAATTAGCTCATACTCGTTGATAG
Ocludin 3' CAAGAATATGTACTGCCATGTC
ZO-1 5' AGATCCTGAGCCGGTGTCTG
ZO-1 3' TCCTCTCCCTGCTTGCACTC
Atp1b1 5' GCCTACGTGCTAAACATCATCAG
Atp1b1 3' GATTGATGTCGCCCCGTTCC
Gapdh 5' CAACGACCCCTTCATTGACCT
Gapdh 3' ATCCACGACCGACACATTGG
194 
 
 
 
APPENDIX B 
 
Supplemental Figures from: 
SNAI1 and SNAI2 Are Asymmetrically Expressed at the 2-Cell Stage and Become 
Segregated to the TE in the Mouse Blastocyst 
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Supplemental Figure 1: Antisera Validation in Preimplantation Embryos 
Antisera validation in preimplantation embryos. (A and B) Antibody pre-absorption 
assays revealed the specificity of the SNAI1 (A) and SNAI2 (B) antisera. Embryos 
incubated in antisera pre-absorbed with SNAI1 or SNAI2 peptide displayed comparable 
levels of SNAI1 or SNAI2 expression with negative controls. (C and D) Negative siRNA 
or siRNA targeting Snai1 or Snai2 was microinjected into 1-cell embryos. Whole-mount 
immunofluorescence was applied detecting SNAI1 (C) and SNAI2 (D) in control and 
knock-down embryos. SNAI1 (C) and SNAI2 (D) expression was significantly down 
regulated in the embryos that were microinjected with siRNA targeted to Snai1 or Snai2. 
 
 
 
 
 
 
 
 
196 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pre-absorbed 
SNAI1 AB
using a 
SNAI1 peptide 
8-cell2-cell
Pre-absorbed 
SNAI2 AB
using  a 
SNAI2 peptide 
+ve Control
Blastocyst2-cell +ve Control
No primary control
A) 
C) 
B) 
D) 
Snai2 siRNA injected 
Negative siRNA 
Control Injected
S
N
A
I2
 e
x
p
re
s
s
io
n
Negative siRNA 
Control Injected Snai1 siRNA Injected
S
N
A
I1
 e
x
p
re
s
s
io
n
197 
 
 
 
Supplemental Figure 2: Antisera Validation in NIH 3T3 cells 
Antisera validation in NIH3T3 cells. (A and B) SNAI1 and SNAI2 antibodies were used 
to detect SNAI1 (A) and SNAI2 (B) in NIH3T3 cells (C- no primary control). This 
experiment revealed that these antisera replicated the published localization pattern of 
SNAI1 and SNAI2 in NIH3T3 cells. (D) Western Blot analysis was performed to 
determine the specificity of the antisera. Single protein bands for both SNAI1 and SNAI2 
were detected at the expected molecular weight for each protein. Protein bands were no 
longer detected when membranes were incubated in pre-absorbed SNAI1 and SNAI2 
antisera. Red = Filamentous Actin; Blue = Nuclei; Green = SNAI1 or SNAI2. Scale bars 
= 10 microns.  
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Supplemental figure 4: 
Diagrammatic representation of SNAI1 localization throughout preimplantation 
development. 
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Supplemental figure 5: 
Diagrammatic representation of SNAI2 localization throughout preimplantation 
development.  
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